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IABSTRACT
Oxidative stress is a feature of many chronic diseases. Two approaches proposed to 
reduce the risk of disease include regular exercise and consumption of a diet rich in fruit 
and vegetables, as both behaviours can improve the antioxidant defence system and 
thereby attenuate oxidative stress. In particular, recent evidence has demonstrated a 
reduced risk of certain diseases with increased consumption of tomato products, in which 
the carotenoid lycopene is the principal antioxidant. The research reported in this thesis 
was conducted in two stages; firstly, two models of oxidative stress were characterised 
prior to progression on to stage two, where the research aimed to investigate the impact 
of lycopene supplementation on modulation of haem oxygenase-1 (HO-1) expression in 
response to oxidative stress.
Expression of the oxidant-responsive enzyme HO-1 is the most appropriate candidate 
gene to assess oxidative stress in vivo. In the first model of oxidative stress employed in 
the present thesis, both prolonged and intermittent running increased HO-1 mRNA 
expression in human mononuclear cells, although considerable inter-individual variation 
in the HO-1 response to exercise was evident. A second model was therefore developed 
to further explore the cellular response to oxidative stress using hydrogen peroxide 
(H2O2) treatment of freshly harvested lymphocytes and monocytes ex vivo. The HO-1 
protein response to H2O2 was a reproducible response and was used as a subsequent 
stressor following an acute bout of exercise. In this investigation, increased lymphocyte 
HO-1 mRNA 2 h post-exercise was associated with a reduced induction o f HO-1 protein 
in the ex vivo model, possibly indicating an adaptive response to prior exercise.
The second part of the research reported in this thesis demonstrates that tomato 
supplementation significantly increased plasma lycopene levels. However, the basal and 
induced level of HO-1 protein was not altered with supplementation. Furthermore, cell 
viability following H2O2 treatment did not differ with supplementation although the basal 
level of apoptosis was significantly lower in lymphocytes following tomato 
supplementation. As the basal and induced level of HO-1 protein was not modulated by 
tomato supplementation, it would appear that the reduction in lymphocyte apoptosis is 
mediated by some non-oxidative mechanism of lycopene. The objectively determined 
physical activity level of the subjects used in this investigation was high and it is possible 
this may have affected the response to the intervention. As 60% of the global population 
is inactive, it is possible that future work should examine the effect of tomato 
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1CHAPTER 1
INTRODUCTION
1.1 Exercise and physical activity
The terms ‘exercise’ and ‘physical activity’ may be understood differently by different 
people (Booth, 2000) and, therefore, a distinction between physical activity and exercise 
should be made. Physical activity is defined as ‘bodily movement, produced by the 
contraction of muscle, substantially increasing energy expenditure’ (DHHS, 1996), 
whereas exercise is the ‘planned structured and repetitive bodily movement done to 
promote or maintain components of physical fitness’ (IOM, 2002). In the present thesis, 
these terms will generally be used interchangeably as many authors use both exercise 
and physical activity without distinguishing any differences.
1.1.1 Relationship between regular exercise and disease
Physical activity beneficially affects the body in a multi-factorial manner and is 
suggested to be responsible for the prevention of many chronic diseases (Booth et al., 
2000; Booth et al., 2002). A wealth of evidence has revealed that regular physical 
activity is related to the reduced incidence o f many chronic conditions such as 
cardiovascular disease (CVD), obesity, type 2 diabetes, certain cancers, and osteoporosis 
(McCarter, 2000; DoH, 2004). Worldwide, physical inactivity is estimated to cause 
approximately 1.9 million deaths annually, accounting for 23% of all cases of CVD, 16- 
17% of colon cancer, 15% of diabetes, 12-13% of strokes and 11% of breast cancer 
(WHO, 2002). In the UK, the prevalence of inactivity is increasing with two separate 
surveys reporting approximately two thirds of men and three quarters of women aged 
over 16 years participate in less than 30 min of moderate intensity activity on five or 
more days of the week (Stamatakis, 2003; Office for National Statistics, 2004). 
Furthermore, the Global Burden of Disease Study puts physical inactivity among the top 
ten risk factors that threaten global health (Murray and Lopez, 1996). People who are 
physically active reduce the risk of developing CVD, stroke and type 2 diabetes by up to 
50% and the risk of premature death by 20-30% (DoH, 2004). It is recognised that 
regular physical activity is an important component o f lifestyle and this has resulted in 
the development of exercise guidelines that aim to reduce the prevalence of chronic 
disease. However, there are numerous different public health recommendations and the
2minimum frequency, duration and intensity of exercise required for good health still 
remains unclear (Blair et al., 2004).
1.1.2 Exercise Recommendations
In the mid 1990s, reports on physical activity and health recommendations were 
established by the US Centers for Disease Control and Prevention (CDC) and the 
American College of Sports Medicine (ACSM) which were supported by the US 
Surgeon General’s Report (1996). It was recommended that ‘every US adult should 
accumulate 30 min or more of moderate-intensity physical activity on most, preferably 
all days of the w eek...’ (DHHS, 1996). Individuals already meeting the basic 
recommendations were advised they could gain additional health benefits by doing more 
exercise, perhaps including higher intensity activities (DHHS, 1996). These guidelines 
were directed at reducing the public health burden of disease and therefore it was 
necessary that the prescribed amount of physical activity was seen as achievable. More 
recently, the Institute of Medicine (IOM) suggested that ‘...to  prevent weight gain, as 
well as to accrue additional, weight-independent health benefits of physical activity, 60 
min of moderate intensity physical activity is recommended....’ (IOM, 2002). The 
current exercise recommendation of 30 min of moderate exercise a day is not met by at 
least 60% of the global population (WHO, 2002).
The health benefits gained from regular exercise participation have been classified by 
level of physical activity (Table 1.1). From this, it has been suggested that a level of 
light activity is better than inactivity, although progression to levels three and four 
provides superior protection against chronic diseases. The different levels of activity 
have been classified using metabolic equivalents (METS). This is a unit expressed as 
multiples of an individual’s resting oxygen (O2) uptake, with one MET defined as a rate 
of O2 consumption of 3.5 m l.kg .'W n.'1, equivalent to the resting metabolic rate (RMR) 
obtained whilst sitting. The joint CDC-ACSM position statement identified three 
different intensity categories for physical activity (light: < 3 METS, moderate: 3-6 
METS, vigorous: > 6  METS) (Pate et al., 1995). In addition, a reference database of 
activities deemed to be of low, moderate, and vigorous intensity according to the energy 
expended in METS has been developed, generating a compendium of physical activities 
(Ainsworth et al., 2000).
Table 1.1 Levels of physical activity according to recommendations
Level Descriptor METS Typical activity pattern Health benefits
1 Inactive 1
Drives/ Public transport 
Sedentary job 
Minimal household activities 
No active recreation
Nil
2 Lightly active < 3
May walk/cycle 
Walking, lifting, carrying as part of work 
Some light intensity recreation




Regular active commuting 
Regular work-related physical tasks 
Regular moderately active recreation
High level o f protection
4 Very active > 6
Regular active commuting 
Very active job 
Vigorous intensity sport
Maximal protection against chronic disease 
Slight increase in risk o f injury
5 Highly active > 6 Performs high volumes o f vigorous or very vigorous 
fitness training, often in order to play sport
Maximal protection against chronic disease 
Increased risk o f injury
METS have been added as a guide to show the relative intensity of activity performed at each descriptor, and are not intended to indicate that all 
activities at each level will be between these ranges. (Adapted from ‘At least five a week’ Department o f Health, The Chief Medical Officer,
2004).
u>
4The doubly labelled water method (DLW) is generally held to be the criterion standard 
for estimating energy expenditure (Schoeller, 1999; Ainslie et al., 2003). This method is 
relatively non-invasive and allows quantification of total energy expenditure over a 
prolonged period of time. As a result, a large number of studies have investigated 
physical activity using this technique and this has led to the development of a database 
enabling comparisons between individuals of different age groups and body mass to be 
made (IOM, 2002).
A limitation of the doubly labelled water method is that it only estimates total energy 
expenditure. Once an estimate of resting energy has been made it is possible to estimate 
energy expenditure above rest although it is impossible to quantify the intensity, 
duration or frequency of physical activity (Ainslie et al., 2003). Measurement of these 
subcomponents of physical activity energy expenditure will enable investigators to 
establish whether individuals are meeting exercise recommendations and therefore 
improve understanding o f the relationship between physical activity and health. Motion 
sensors have been developed and provide a crude index of physical activity intensity 
although this too has its limitations (Ainslie et al., 2003). A new device has been 
designed to assess physical activity in populations and uses a combined motion sensor 
and heart rate monitor to predict energy expenditure from physical activity (Brage et a l ,
2005). This has been validated and has been shown to be a reliable method of assessing 
physical activity (Brage et a l , 2005). Consequently, this type of device may improve the 
understanding of the dose-response relationship between physical activity and health 
(Ainslie et a l, 2003).
1.1.3 Adaptations to regular exercise
Physical inactivity potentiates at least 20 unhealthy conditions (Booth et a l,  2002). 
Appropriately performed physical activity has been termed a ‘magic bullet’ as a result of 
its ability to positively impact so many risk factors for chronic disease (Booth et a l,
2000). The positive effect gained from exercise is a consequence of the many 
adaptations to regular exercise, which can reduce the risk of virtually all chronic 
diseases simultaneously (Booth et a l, 2000). However, the responses to an acute bout of 
exercise are quite different to the responses to regular exercise (Figure 1.1).
Acute exercise is accompanied by biochemical changes including oxidative stress 
(Section 1.2 and 1.4). This condition is associated with the pathology of many chronic 
diseases and oxidative stress is generally considered to be a harmful and unwanted 
event. This has led to acute physical exercise being employed as a model for studying
5the responses of physiological regulatory mechanisms (Sen, 2001b). Ostensibly, a 
transient increase in oxidative stress might initially appear to contradict the well- 
documented protective effect of regular exercise. However, this points towards the 
classical physiological concept of hormesis, which was fittingly described by Finkel and 
Holbrook (2000) in a recent review for Nature as ‘what won’t kill you will make you 
strong’. These authors proposed that the anti-ageing benefits of regular exercise are 
mediated by the adaptive response to regular episodes of exercise-induced oxidative 
stress.
The adaptations to regular exercise are associated with improved health and include 
changes to the musculoskeletal, cardiovascular, respiratory, immune and endocrine 
systems (Fentem, 1992). The magnitude of these changes will vary depending on the 
duration, intensity and mode of exercise, which is why it is important to be able to 
quantify these subcomponents of physical activity. Long term exercise training is 
associated with improved antioxidant defence systems in tissue such as skeletal muscle 
and erythrocytes (Powers et a l , 1999; Miyazaki et a l , 2001) and this has been reported 
to lower resting markers of oxidative stress (Niess et a l , 1999b; Vincent et a l ,  1999; 
Miyazaki et a l,  2001).
Although the adoption o f an active lifestyle leads to a reduction in the risk of chronic 
diseases it is possible that under certain conditions exhaustive exercise may be 
detrimental to health. In even the most well trained and therefore well adapted 
individuals an acute bout of demanding exercise leads to damage to lipids, proteins and 
DNA (Mastaloudis et a l, 2001; Tsai et a l,  2001; Fehrenbach et a l ,  2003b; Nieman et 
a l,  2003). This is associated with an acute inflammatory response and protracted 
immuno-suppression (Nieman and Pedersen, 1999; Pedersen and Hoffman-Goetz,
2000). Because of these changes it has been proposed that very active individuals 
should consider prophylactic intervention to avoid these potentially unwanted side 
effects of exercise. For example, it may be appropriate to consume antioxidant 
supplements to enhance the antioxidant defence system, since the changes derived from 
regular exercise training may not be enough to suppress exercise-induced oxidative 
stress (Sen, 1995; Ashton et a l, 1998). Furthermore, this may also be very important for 
people who exercise infrequently as they are unlikely to be adapted to the demands of 
the activity and may be at even greater risk of exercise-induced oxidative stress 
(Davison et a l,  2002; Vincent et a l, 2005). In these situations, the use of nutritional 
therapies designed to reduce oxidative stress may be of direct benefit. In addition, it is 
noteworthy that it is only through intervention with specific nutrients that it will be
6possible to determine whether a particular nutrient has a particular role and whether 
intervention is justified for the long-term maintenance of health.
This thesis will explore these possibilities in humans. The initial investigations that are 
reported examine the responses to exercise-induced oxidative stress in mononuclear 
cells following prolonged running. Subsequent work characterises the responses to an 
exogenous oxidant challenge; prior to using these two approaches in combination to 
determine whether an acute bout of exercise modifies the response to an exogenous 
oxidative challenge. These studies were designed to develop an appropriate model for 
the final experiment - where nutritional modulation of the responses to oxidative stress 
was investigated using a potentially important carotenoid (lycopene).
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Figure 1.1 Responses to acute exercise and oxidative stress. The pathway on the left 
represents the response to a moderate bout of exercise and is beneficial. In contrast, a 
prolonged and intense period of exercise can cause excessive free radical production and 
may have negative consequences for tissues.
81.2 Oxidative stress
Oxygen is essential for the survival of aerobic organisms, although too much oxygen 
results in toxicity (Halliwell and Gutteridge, 1999). Aerobic organisms produce reactive 
oxygen species (ROS) during normal respiration and inflammation and are important 
regulators of cell function. Reactive oxygen species is the collective term for oxygen 
derived and non-oxygen derived free radicals (Section 1.2.1). The body is equipped with 
an elaborate defence system providing protection against free radical production since 
an increase in radical formation can cause an imbalance of the redox state of the cell, 
causing a situation known as ‘oxidative stress.’ Sies (1991) defined this as ‘a 
disturbance of the pro-oxidant-antioxidant balance in favour o f the former leading to 
potential damage.’ In principal, molecules such as lipids, protein and DNA are 
susceptible to this ‘potential damage.’
1.2.1 Free radical production
A free radical is an atom, group of atoms or molecule in a particular state, with one 
unpaired electron occupying the outer orbital (Del Maestro, 1980). This feature 
contributes to the very unusual chemical reactivity and physical characteristics of free 
radicals, allowing them to participate in chain reactions (Jenkins, 1988), initiating 
damage to DNA, lipids and proteins. Molecular oxygen is an example of a biradical, a 
species containing two unpaired electrons in its outer orbital. The reduction of O2 to 
water requires four electrons which can occur by the tetravalent reduction of O2 to water 
with cytochrome oxidase as the final catalyst, or by the univalent pathway. The main 
difference in these two processes is the highly reactive intermediate oxygen species 
which are produced by the four stage univalent reduction to water (Figure 1.2).











Figure 1.2 The univalent reduction of oxygen to water. (Source: Del Maestro, 1980).
9From Figure 1.2, the univalent reduction of molecular oxygen produces superoxide 
(O2*’) (1), hydrogen peroxide (H2O2) (2 ), and the hydroxyl radical (OH’) (3), before 
producing water (H2O) (4). Superoxide and H2O2 are relatively non-toxic and can be 
regulated by enzymatic mechanisms present in the cellular environment, although they 
can also react with one another to form highly reactive OH’ [Equations 1.1]. In addition, 
OH* and 0 2 *’ can also be generated through interaction with transition metals in the 
Haber-Weiss reactions [Equations 1.2-1.4].
O2 ’ + H2O2 —> 0 2  + OH' + OH’ [Equation 1.1]
OH’ + H2O2 —> H2O + O2*' + H+ [Equation 1.2]
Fe2+ + H20 2 -> OH- + OH' + Fe3+ [Equation 1.3]
Fe2++ O2 —»Fe3++O2 ' [Equation 1.4]
Hydrogen peroxide is a non-oxygen derived radical and is a weak oxidising agent, 
however, it crosses membranes readily and can extend the cellular damage through its 
involvement in the formation of OH* which oxidises lipids, proteins and nucleic acids. 
Other non-oxygen derived radicals include hypochlorous acid (H0C1), singlet oxygen 
( ^ 2) and ozone (O3). The superoxide radical, hydroxyl radical, peroxyl radicals (ROO*) 
and alkoxyl radicals (RO*) form the oxygen-centred radicals. Free radicals are generated 
as a consequence of normal metabolism and are essential for the maintenance of cellular 
function. Superoxide is the precursor of most ROS and therefore the potential sites at 
which O2'’ is produced will be reviewed.
1.2.2 Mitochondrial electron transport
The main function of mitochondria is energy production (Leeuwenburgh and Heinecke,
2001). Under normal physiological conditions, approximately 95% of oxygen 
consumption is reduced to water, with 2-5% forming 0 2 *’ (Ames et al., 1995). This 
production of O2*' is described as a ‘leak’ with at least two sites in the electron transport 
chain identified; NADH-ubiquinone reductase (complex 1) and ubiquinone-cytochrome 
c reductase (complex 3) (Chance et al., 1979). Fortunately, the mitochondrial 
membranes posses a well developed scavenger system to protect against free radical 
reactions (Section 1.7).
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At rest (State 4 respiration), low rates of O2 are consumed as the metabolic demands of 
the body are low. During this state, approximately 1-5% of the O2 consumed produces 
reactive oxygen intermediates (Boveris and Chance, 1973). Resting O2 consumption 
utilises approximately 3.5 ml.kg^.min ' 1 and, assuming only 1% of this O2 is converted to 
O2*' in the mitochondria, it is estimated that approximately 0.147 mole O2'" and 0.074 
mole H2O2 are produced per day in state 4 respiration (Leeuwenburgh and Heinecke,
2001). In comparison, an increase in O2 consumption causes the rate of oxidative 
phosphorylation to be high (State 3-ADP stimulated). The rate of leakage from lung 
mitochondria was found to increase proportionately to the increase in oxygen tension 
associated with hyperoxia, translating into an increase in O2*' formation (Halliwell and 
Gutteridge, 1999). It is generally assumed that an increase in oxygen consumption 
results in an increase in the production of ROS, and this is the suggested mechanism for 
the production of free radicals during exercise (Ji, 1999).
Oxygen consumption during exercise can increase 15 to 20-fold above resting levels (Ji, 
1999) when the increase at the muscle level will be in the region of 100 to 200-fold 
(Sen, 1995; Halliwell and Gutteridge, 1999). Therefore, following the assumption that 
the percentage o f oxygen produced as 0 2 *' remains the same, this would result in a 
proportionate increase in free radical production. However, this hypothesis was 
challenged by Chance and colleagues (1979), who demonstrated ROS production rate in 
isolated mitochondria in state 3 respiration (for example, exercise) is actually lower than 
state 4 (rest). Heavy exercise is not equivalent to state 3 respiration and is associated 
with increased free radical production and oxidative stress. Therefore, the mitochondrial 
electron chain is not the only mechanism for increased ROS production during exercise. 
For example, ROS production can occur as a consequence of inner membrane damage 
(Davies et al., 1982). Furthermore, during very intense exercise, the xanthine oxidase 
system can be employed increasing ROS production. However, the mitochondrial 
electron transport chain is the main producer o f O2’’ in vivo (Halliwell and Gutteridge,
1999), and this is indirectly supported by the training adaptations to mitochondrial 
antioxidant enzymes (Powers et al., 1999) (Section 1.7).
1.2.3 Xanthine Oxidase
In situations where the rate of adenosine triphosphate (ATP) synthesis does not match 
the rate of ATP hydrolysis, the consequence is an insufficient availability of 
mitochondrial-derived ATP. This environment favours the activation of the xanthine 
oxidase pathway (Hellsten, 2000), which is particularly important in ROS generation in 
ischaemia and reperfused (I-R) cardiac muscle. When a tissue has a high energy
11
demand, for example during demanding exercise, ATP utilisation exceeds the rate of 
ATP regeneration. An accumulation of adenosine diphosphate (ADP) is prevented 
through the adenylate kinase reaction leading to the formation of ATP and adenosine 
monophosphate (AMP) from 2ADP. An increase in AMP leads to the activation of 
AMP deaminase forming inosine monophosphate (IMP) which is catabolised to 
hypoxanthine (HX), the substrate for xanthine dehydrogenase (XDH). This enzyme is 
found in the capillary endothelium of most tissues and exists in two forms, the XDH and 
the oxidase form (XO). In certain conditions, XDH is converted to XO by intracellular 
proteases activated by calcium ions in an irreversible reaction. Both enzymes participate 
in the purine degradation pathway oxidizing two reactions, HX to xanthine and xanthine 
to urate (UA), however, they utilise different electron acceptors. As XDH requires 
NAD+ and XO requires molecular oxygen, O2*’ formation only occurs in the XO 
catalysed reaction. In the XDH conversion no reactive intermediates are generated. 
Several inflammatory conditions activate xanthine oxidase, including atherosclerosis, 
rheumatic diseases and influenza (Hellsten, 2000).
A positive relationship between the peak HX concentration and change in urate of 
plasma following high-intensity exhaustive cycling has been demonstrated with the 
muscle the main source of plasma HX (Hellsten-Westing et al., 1994). Similarly the 
xanthine oxidase pathway is activated in maximal intensity intermittent treadmill 
sprinting (Balsom et al., 1992). In comparison, moderate intensity exercise leads to a 
low release of HX from muscle and therefore it is less likely that HX will accumulate in 
the plasma for conversion to urate (Hellsten, 1994).
1.2.4 Phagocytosis
Phagocytosis is a response to acute inflammation initiated by the migration of a variety 
of leukocytes to the site of injury (Conner and Grisham, 1996). Chemotactic factors 
released by the damaged cells attract neutrophils where they function to destroy 
invading pathogens. Neutrophils contain NADPH oxidase and myeloperoxidase which 
generate 0 2 *’, H2O2 and HOC1. Resting neutrophils use little oxygen as they have rich 
stores of glycogen and can produce ATP via glycolysis. However, when neutrophils 
phagocytose they require a marked increase in oxygen uptake. The increased oxygen 
uptake can be 1 0 -2 0  times the ‘resting’ oxygen consumption and this is known as the 
‘respiratory burst’ (Babior, 1997). The increased oxygen uptake activates an enzyme 
complex on the plasma membrane which in turn activates the NADPH oxidase complex. 
This complex contains NADPH oxidase, FAD and a 6 -type cytochrome located in the 
plasma inner membrane. Activation of the complex operates an electron transport chain
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oxidizing NADPH in the cytosol to NADP+ releasing two electrons that consequently 
reduce molecular oxygen to form O2*' (Cannon and Blumberg, 2000) [Equation 1.5] 
(Figure 1.3).
2 reduced
oxidised FADNADPH cytochrome b
[ /  \ ]  2 oxidised
reduced FADNADP
cytochrome b
Figure 1.3 The electron transport chain within the NADPH oxidase complex. 
(Source: Halliwell and Gutteridge, 1999).
Dismutation of O2*’ forms H2O2 , which is capable of crossing membranes. Hydrogen 
peroxide is toxic to bacteria, therefore causing damage directly or it can react with free 
iron to form OH*. Furthermore, HOC1 is generated from O2*' in the presence of the 
enzyme myeloperoxidase (Weiss et al., 1985) and can also be used to form OH* 
[Equation 1.6].
NADPH + 2 0 2 -+ NADP+ + H+ + 2 0 2*' [Equation 1.5]
0 2*' + HOC1 -> 0 2 + OH* +Cr [Equation 1.6]
The function of phagocytes is critical in the removal of damaged tissue and prevention
of bacterial and viral infection. However the cocktail o f reactive species generated can
also damage healthy tissue, oxidizing lipids, proteins, and DNA (Halliwell and 
Gutteridge, 1999). In addition, phagocyte-derived ROS may amplify inflammation via 
the up-regulation of genes involved in the inflammatory response, initiating the release 
of pro-inflammatory cytokines (Conner and Grisham, 1996) further augmenting free 
radical production and hence the resulting oxidative damage.
The inducible form of nitric oxide synthases (iNOS) is present in neutrophils, 
monocytes and T-lymphocytes (Lincoln et al., 1997). Two other forms of NOS exist; 
neuronal NOS (nNOS) and endothelial NOS (eNOS). Certain cytokines can induce 
iNOS converting the amino acid L-arginine into nitric oxide (NO*). Superoxide reacts 
rapidly with NO* forming peroxynitrite (ONOO'), a potent oxidising and nitrating
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intermediate (Equation 1.7). Peroxynitrite can be decomposed forming peroxynitrous 
acid (ONOOH) and other end products such as nitrogen dioxide radicals (NO2*) and OH’ 
which damage tissue (Equation 1.8).
0 2"  + NO* -*  ONOO' [Equation 1.7]
ONOOH -»  N 0 2* + OH* [Equation 1.8 ]
Nitric oxide has been implicated in multiple physiological processes including the 
regulation of blood pressure, inhibition of platelet aggregation, neurotransmission and 
lung vasodilation. However, excess production of NO’ may cause cellular injury often 
resulting from the action of iNOS and its conversion into other reactive nitrogen species 
such as ONOO'. The tissue injury resulting from NO’ has been demonstrated in the 
pathology of diseases including epilepsy, stroke, rheumatoid arthritis, transplant 
rejection and asthma (Halliwell and Gutteridge, 1999).
1.3 Consequences of oxidative stress
Free radical production is part of normal metabolism and is generally balanced by 
antioxidant defence systems. When the balance is disturbed oxidative stress develops, 
which may cause cellular adaptation, injury or death. Non-lethal exposure to free 
radicals is known to induce specific stress proteins which function by protecting the cell 
from further oxidative challenges (Jackson et al., 1998). The alternative response is
cellular injury, resulting from free radical reactions with lipids, proteins and nucleic
acids. The primary cellular target of oxidative stress varies depending on the cell, the 
type of stress imposed and the severity of the stress. Ultimately, when the cell cannot 
cope with the demands placed upon it, cell death ensues either as apoptosis or necrosis 
(Section 1.3.2). The damage caused by oxidative stress can be measured by quantifying 
the degree of oxidative stress encountered by a specific tissue, although there are many 
different techniques employed and no gold standard marker of oxidative stress has yet 
been identified (Griffiths et al., 2002).
1.3.1 Markers o f  oxidative stress
A marker of oxidative stress should be a major product of oxidative modification that is 
implicated in the development of disease and is unaffected by normal cell processes 
(Griffiths et al., 2002). In addition, a valid marker should be a stable product that can be
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determined by an assay that is specific, sensitive, reproducible and robust (Griffiths et 
al., 2002). As oxidants have the potential to damage membranes, proteins and DNA, 
suitable markers are often the biomolecules formed as a consequence of this damage 
(hence the term ‘biomarker’). Despite this, many of the available detection methods and 
end products are not sensitive enough or specific, giving rise to artifactual oxidation 
products making them unsuitable for in vivo application. The conflicting research 
available in the literature that has investigated oxidative stress in vivo demonstrates the 
difficulty encountered in quantifying oxidative stress (Han et al., 2000). For example, 
total lipid peroxidation is difficult to definitively measure as a result o f the wide range 
of products generated, with lipid hydroperoxides, aldehydes, conjugated dienes, volatile 
hydrocarbons, and F2-isoprostanes all being potential options. In addition, using one 
biomarker to evaluate lipid peroxidation can be misleading because the biomarkers are 
the products of different stages of lipid peroxidation and this could explain why some 
laboratories have reported oxidative stress induced by a particular stressor and others 
have not.
Lipid peroxidation products tend to be very unstable and extra caution needs to be taken 
during processing and extraction. A discussion on this topic is beyond the scope of this 
literature review and therefore the reader is referred to Gutteridge (1995). Several 
investigations have demonstrated an increase in lipid peroxidation following damaging 
exercise (Maughan et al., 1989) and prolonged exercise (Mastaloudis et al., 2004a) with 
antioxidant supplementation capable of attenuating the increase in lipid peroxidation 
(Meydani et al., 1993) and inflammation associated with exercise (Cannon et al., 1991).
The only method that can directly detect free radical species is electron spin resonance 
(ESR) using spectroscopy to detect unpaired electrons. Free radicals have a very short 
life time and in order to detect free radicals in biological systems, spin traps must be 
used to ensure specific and stable products. Spin traps which are commonly used are 
nitrones, such as phenyl-tert-butylnitrone (PBN) and 5, 5-dimethyl-l-pyrroline N-oxide 
(DMPO). This method has been used to demonstrate exercise-induced oxidative stress in 
skeletal muscle (Davies et al., 1982; Jackson et al., 1985) and human plasma (Ashton et 
al., 1998). Although this technique directly detects free radicals, only a few radical 
species have been identified. Furthermore, an increase in a single free radical species 
does not provide information relating to oxidative stress. An increase in the detection of 
one free radical species may be accompanied by decreases in other free radical species 
and, therefore, this does not provide information relating to the overall concentration of 
free radicals or whether this has been accompanied by a compensatory increase in
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antioxidant molecules. Consequently, this method does not measure redox status or 
quantify oxidative stress.
There are many techniques available to detect oxidatively modified products of DNA 
and proteins. The damage caused by ROS can lead to DNA strand breaks, DNA 
crosslinks and base pair oxidation. In exercise studies the measurements of oxidised 
base pairs 8 -oxoguananine (8 -oxoG) or 8 -deoxyguanosine (8 -oxodG) are widely used 
and can be detected using high performance liquid chromatography (HPLC), gas 
chromatography-mass spectroscopy (GC-MS), and enzymatic assays. Variation in 
values among these different techniques is common and is probably the consequence of 
artifacts generated during extraction and analysis. Several investigations have reported 
lymphocyte DNA damage as a result of exercise, hypoxia and H2O2 treatment (Hartman, 
2000; Moller et a l , 2001; Rothfuss et a l , 2001; Tsai et a l,  2001).
The oxidative modification of proteins can be assessed by the measurement of 
thiol/disulphide redox status, protein carbonyls and oxidized amino acids. A wide 
variety of methods exist for the measurement o f reduced glutathione (GSH) in biological 
systems, although the measurement of the GSH/GSSG (glutathione disulphide) redox 
status is a more specific marker of oxidative stress than GSH alone. When there is 
excessive production of ROS that exceeds the recycling capacity of glutathione 
reductase, GSSG levels will rise resulting in a decrease in the GSH/GSSG ratio. The 
major limitation of this marker is the auto-oxidation of GSH to GSSG during sample 
processing providing discrepancies in values. Exercise has been shown to increase levels 
of GSH and GSSG without changing the GSH/GSSG ratio in rat skeletal muscle (Ji et 
a l,  1992) as well as reduce whole blood GSH concentration and increase GSSG 
following eccentric exercise (Goldfarb et a l, 2005). Additionally, eccentric exercise has 
been shown to induce oxidative stress, assessed by increased plasma protein carbonyl 
concentration, without alterations in the blood glutathione status (Lee et a l,  2002). 
However, it should be pointed out that the use of protein carbonyls as a biomarker of 
oxidative stress is controversial because protein carbonyls can be formed by reactions 
that are not specific to oxidative stress (Han et a l,  2000).
It is clear that the measurement of oxidative stress and damage in biological systems is a 
difficult task. Rather than attempting to determine a specific product o f oxidative 
modification, it may be possible to use the altered expression of oxidant-sensitive genes 
as tools to determine whether there has been a disturbance in redox status (Offord et a l,
2000). The most appropriate candidate at the present time appears to be Haem 
Oxygenase-1 (HO-1) (Offord et a l,  2000; Griffiths et a l ,  2002). Haem oxygenase-1 is
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often described as an oxidant stress protein (Applegate et al., 1991; Abraham et al., 
1996). The current criteria used to determine whether a biomarker is valid include (i) 
specificity (both biological in source, and chemical in terms of analysis) (ii) knowledge 
of its functional significance (iii) stability (iv) an assay which is specific, sensitive and 
reproducible (v) accessibility in a target or valid surrogate tissue (Griffiths et al., 2002). 
Haem oxygenase-1 potentially satisfies all these criteria and has been used as a 
biological marker o f oxidative stress in vitro (Tyrrell and Basu-Modak, 1994). The role, 
function and relevance of HO-1 is discussed later in this review (Section 1.5).
1.3.2 Cell death
Exposure of cells to severe oxidative stress leads to cell death. This can occur by two 
mechanisms; apoptosis (programmed cell death) and necrosis. Treatment with high 
concentrations (mM) of H2O2 induce cell death by necrosis while lower concentrations 
induce apoptosis (Hampton and Orrenius, 1997; Antunes and Cadenas, 2001). This 
suggests that apoptosis is a mechanism that has developed to sacrifice individually 
damaged cells for the sake of the organism. Necrosis occurs as a result of trauma or 
injury and has specific and different morphological and biochemical features to those 
observed in apoptosis (Table 1.2). Although apoptosis is a mode of cell death, it is 
generally accepted that this strategy maintains the dynamic balance and equilibrium of 
living systems, occurring as a normal mechanism in development and homeostasis 
(Zhivotovsky etal., 1999).
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Single cells Groups of cells
Phagocytosis by other cells Phagocytosis by macrophages
No inflammatory response Inflammatory response
Morphological features
Cell shrinkage Swelling of the cell and lysis
Membrane blebbing Loss of membrane integrity
Formation of apoptotic bodies No vesicle formation, complete lysis
Intact organelles Swelling of organelles
Biochemical features
Gene activation and protein synthesis Loss of regulation of ion homeostasis
ATP dependent (active) No energy requirement (passive)
Non-random DNA fragmentation Randomised digestion of DNA
Pre-lytic DNA fragmentation Post-lytic DNA fragmentation
Phosphatidylserine (PS) exposure Absent
Activation of caspases Absent
(Adapted from Zhivotovsky et al., 1999).
Apoptotic cells shrink and, if relevant, they will retract from their neighbouring cells. 
The process is followed by condensation of the chromatin at the nuclear membrane. The 
membrane forms blebs and vesicles and finally there is nuclear fragmentation and the 
formation of apoptotic bodies (Wyllie, 1980). These ‘bodies’ contain fragments of 
nuclear chromatin and can be phagocytosed, preventing the spillage of cellular contents. 
These characteristics of apoptosis reflect the activation of a cascade of cysteine 
proteases known as caspases. Caspases are cysteine-containing, aspartic acid-specific 
proteases which exist as zymogens in the cytoplasm, intermembrane space of
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mitochondria and the cell nucleus (Nicholson and Thomberry, 1997). Apoptosis is 
regulated by an extrinsic and an intrinsic pathway. In the extrinsic pathway, cell surface 
receptors are activated which recruit caspases; whereas the intrinsic pathway depends on 
the release of cytochrome c from mitochondria into the cytoplasm as a result of changes 
in the membrane permeability (Green and Reed, 1998). The latter pathway is suggested 
to occur in H2 0 2 -induced apoptosis with cytochrome c binding to apoptotic protease 
activating factor (Apaf-1), forming an apoptosome (Chandra et al., 2000). The 
apoptosome forms a complex with procaspase-9, converting it to its active form, 
initiating a caspase cascade. The formation of the protein complex between Apaf-1, 
cytochrome c and procaspases requires energy, hence, apoptosis is seen as an active 
form of cell death (Stoneman and Bennett, 2004).
^ I
Apoptosis can also be initiated by changes in the dysregulation of Ca metabolism.
94 -  94 -Increases in Ca can activate Ca -dependent endonucleases in the cell nucleus, causing 
DNA fragmentation (Wyllie, 1980). Certain oxidants open a permeability transition pore 
(PTP) between the inner and outer mitochondrial membranes, which becomes activated 
by a high intracellular Ca2+ concentration in the mitochondrial matrix and oxidative 
stress, resulting in the release of cytochrome c (Orrenius et al., 2003). In healthy cells, 
phospholipids are distributed asymmetrically with phosphatidylserine (PS) located in the 
inner plasma membrane, however, in apoptotic cells PS translocates to the cell surface, 
providing a signal for phagocytosis. Currently, it is recognised that PS exposure in
94-  94 -apoptosis is Ca dependent, demonstrating the role of Ca in apoptotic cell death 
(Orrenius et al., 2003).
Cell death is regulated by the Bcl-2 family of proteins, consisting of pro-and anti- 
apoptotic proteins. The Bcl-2 protein is localised to the mitochondria, endoplasmic 
reticulum and nuclear membrane. Bcl-2 family proteins are known to play a pivotal role 
in the induction of caspase activation and in the regulation of apoptosis. Bcl-2 has been 
shown to inhibit oxidative stress-induced apoptosis supporting the notion that this 
protein possesses antioxidant properties (Hockenbery et al., 1993). Furthermore, over­
expression of Bcl-2 was found to reduce UVA-induced apoptosis which was associated 
with a reduced expression of the oxidant-responsive gene HO-1 (Pourzand et al., 1997). 
The induction of HO-1 forms a major part of this thesis and will be discussed in section 
1.5. The role of Bcl-2 proteins in apoptosis is beyond the scope of this literature review 
and the reader is referred to Burlacu (2003).
The different characteristics of apoptosis and necrosis have resulted in the development 
of a wide variety of techniques to assess cytotoxicity. Evidence of apoptosis and
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necrosis is discussed in later sections of this review in relation to exercise, H2O2 
treatment, HO-1 expression and antioxidant supplementation (Sections 1.4.2, 1.6.2, and 
1.6.3).
1.4 Exercise-induced oxidative stress
Acute exercise places the body under a range of different stressors, with several 
different exercise protocols demonstrating an induction of oxidative stress in both 
skeletal muscle (Jackson, 2000), blood leukocytes (Niess et al., 1998; Suzuki et al.,
1999), and plasma (Lee et a l, 2002; Sacheck et al., 2003; Vincent et a l,  2004). The 
magnitude of oxidative stress induced by exercise is related to the mode of exercise, 
intensity and duration as these factors contribute to the different mechanisms capable of 
producing free radicals (Jackson, 2000; Konig et a l ,  2001).
During and following a bout of exercise many biochemical reactions take place which 
can lead to the formation of free radicals (Figure 1.4). As mentioned previously, 
exercise-induced increases in oxygen consumption amplify free radical production via 
the electron transport chain. Furthermore, splanchnic blood flow is reduced during 
demanding exercise (Clausen, 1977), and this relative ischaemia may lead to increased 
superoxide production upon reperfusion. The reduced blood flow may also cause 
alterations in gastro-intestinal function, increasing the permeability of the gut wall 
allowing bacterial lipopolysaccharide (LPS) to translocate from the gut into the plasma, 
causing endotoxaemia (Bosenberg et a l,  1988). Plasma LPS has been reported to 
increase significantly in individuals immediately following a long distance triathlon 
(Bosenberg et a l,  1988; Jeukendrup et a l ,  2000) and short-term maximal aerobic 
exercise (Ashton et a l,  2003). Additionally, the xanthine oxidase pathway is activated in 
intense exercise, leading to increases in uric acid production following exercise (Balsom 
et a l,  1992). Exercise increases catecholamine levels (Muir et a l ,  1984), which can 
auto-oxidise generating free radicals. Changes in blood leukocyte levels occur during 
and in the hours following exercise and this inflammatory response can increase free 
radical production and augment oxidative stress (Suzuki et a l ,  1996; Morozov et a l, 
2003). Therefore, exercise provokes a number o f pathways that have the potential to 
overwhelm antioxidant defences and induce oxidative stress.
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Figure 1.4 Proposed mechanisms for the induction of oxidative stress in non-damaging 
acute exercise.
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Exercise-induced oxidative stress has been assessed using indirect markers of free 
radical production, such as lipid peroxidation (Maughan et al., 1989), protein oxidation 
(Radak et a l,  1997), thiol status (Radak et al., 2004) and DNA damage (Hartman,
2000). The use of ESR provides a direct measurement o f free radical concentration in 
biological tissue, although some investigations have not been able to definitively 
identify the free radical species detected (Ashton et al., 1998). The first investigation 
using ESR to detect oxidative stress was conducted in muscle homogenate of rat after an 
acute bout of treadmill running to exhaustion (Davies et al., 1982). The free radical 
species reported to increase was proposed to be a semi-quinone, providing evidence that 
ROS were generated as a result of exercise. In addition, damaging exercise consisting 
of repeated muscular contractions was reported to increase the intensity of the ESR 
signal by 70%, leading the authors to conclude free radical production may play a role in 
muscle damage associated with intense contractile activity (Jackson et al., 1985). The 
free radical species that was detected was believed to be a semi-quinone type radical.
Exhaustive aerobic exercise was demonstrated to increase free radical production in 
human plasma, detected using ESR, and this was temporally associated with increased 
lipid peroxidation post-exercise (Ashton et al., 1998). Recently, the first evidence for 
oxygen- (alkoxyl/peroxyl radical) or carbon- centred (alkyl radical) free radical outflow 
from an active muscle bed in humans was reported (Bailey et al., 2003). In this 
investigation, individuals completed incremental exercise encompassing 25 and 70% of 
their previously established maximal work rate using a single-leg knee extensor model, 
establishing support for the production of free radicals in humans participating in 
exercise.
As mentioned previously, the magnitude of oxidative stress induced by exercise is 
dependent on several factors, although few investigations have compared different 
exercise protocols to determine which protocols generate a greater level of oxidative 
stress. Intermittent exercise performed at the same average work rate as continuous 
exercise has been associated with increased physiological strain (Edwards et al., 1973). 
It is known that oxygen consumption of continuous and intermittent aerobic exercise 
and contractile activities differs, therefore the production of free radicals in these 
different exercise protocols should differ. However, as illustrated in Figure 1.4, several 
biochemical mechanisms produce free radicals in exercise and different protocols will 
activate any number of sources.
In a study examining oxidative stress induced by aerobic or isometric exercise both 
protocols demonstrated increases in plasma lipid hydroperoxides, protein carbonyls and
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antioxidant capacity, although the degree of change in each measure differed between 
protocols (Alessio et al., 2000). Aerobic exercise resulted in a 14-fold change in oxygen 
consumption compared to only two-fold with isometric exercise and had a greater 
increase in protein carbonyl concentration immediately post-exercise (67% vs. 12%, 
respectively). However, lipid hydroperoxide concentration following the isometric 
exercise increased 36% from pre-exercise values compared to 24% in the aerobic 
exercise protocol. This investigation suggests that although both protocols are capable of 
inducing oxidative stress, the nature of the oxidative stress may differ due to the very 
different metabolic demands of the two exercises. Similarly, 30 min downhill running 
was associated with elevated plasma MDA concentrations whereas running on a flat for 
the same period of time did not alter plasma MDA concentration and did not induce 
oxidative stress (Close et a l,  2004). The responses to exercise are made even more 
difficult to predict since the inflammatory response to exercise changes with different 
exercise protocols (Natale et a l ,  2003) and this may be a possible mechanism for 
differences in the degree of oxidative stress.
1.4.1 Inflammation
The inflammatory response associated with exercise represents a mechanism for the 
production of free radicals. Intense exercise causes an increase in total blood leukocyte 
counts during and following exercise, with changes to leukocyte subpopulations 
(Hoffman-Goetz and Pedersen, 1994). The change in leukocyte number is largely the 
result o f the increase to the neutrophil population with a smaller increase in monocytes. 
During exercise, lymphocyte count increases (Field et al., 1991; Natale et al., 2003) 
with increased recruitment of natural killer (NK) cells, B cells, and T cells to the blood 
(Nieman et al., 1991). The increase in leukocyte number has been reported to be related 
to exercise intensity, increasing in an intensity-dependent manner (Miles et al., 2003; 
Quindry et al., 2003). The neutrophil count remains elevated several hours following 
exercise, whereas the decline in monocyte and lymphocyte counts occurs earlier, at one 
or two hours post-exercise.
Activated neutrophils are capable of producing O2’’ (Section 1.2.4), and can generate 
HOC1 in the presence of myeloperoxidase, destroying invading bacteria and removing 
damaged tissue. Several groups have reported an increase in neutrophil activation 
following exercise (for review see Woods et al., (1999)) demonstrated by the presence 
of myeloperoxidase in the plasma (Morozov et al., 2003; Suzuki et al., 2003). Although 
the removal of damaged tissue is a desirable function, neutrophils also secrete pro- 
inflammatory cytokines and other destructive agents which can lead to further
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augmentation of ROS production and inflammation (Cannon et a l ,  1991). Cytokines are 
secreted by and influence the action of most cells in the body. The inflammatory 
response is regulated by pro-inflammatory and anti-inflammatory cytokines. Increases in 
the pro-inflammatory cytokines interleukin-ip (IL-ip), interleukin-6  (IL-6 ), interleukin- 
8 (IL-8 ) and tumour necrosis factor-a (TNF-a) have been reported following exercise 
(Cannon et a l,  1991; Niess et al., 1999b; Moldoveanu et al., 2000). Infusion of IL-6  at 
levels equivalent to those observed in strenuous exercise resulted in increased plasma 
concentrations of anti-inflammatory cytokines [interleukin- 1 receptor antagonist 
(IL-lra) and interleukin-10 (IL-10)] and increased cortisol concentration altering 
neutrophil and lymphocyte counts (Steensberg et al., 2003).
A recent review examined the effects of glucocorticoid hormones and catecholamines in 
their ability to alter the function of leukocytes and subsequent release of cytokines 
(Padgett and Glaser, 2003). Evidence o f this role was reported as early as 1984 with the 
infusion of intravenous adrenaline increasing circulating leukocyte number in the lung 
(Muir et al., 1984), although much smaller increases than those observed following 
exercise were documented. Similarly, the redistribution of lymphocyte subsets caused 
by exercise has been shown to be the result of adrenaline-induced changes in beta- 
adrenergic receptors (Frey et al., 1989). The role of adrenalin was supported by Field 
and colleagues (1991) observing a positive correlation between total leukocyte counts 
following a short exhaustive aerobic exercise protocol and plasma adrenalin 
concentration. This relationship suggested a causal effect was possible. However, 
cortisol levels change during exercise and an increase in this hormone may explain the 
decline in lymphocyte number in the hours following exercise (Nieman et al., 1993), as 
cortisol causes NK cells to exit the circulation in large numbers. The alternative 
proposed mechanism for the decline in lymphocyte cell number following exercise is 
lymphocyte apoptosis.
1.4.2 Exercise-induced apoptosis
Strenuous exercise results in increased glucocorticoid secretion and ROS production, 
and has been shown to increase the intracellular calcium concentration in lymphocytes 
(Mooren et al., 2001). These signals are known to induce apoptosis (Green and Reed, 
1998). The oxidative damage caused by exercise could contribute to lymphocyte 
damage resulting in apoptosis (Azenabor and Hoffman-Goetz, 1999). It is speculated 
that exercise-induced apoptosis is a normal regulatory process that serves to remove 
certain damaged cells without a pronounced inflammatory response, thus ensuring 
optimal body function (Phaneuf and Leeuwenburgh, 2001). This has led authors to
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postulate that lymphocyte apoptosis could be the reason for the decline in lymphocyte 
count following exercise (Mars et a l , 1998; Mooren et a l , 2002).
It is possible that changes in cortisol alone may affect lymphocyte apoptosis. Indeed, in 
vitro exposure to corticosterone at physiological concentrations (< 450 ng.m f1) 
observed after a moderate exercise stress induces apoptosis in thymocytes and necrosis 
in both thymocytes and splenocytes (Hoffman-Goetz and Zajchowski, 1999). 
Interestingly, investigations examining lymphocyte apoptosis in mice have reported 
contradictory results with lower apoptosis reported two hours following submaximal 
treadmill running despite elevated cortisol levels (Hoffman-Goetz et a l , 1999) and 
higher apoptosis observed 24 h following treadmill running for the same duration 
(Hoffman-Goetz and Quadrilatero, 2003). The difference in these findings is likely to be 
the result of different time points used for analysis. The administration of antioxidants 
was reported to attenuate lymphocyte apoptosis following exercise in mice (Lin et a l , 
1999; Quadrilatero and Hoffman-Goetz, 2005), suggesting that oxidative stress was the 
cause of exercise-induced apoptosis.
Although there is some evidence that lymphocyte apoptosis may be the mechanism for 
lymphocytopenia (Mars et a l , 1998), some research suggests that this is not the case. 
Steensberg and colleagues (2002) asked participants to complete a strenuous treadmill 
protocol running at 75% VC^max for 2.5 h. Lymphocyte count increased after 30 min of 
running and significantly declined by 50% one hour post-exercise, remaining at this 
level at the 2 h post-exercise time point. Although the percentage o f apoptotic cells 
increased by 60% at 2  h post-exercise, the total number of circulating apoptotic 
lymphocytes did not change in relation to exercise, indicating that the cells leaving the 
circulation were not apoptotic (Steensberg et al., 2002).
The training status of individuals has been reported to affect the basal level of apoptosis 
observed in lymphocytes, with highly trained people exhibiting a higher resting level of 
apoptotic cells and a decline in lymphocyte apoptosis 24 h following a marathon 
(Mooren et a l,  2004). In contrast, ‘badly trained’ individuals had a lower basal level of 
apoptosis and increased apoptosis 24 h following a marathon. The effects of endurance 
training are known to attenuate exercise-induced oxidative stress (Miyazaki et a l,  2001) 
and, therefore, the reduced oxidative stress post-marathon could result in the attenuation 
of apoptosis in highly trained individuals. Furthermore, regular exercise is known to 
affect the expression of protective proteins in various tissues (Powers and Sen, 2000) 
and this may affect the basal level of apoptosis in lymphocytes.
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1.4.3 Expression o f  protective proteins
Acute or unaccustomed exercise results in muscle damage (Pyne, 1994). However, it has 
been shown that training adaptations occur within muscle, leading to increased levels of 
various enzymes that improve protection against muscle damage and oxidative stress 
(Powers et al., 1999). Levels of superoxide dismutase (SOD) and SOD activity have 
been reported to increase following acute exercise in skeletal muscle and leukocytes in 
both human and animal studies (Suzuki et al., 2000; McArdle et al., 2001; Tauler et a l, 
2003) supporting the hypothesis that protection against oxidative stress is via increased 
antioxidant defences. Indeed, oxidative stress has also been related to the up-regulation 
of specific and protective proteins following acute exercise (Niess et al., 1999b; 
Febbraio and Koukoulos, 2000; Fehrenbach et al., 2000a; Fehrenbach et al., 2000b; 
Khassaf et al., 2001; McArdle et al., 2001; Powers et a l ,  2001; Fehrenbach et al., 
2003a). The up-regulation of heat shock proteins (HSPs) has been related to the 
attenuation o f tissue damage induced by subsequent exposure to oxidative stress and 
other forms of stresses (McArdle et a l,  2004). Similarly, the up-regulation of the 
oxidant-responsive gene HO-1 in muscle and leukocytes has been reported following 
strenuous exercise and has been used as a marker of oxidative stress (Essig et al., 1997; 
Niess et al., 1999b; Pilegaard et a l,  2000; Thompson et al., 2005). The use of this 
enzyme as a marker of oxidative stress is related to its functional significance with the 
induction of HO-1 being associated with protection against ischaemia-reperfusion injury 
(Zhang et al., 2004), oxidative stress (Yachie et al., 1999), inflammation (Nath et al.,
2001), transplant rejection (Soares et al., 2001), and apoptosis (Choi et a l,  2004). The 
importance o f HO-1 is discussed in the following section, where further evidence of the 
relationship between HO-1 expression and exercise will be examined (Section 1.5.3).
1.5 Haem oxygenase-1 (HO-1)
The enzyme haem oxygenase (HO) (E.C. 1.14. 99.3) was identified in 1968 and 
described as a ‘hepatic microsomal mixed function oxygenase’ (Tenhunen et a l, 
1968; 1969) confirming earlier observations by Wise and Drabkin (1964) of the in vitro 
degradation of haem to biliverdin. Despite the late discovery o f this enzyme its presence 
can be traced back centuries, as it is a distinct visible colourimetric biological process. 
When a bruise appears on the skin it is a black/purple colour and, as haem catabolism 
occurs, the colour of the bruise changes from black (the colour of haem) to green (the 
colour of biliverdin) and finally to yellow (the colour of bilirubin). The different colours 
represent the different products of haem catabolism with HO-1 providing the rate- 
limiting step of this reaction.
26
In mammals, three isoforms of haem oxygenase have been identified; HO-1, HO-2, and 
HO-3 (Maines, 1997), which are the products of different genes. Their localisation and 
characteristics differ and this leads to variations in their inducibility and resulting 
function (Table 1.3). The molecular weight of these enzymes is approximately 32, 36 
and 33 kDa, respectively. Haem oxygenase-1 is the most widely distributed isoform 
throughout the body tissues and is most concentrated in the spleen and liver where haem 
degradation of aged red blood cells occurs.
Table 1.3 Characteristics of the isoforms of HO
Characteristic HO-1 HO-2 HO-3
Major function Haem degradation Haem degradation Haem binding
Inducibility Highly inducible 
Diverse conditions
Constitutive Uninducible
Localisation Ubiquitous Mainly brain and testes Ubiquitous
(Adapted from Elbirt and Bonkovsky, 1999).
1.5.1 Role and function
The degradation of haem to biliverdin is dependent on the enzyme activity of HO. The 
action of biliverdin reductase converts biliverdin to bilirubin, which has been shown to 
possess in vitro antioxidant properties (Stocker et al., 1987). Equimolar amounts of iron 
and carbon monoxide (CO) are also released from the breakdown of haem (Figure 1.5). 
The complex of catalytically active iron is referred to as haem, requiring eight molecules 
each of glycine and succinyl CoA to synthesise one molecule of haem (Galbraith, 1999). 
The function o f haem is essential to aerobic metabolism because active iron can donate 
electrons as it is in a reduced ferrous state and has a high affinity for molecular oxygen. 
This process allows for the transport of oxygen via haemoglobin (Hb), storage of 
oxygen via myoglobin (Mb), cellular respiration (cytochromes) and destruction of 
oxygen free radicals. Free haem is a pro-oxidant and therefore the induction of HO is 
essential to restore cellular oxidant to antioxidant ratio by removal of the pro-oxidant, 
haem, from the cell (Stocker et al., 1987). Cellular damage produced by ROS is 
enhanced in the presence of even small amounts of haem (Fogg et a l,  1999) although 
the presence of the iron-sequestering protein ferritin improves the antioxidant status of
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the cell. Ferritin is induced as a protective measure in response to free iron and therefore 
enhances cellular antioxidant status.
Fe 2+ ---------- ► Ferritin
BILIVERDIN REDUCTASEHAEM OXYGENASE
> Biliverdin >  BilirubinHaem
CO
Figure 1.5 Haem degradation catalysed by HO.
The generation o f bile pigments from the degradation of haem contributes to the 
antioxidant status of the cell, as it is known to be a very efficient scavenger of free 
radicals (Stocker et al., 1987; Neuzil, 1993). Bilirubin is a potent antioxidant and plays a 
role in the cytoprotection offered by HO (Hayashi et al., 1999; Novotny and Vitek, 
2003). Vile and Tyrrell (1993) demonstrated a 4-fold increase in HO-1 activity was 
coupled to a 2-fold increase in ferritin levels following ultraviolet A irradiation. The 
activation of HO-1 metabolises the pro-oxidant haem molecule, and as a consequence 
the concentration of non-haem ‘free’ iron is increased (Fogg et al., 1999). This causes 
the induction of ferritin, which reduces the oxidant state of the cells by sequestering free 
iron. Therefore, ferritin up-regulation decreases the availability o f free iron, restricting 
iron-catalyzed free radical reactions during periods of subsequent oxidative stress (Vile 
and Tyrrell, 1993). According to Fogg and co-workers (1999) the degradation of haem 
by HO may be an adaptive response to oxidant stress, which is due to its dual 
antioxidant function by (i) preventing free haem participating in pro-oxidant reactions 
(Keyse and Tyrrell, 1989) and (ii) by the generation of biliverdin and bilirubin.
1.5.2 Induction o f  HO-1
Haem oxygenase-1 has been described as a heat shock protein (Shibahara et al., 1987; 
Kitani et al., 1993) as well as a stress protein, induced by oxidative damage (Keyse and 
Tyrrell, 1987;1989). Haem oxygenase-1 expression is up-regulated in the presence of 
oxidants and this induction appears to be a protective response. The cellular protection 
offered by HO-1 is evident against a wide range o f oxidant stresses both in vitro and in 
vivo (Applegate et a l ,  1991; Nath et al., 1992; Vile et a l ,  1994; Lee et al., 1996) 
(Table 1.4). The induction of HO activity is affected by the cellular redox potential and
28
the metabolic fate o f haem, and consequently this enzyme has the potential to become 
either a pro- or antioxidant (Ryter and Tyrrell, 2000).
Table 1.4 Inducers of HO-1 expression
Inducer Reference
Cytokines Cantoni et al, (1991) Fernandez et al, (2003)
Endotoxin Wiesel et a l, (2000) Vicente et al, (2003b)
Glutathione depletion Lautier et a l, (1992) Ewing et al, (1993)
Haem Abraham et al, (1995) Nath et al, (2001)
Heavy metals Alam et a l, (1994)
Hyperbaric oxygen treatment Rothfuss et a l, (2001)
Hyperoxia Lee et al, (1996) Otterbein et al, (1999)
Hypoxia Panchenko et al, (2000) Motterlini et al, (2000)
Hydrogen peroxide Keyse et al, (1987; 1989)
Nitric oxide Foresti et a l, (1997) Motterlini et a l, (2002)
Ultraviolet A Keyse et al, (1987; 1989)
Free radicals play a role as intracellular messengers and redox-based regulation of gene 
expression plays a fundamental mechanism in cell biology (Sen, 2001a). The induction 
of HO-1 has been shown to be regulated by redox signalling, involving the activation of 
mitogen-activated protein kinases (MAP kinases) (Ryter and Choi, 2002). There is 
evidence that the c-Jun N-terminal kinase (JNK) pathway (Morse et al., 2003), p38 
MAP kinase pathway and extra cellular signal-regulated kinase (ERK) pathways 
mediate the regulation of HO-1 (Elbirt et al., 1998; Lee and Chau, 2002). In addition, 
DNA binding sites for oxidative stress-responsive transcription factors such as nuclear 
factor (NF)-kB and activator protein-1 (AP-1) have been identified in the promoter 
region of HO-1 (Choi and Alam, 1996). Furthermore, the promoter region of HO-1 has 
been shown to be functionally active in response to various inducers such as UV 
irradiation, cadmium, H2O2 and haem (Tyrrell et a l ,  1993). The recent discovery of the 
haem-binding factor Bach-1 furthered the understanding of HO-1 regulation with 
Bach-1 acting in a simple feedback loop directly sensing haem levels (Sun et a l,  2002). 
The expression of HO-1 and Bach-1 has been shown to be inversely related, with
29
inducers of Bach-1 causing repression of HO-1 (Kitamuro et a l , 2003). It is postulated 
that the regulation of HO-1 activity may be a therapeutic strategy for a number of 
inflammatory and disease conditions (Immenschuh and Ramadori, 2000; Alcaraz et al., 
2003). Clearly, it is important that the signal transduction pathways inducing HO-1 are 
understood.
The physiological importance of HO-1 has been highlighted in investigations examining 
the role of HO-1 deficiency. Studies using the targeted deletion of HO-1 in mice 
demonstrated an accumulation of hepatic and renal iron which was associated with 
oxidative damage and chronic inflammation (Poss and Tonegawa, 1997a). Furthermore, 
cultured embryonic fibroblasts lacking the gene were hypersensitive to cytotoxicity 
caused by haemin and H2O2 treatment (Poss and Tonegawa, 1997b). In 1999, the first 
case of human HO-1 deficiency was reported demonstrating a similar phenotype to 
knock-out mice, suffering from growth failure, anaemia, tissue iron deposition, 
leukocytosis, and increased sensitivity to oxidants (Yachie et al., 1999). Additionally, 
accumulating evidence supports a role for HO-1 in preventing rejection of transplanted 
organs with exposure of the donor graft to CO increasing HO-1 expression in this organ 
as well as playing a pivotal role in suppression of the immune response to the new graft 
(Soares et al., 2001; McDaid et al., 2005). Recently, a link between IL-10 expression 
and HO-1 induction was demonstrated in macrophages in vitro in response to LPS 
stimulation, associated with down-regulation of pro-inflammatory cytokines (IL-1 p, 
TNF-a) and up-regulation of IL-10 (Otterbein et al., 2000). Evidence supporting a role 
of HO-1 in the anti-inflammatory function of IL-10 was observed in mice with increased 
expression of HO-1 protein following intraperitoneal administration o f IL-10 (Lee and 
Chau, 2002), providing an alternative mechanism for HO-1 induced protection. Studies 
have shown protection against atherosclerosis independently through increased HO-1 
expression (Yet et al., 2003) and IL-10 expression (Mallat et al., 1999). Taken together, 
these investigations reveal a role for HO-1 induction as an adaptive mechanism 
protecting cells from oxidative damage during stress.
The production of free radicals and oxidative stress contributes to the pathology of many 
chronic diseases, with increased HO-1 expression associated with conditions such as 
asthma (Kitada et al., 2001), atherosclerosis (Yet et al., 2003), and hypertension (Wiesel 
et al., 2001). In contrast, decreased levels of HO-1 mRNA have been found in 
individuals suffering from diabetes (da Silva et al., 1997) and Alzheimer’s disease 
(Ishizuka et al., 2002). The ability of individuals to respond strongly in terms of up- 
regulating HO-1 may be an important endogenous protective factor, although there 
seems to be large degree of inter-individual variation. The presence o f a microsatellite
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polymorphism in the promoter region of the gene known as a (GT) n repeat was first 
reported by Yamada (2000) demonstrating that individuals with long (GT) n repeats had 
a higher risk o f emphysema caused by cigarette smoking. Furthermore, lymphoblastoid 
cells from individuals with short (GT) n repeats were more resistant to oxidant-induced 
apoptosis than those with long (GT) n repeats (Hirai et al., 2003). This provides 
evidence that polymorphism of the HO-1 gene is associated with the strength of anti- 
apoptotic effects of HO-1, resulting in an association with susceptibility to oxidative 
stress-mediated diseases. The effect of the HO-1 promoter polymorphism and the 
resulting implications to diseases has been recently comprehensively reviewed (Exner et 
a l , 2004).
1.5.3 HO-1 induction with exercise
It is accepted that acute exercise causes oxidative stress although as mentioned 
previously, there is no criterion standard marker for the assessment of oxidative stress 
(Section 1.3.1). The induction of HO-1 is a general response to oxidant stress in 
mammalian cells (Keyse and Tyrrell, 1989; Applegate et al., 1991) and its altered 
expression is used as a marker of oxidative stress in vitro (Tyrrell and Basu-Modak, 
1994). The response of HO-1 to exercise has been examined in a small number of 
exercise studies, using both animals and humans (Table 1.5).
Table 1.5 Summary of exercise studies investigating HO-1 expression
Reference n Exercise Outcome Notes
Essig et al., (1997) rats n=19 
rats n=6
3 h muscular contractions 
1 h exhaustive running
t  HO-1 mRNA 4-fold in muscle 0 h PE 
t  HO-1 mRNA 7-fold in muscle 0 h PE
RT-PCR
Niess et al., (1999) n=9 (ET) 
n=12 (UT)
Half marathon race t  leukocyte HO-1 protein 0-24 h PE (ET) 
i  basal leukocyte HO-1 protein in ET compared to UT
Flow cytometry
Niess et al., (2000) n=13 Exhaustive run Neutrophil and monocyte HO-1 protein |  PE Flow cytometry
Pilegaard et al., (2000) n=6 60 min 1LKE repeated for 5 days Muscle HO-1 mRNA |  11-fold 2 h post 1LKE (day 5) RT-PCR
n=4 4 h cycle at 60% V 02max Muscle HO-1 mRNA |  4-fold 0 h PE




6 x10 reps eccentric contractions 
Half marathon race
t  in neutrophil and lymphocyte HO-1 protein 3 h PE 
No change in leukocyte HO-1 protein 
Significant t  leukocyte HO-1 protein 0-24 h PE
Flow cytometry
45 min run at 50% V 02max (LIE) Different muscle types responded differently to exercise. RT-PCR
Hildebrandt et al., (2003) rats 3 h run at 50% V 02max (LIE) RG t  HO-1 mRNA >30 fold 0 h PE (3 h LIE) and WG T
n=5-8 45 min run at 75% V 02max (HIE) HO-1 mRNA >15 fold (3 h LIE/ 45 min HIE)
Thompson et al., (2005) n=8 75 min run at 70% V 02max 
75 min rest
Lymphocyte HO-1 mRNA |  ~2-fold PE 
Lymphocyte HO-1 protein |  2 h PE
RT-RTPCR 
and westerns
PE: post-exercise, ET: endurance-trained, UT: untrained, lLKE:one-legged knee extensor exercise, RG: red gastrocnemius, WG: white gastrocnemius, 
HIE: high-intensity exercise, LIE: low-intensity exercise.
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The first evidence of increased HO-1 protein expression was reported by Niess and 
colleagues (1999b) with neutrophil, monocyte and lymphocyte HO-1 protein expression 
increasing following a half marathon race. The differential expression of HO-1 was 
associated with the capability o f the particular cell type to produce ROS (Thiebauld and 
Mannes, 1997) as the increase in neutrophil and monocyte HO-1 protein was greater 
than the increase in HO-1 observed in lymphocytes. In addition, the level of IL-8  
concentration post-exercise was positively correlated with the level of HO-1 expression 
in neutrophils (Niess et a l,  1999b), supporting a role for HO-1 in the inflammatory 
response. This investigation observed a difference in the basal expression of HO-1 
protein between trained and untrained individuals, with a reduced level of HO-1 found 
in trained athletes (Niess et a l,  1999b). This finding was believed to be the result of 
training adaptations causing a lower pro-oxidant state through improved antioxidant 
defences.
Previous work using rats demonstrated that different modes, duration and intensity of 
exercise affected the induction of HO-1 in skeletal muscle (Essig et a l,  1997) with the 
expression of HO-1 mRNA increasing 7-fold following exhaustive exercise compared to 
a 4-fold increase immediately after a longer duration of eccentric contractions. The 
different parameters of exercise and HO-1 mRNA induction in skeletal muscle in 
humans have been examined, although there are conflicting results. Pilegaard and co­
workers (2000) demonstrated a greater expression of HO-1 mRNA in skeletal muscle 
following a 1 h bout of one-legged knee extensor exercise, performed on five 
consecutive days, at 70% of their 2 min maximal resistance compared to a prolonged 
lower intensity cycle. This finding suggests HO-1 induction may be sensitive to 
intensity, and the fact that HO-1 was induced to a greater extent following one-legged 
contractions may reflect the increased production of ROS in the muscle with this mode 
of exercise. The increase in HO-1 expression may be induced in response to exercise to 
help minimise oxidative damage to skeletal muscle. Furthermore, the induction of HO-1 
mRNA in rats in response to exercise of different duration and intensity seems to occur 
in a fibre type-specific manner (Hildebrandt et a l,  2003) suggesting that the induction 
of HO-1 was required to meet a specific need in the myofibres.
Presently, only one study has examined exercise protocols o f differing durations and 
intensities in human leukocytes. In this study, a large increase in HO-1 protein 
expression following a half marathon race was observed, with smaller increases evident 
after an exhaustive run, which was largest in monocytes (Fehrenbach et a l,  2003a). In 
contrast to the evidence provided from studies examining HO-1 in skeletal muscle, no 
changes in HO-1 protein expression in human leukocytes were observed following
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eccentric contractions (Fehrenbach et al., 2003a). Both concentric and eccentric 
contractions are employed during endurance running, and are more likely to induce 
damage and produce free radicals than either form of contraction alone (Jackson, 2000). 
In addition, endurance running has a high mechanical impact and may lead to the 
destruction of erythrocytes (Jackson, 2000), releasing haem in to the circulation which 
may be responsible for the increase in HO-1 observed following prolonged running.
Although there is evidence to support an increase in HO-1 protein expression in human 
leukocytes following exercise, there is limited information concerning the induction of 
HO-1 mRNA in response to exercise. Thompson and co-workers (2005) provided the 
first evidence for an accumulation of lymphocyte HO-1 mRNA expression in response 
to 75 min running at 70% V0 2 max. A 2-fold or greater induction of HO-1 mRNA post­
exercise was evident in six out of the eight subjects, which was accompanied by 
increased protein expression 2 h post-exercise. In addition, one subject experienced a 
remarkable 20-fold increase in HO-1 mRNA 24 h after exercising, indicating a degree of 
variability in the ability to increase HO-1 expression. This study also found plasma 
concentrations of IL-6  increased ~ 4-fold immediately post-exercise and it is tempting to 
speculate that increased lymphocyte HO-1 is a response to oxidative stress initiated by 
exercise-induced inflammation.
It is apparent that the exercise-induced expression of HO-1 is dependent on the intensity 
and duration of exercise, with some studies suggesting that intensity is the determining 
factor (Pilegaard et al., 2000). However, it is likely that a combination of both intensity 
and duration maximises the HO-1 response. The influence of regular training on HO-1 
expression requires further clarification. Although trained individuals demonstrated a 
lower basal HO-1, they were able to up-regulate HO-1 in response to prolonged exercise 
(Niess et a l , 1999b). In contrast, Pilegaard and colleagues (2000) observed a 2-fold 
increase in the basal level of HO-1 mRNA expression in skeletal muscle following five 
consecutive days of one-legged knee extensor exercise in comparison to the non­
exercised control leg. Similarly, Boshoff and co-workers (2000), demonstrated an 
inverse relationship between the inducibility of HSP70 and its basal expression. 
According to this relationship, a higher basal level of HO-1 would result in a decrease in 
the HO-1 response to oxidative stress.
In summary, different techniques and exercise protocols have been used to analyse 
HO-1 with both changes in protein and mRNA reported. Discrepancies in the results 
may be due to the use of different end points and methods. Collectively, the findings 
indicate that the induction of HO-1 in skeletal muscle and lymphocytes differs in
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response to exercise, possibly implying the up-regulation of HO-1 is dependent on 
specific requirements of the tissue or that the strength of the stimulus varies between 
skeletal muscle and lymphocytes.
1.6 Lymphocytes
Lymphocytes play a pivotal role in host defence and the maintenance of normal 
function. Previous investigations have shown that lymphocytes respond to hyperbaric 
oxygen treatment (HBO) (Rothfuss et al., 1998), heavy metals (Menzel et a l , 1998), 
heat shock (Rao et a l , 1999) and H2O2 (Marini et al., 1996a) with an up-regulation of 
various HSPs and HO-1 following recovery from treatment. The increased expression of 
these proteins is associated with cellular protection. Since lymphocytes are widely 
distributed throughout the body, this tissue may provide a clearer picture o f the overall 
situation experienced by the body during oxidative stress. This feature makes 
lymphocytes an attractive tissue for examining the responses to oxidative stress.
1.6.1 Function and distribution
Lymphocytes are composed of B and T cells, with T cells playing a role in cell-mediated 
immunity and assisting B cells in antibody production. T cells can be further classified 
as CD4+ cells (T-helper cells) and CD8 + cells known as cytotoxic T cells. Another 
subpopulation of lymphocytes includes NK cells, comprising less than 10% of the total 
B and T lymphocyte population. As a result of their role in immunity, lymphocytes are 
distributed throughout the body in tissues and fluids including classical lymphoid organs 
such as the thymus, lymph nodes and spleen and non-lymphoid organs including the 
lung, gut and skin (Westermann and Pabst, 1992). In healthy adult humans, it is 
estimated there are twice as many T cells as B cells with more than 50% of B and T 
lymphocytes residing in the lymph nodes and spleen and with NK cells located mainly 
in the liver (35%), lung (25%) and spleen (15%) (Westermann and Pabst, 1992). At any 
one time, the blood contains very few lymphocytes at only 2% o f the total lymphocyte 
pool. Each day approximately 500 x 109 lymphocytes migrate from the blood in to the 
lymphoid tissue throughout the body and back to the blood, equivalent to the total 
lymphocyte number in the body.
Lymphocyte recirculation is a dynamic process involving large numbers of cells moving 
between a variety of pools (Hay and Andrade, 1998). Lymphocytes continuously 
migrate from the blood, through tissues into the lymphatic system and lymph nodes, and
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back to the blood, providing an important function of immune surveillance of organs 
and tissues. In addition, lymphocytes are the only leukocyte subpopulation to leave the 
blood and enter tissues as well as recirculate back to the blood via the lymphatics. Most 
of the literature investigating lymphocyte recirculation has involved the use of sheep due 
to the convenient location of the lymph nodes in these animals. The lymphatic vessels 
draining individual lymph nodes can be accessed surgically in sheep where a single 
efferent lymphatic drains each lymph node, in contrast to humans where lymph nodes 
occur in chains (Young, 1999). When a sheep lymph node weighing 1 g received an 
average 24 ml/h blood, -25%  of lymphocytes entering the lymph node migrated out of 
the blood through the node into the efferent lymph, reflecting the dynamic process of 
lymphocyte recirculation (Hay and Hobbs, 1977).
The recirculation of lymphocytes has been monitored in sheep using fluorescent dyes 
and has shown that the concentration of labelled lymphocytes in lymph is reduced by 
50% every 16.5 days (Young and Hay, 1995). During exercise, an immune response is 
mounted with increases in neutrophils, monocytes and lymphocytes caused by the 
movement o f leukocytes from marginal pools. As the spleen is the largest lymphoid 
organ it has been suggested that the spleen contributes to changes in lymphocyte 
number, although studies investigating the effects of splenectomy on lymphocytosis 
during maximal exercise have provided conflicting results (Iversen et a l , 1994; Nielsen 
et al., 1997). Physical exercise has been shown to affect the distribution and function of 
NK cells (Shephard and Shek, 1999) as well as the composition of B, T and CD4+ and 
CD8+ cells, which increase in concentration during exercise (Nielsen, 2003). As the 
proportion o f CD8+ cells has been reported to increase more than CD4+ cells, the ratio 
of CD4/CD8 cells may decline (Nielsen, 2003). During recovery from exercise, 
lymphocyte cell number declines below resting levels (Field et a l ,  1991) and this is 
associated with a decrease in the NK cell number and the proportion o f B and T cells.
In summary, lymphocytes represent an appropriate tissue for examining oxidative stress 
as their ability to recirculate throughout the body may provide more information 
regarding the overall response to oxidative stress. The blood is a convenient pool to 
sample from and lymphocytes can be obtained relatively easily. Furthermore, once 
harvested, the lymphocyte response to oxidative stress can be manipulated ex vivo and 
examined using a range of biomarkers. Therefore, lymphocytes are an appropriate target 
tissue which can be used to assess the response to oxidative stress.
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1.6.2 Lymphocytes and induction o f HO-1
The induction of HO-1 in lymphocytes in vitro and ex vivo has been reported following 
treatment with different types of oxidant (Applegate et al., 1991; Marini et al., 1996a; 
Menzel et al., 1998; Speit et al., 2000). Cultured lymphoblastoid cells (TK6 ) treated 
with 100 pM H2O2 for 30 min resulted in an 8 -fold increase in HO-1 mRNA expression 
between 4 and 8 h of incubation following treatment (Applegate et a l ,  1991). When 
lymphocytes were isolated from humans and treated with H2O2 (50 pM, 60 min) the 
induction of HO-1 protein occurred 6  h following treatment and was maintained a 
further 12 h (Marini et a l, 1996a). However, there was a large degree of inter-individual 
variability in the HO-1 response and this has also been observed in another investigation 
following treatment with heavy metals (Menzel et al., 1998).
The exogenous administration of H2O2 to lymphocytes provides a physiological model 
of oxidative stress, as this oxidant is generated from nearly all sources of free radical 
production. In addition, H2O2 can diffuse freely in and out o f cells and tissues with 
plasma concentrations of H2O2 reported to be ~4-5 pM (Yamamoto et al., 1987). 
Hydrogen peroxide treatment causes DNA damage to lymphocytes (Gardner et al., 
1997; Rothfuss et al., 1998; Barbouti et al., 2002). Preconditioning of lymphocytes with 
an inducer treatment up-regulating HO-1 was associated with reduced DNA damage 
when cells were challenged with H2O2 (Speit et al., 2000). In theory, such an adaptive 
response following exercise may be of benefit, with HO-1 induction providing 
protection to lymphocytes against secondary sources of exercise-induced oxidative 
stress, such as the inflammatory response.
As described earlier (Section 1.5.2), HO-1 induction in lymphocytes provides resistance 
against apoptosis. Cultured lymphocyte cell lines are routinely used in conjunction with 
H2O2 treatment to investigate oxidative stress and the effects of this oxidant on cell 
death are well characterised. Although these cell lines provide useful models, the 
treatment of freshly harvested lymphocytes ex vivo may be a more useful model since 
these cells have not adapted to the conditions of cell culture. Halliwell (2003) discusses 
the issue of oxidative stress in cell culture and highlights that culture conditions increase 
free radical production and oxidative stress. Therefore, researchers should be cautious 
when extrapolating data from cell culture work to the in vivo situation (Halliwell, 2003). 
However, few studies have investigated HO-1 up-regulation in human lymphocytes in 
response to ex vivo H2O2 treatment and cell death.
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1.6.3 Apoptosis and necrosis
The exposure of lymphocytes to low doses (< 100 pM) of H2O2 treatment causes 
lymphocytes to die by apoptosis. However, when lymphocytes are challenged with toxic 
doses of H2O2 the outcome is necrosis, indicating that H2O2 cytotoxicity is dependent on 
concentration (Hampton and Orrenius, 1997). In this investigation, treatment of Jurkat 
cells with 50 pM H2O2 induced apoptosis in 25% of cells, whereas 500 pM H2O2 led to 
the appearance of necrotic cells. Caspase activation wras measured in addition to PS 
exposure with a 10-fold increase in caspase activity observed in cells treated with 50 pM 
H2O2 for 6 h. At higher concentrations (200 pM H2O2), a decline in caspase activity was 
observed with the level of activity falling below levels in control cells. Furthermore, the 
increase in H2O2 concentration to levels that did not activate caspases correlated with the 
switch from apoptotic to necrotic cell death. Cells treated with low concentrations (50 
pM) of H2O2 were impaired in their ability to undergo Fas-mediated apoptosis. In Jurkat 
cells pre-treated with anti-Fas prior to addition o f H2O2 30-60 min after the initial 
trigger, caspase activity is inhibited by 40%. The findings of this study demonstrate a 
dual regulation of H2O2 by triggering caspases and inducing apoptosis, and balancing 
apoptosis by the inhibition of caspase activity (Hampton and Orrenius, 1997).
The induction of HO-1 confers cyto-protection against oxidative stress and has been 
shown to inhibit apoptosis in lymphocytes (Choi et al., 2004). Protection against H2O2- 
induced apoptosis was found to be related to the (GT) n repeat promoter polymorphism 
of the HO-1 gene (Hirai et ah, 2003). Lymphoblastoid cells possessing long alleles were 
more susceptible to apoptosis than those cells with short alleles (Hirai et al., 2003). 
Cells with short alleles demonstrated a greater induction of HO-1 mRNA expression and 
HO-1 activity in response to H2O2 treatment, reducing apoptosis. Therefore, these 
findings show that a polymorphism of the HO-1 gene is associated with the strength of 
induction of HO-1, possibly determining susceptibility to oxidative-stress mediated 
diseases (Hirai et al., 2003).
The induction of HO-1 is described as a molecular switch that protects against acute 
oxidative and inflammatory insults (Wagener et al., 2003). Studies using knockout mice 
have shown that fibroblasts taken from mice deficient in HO-1 had decreased levels of 
survival in comparison to fibroblasts from control animals (Poss and Tonegawa, 1997b), 
thus demonstrating the cytoprotective role of HO-1. Furthermore, a case o f HO-1 
deficiency in humans has been reported (Yachie et al., 1999) displaying symptoms of 
growth retardation, anaemia, iron deposition, and vulnerability to stressful injury. These 
injuries are similar to those found in HO-1 deficient mice and illustrate the important 
role that HO-1 plays in cellular protection in vivo. The over-expression of HO-1 in rats
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exposed to hyperoxia was anti-apoptotic, protecting cells against hyperoxia-induced 
lung injury (Otterbein et al., 1999). This was supported by in vitro studies showing that 
over-expression of HO-1 reduces apoptosis in murine fibroblasts (Petrache et al., 2000) 
and Jurkat cells (Choi et al., 2004). In addition, HO-1 induction is implicated in survival 
of graft transplants (Soares et al., 2001).
Haem oxygenase-1 induction is a general response to oxidative stress (Keyse and 
Tyrrell, 1989) and it may be possible to modulate its response by altering redox status. 
These properties support the use of HO-1 as a useful and relevant marker of oxidative 
stress. The functional anti-apoptotic nature of this response further strengthens the use 
of this gene as a molecular marker of oxidative stress in vitro and in vivo.
1.7 Protection against oxidative stress
Sophisticated intra- and extra-cellular antioxidant systems have evolved to avoid 
oxidative stress. The antioxidant defence system can be manipulated through the 
induction of endogenous internal systems or through supplementation with exogenous 
antioxidants. An antioxidant is defined as ‘any substance, that when present at low 
concentrations compared to those of an oxidisable compound, significantly delays or 
inhibits oxidation of that substrate’ (Halliwell and Gutteridge, 1999). The antioxidant 
defence system comprises many substances, including enzymes which catalytically 
remove free radicals, proteins which minimise pro-oxidant availability, proteins that 
protect against oxidative damage (HSPs) and low molecular mass agents that scavenge 
ROS.
The antioxidant defence system provides a protective mechanism to cells and tissues. 
The composition of antioxidants differs from tissue to tissue and between cell-types, and 
this is dependent on (i) which ROS are generated, (ii) the source of ROS production and 
(iii) where the target of damage is measured (Halliwell and Gutteridge, 1999). 
Therefore, the antioxidant defence system in each tissue is dependent on the level of 
oxidative stress encountered. The body has a sophisticated defence system which can be 
further enhanced through the diet. These two types o f defences are described separately 
in the following sections.
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1.7.1 Endogenous antioxidants
Endogenous protective mechanisms consist of both enzymatic and non-enzymatic 
antioxidants (Table 1.6), which are located in the intra- and extra-cellular environments 
offering maximum protection against ROS. The three main antioxidant enzymes are 
superoxide dismutase (SOD), glutathione peroxidase (GPX) and catalase (CAT). These 
enzymes provide protection through different strategies including the conversion of 
ROS to less active molecules and the prevention of these less reactive ROS into more 
deleterious forms of ROS.
Table 1.6 Summary o f the major enzymatic and non-enzymatic antioxidants
Antioxidant Category Properties
Superoxide dismutase Enz}mie Dismutates superoxide; Located in the cytosol and mitochondria
Glutathione Peroxidase Removes hydrogen peroxide and organic hydroperoxides; Located in the cytosol and mitochondria
Catalase 4 Removes hydrogen peroxide; Located in peroxisomes and mitochondria
Vitamin E Non-enzymatic Lipid-soluble; major chain-breaking antioxidant found in cell membranes
Carotenoids Lipid-soluble; located primarily in tissue membranes
Bilirubin By-product o f haem catabolism; extracellular antioxidant
Ubiquinone Lipid-soluble quinone derivatives; reduced forms are efficient antioxidants
Flavonoids and polyphenols Lipid-soluble scavenger and metal chelators
Glutathione Non-protein thiol in cells
Uric acid By-product o f purine metabolism; scavenges hydroxyl radicals
Vitamin C r Water-soluble; radical scavenger and recycles vitamin E
This is only a short list and does not include all antioxidants. There are many other compounds with protective properties.
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The superoxide radical is the precursor to most ROS and is generated at a number of 
sites. Superoxide dismutase provides the primary cellular defence against superoxide 
radicals converting it to H2O2 and oxygen [Equation 1.9]. Three isozymes o f SOD exist, 
with the CuZnSOD primarily located in the cytosol and the MnSOD found in the 
mitochondrial matrix (Halliwell and Gutteridge, 1999). Extracellular SOD (EC-SOD) 
exists in the plasma as well as in tissues. Glutathione peroxidase catalyses the reduction 
of H2O2 to water generating glutathione disulphide (GSSG) [Equation 1.10] or organic 
hydroperoxides to alcohol and GSSG [Equation 1.11] using reduced glutathione (GSH) 
as the electron donor. Glutathione peroxidase is a selenium-dependent enzyme and an 
important cellular protectant against ROS-mediated damage to membrane lipids, 
proteins and nucleic acids, reducing a variety of hydroperoxides. In order for GPX to 
function the enzyme requires a supply o f GSH and therefore cells must possess a 
pathway for regeneration of GSH. This occurs via the enzyme glutathione reductase 
(GR), which uses NADPH to produce a supply of GSH [Equation 1.12]. The 
distribution of GR is similar to GPX, with greater activity in highly oxidative muscles. 
Although GR is not a primary antioxidant enzyme, it is essential for the normal 
antioxidant function o f GPX. The function of CAT is to remove H2O2 [Equation 1.13], 
which forms from the dismutation of superoxide. Both CAT and GPX remove H2O2 
from the environment, however, their affinity for H2O2 as a substrate differs with GPX 
playing a more active role in removing H2O2 at low concentrations. Catalase is widely 
distributed in the cell, with high concentrations in peroxisomes and mitochondria.
SOD: 2 0 2*’ + 2H+ —► H20 2 + 0 2 [Equation 1.9]
GPX: 2GSH + H20 2 -> GSSG + 2H20 [Equation 1.10]
2GSH + ROOH—► GSSG + ROH [Equation 1.11]
GR: GSSG + NADPH -»  2GSH + NADP [Equation 1.12]
CAT: 2H20 2 -> 2H20  + 0 2 [Equation 1.13]
The distribution of these enzymes varies from tissue to tissue with highly oxidative 
skeletal muscle (Type I and Ha fibres) containing a greater enzyme activity of SOD, 
GPX and CAT than muscles with low oxidative capacity (Powers et al., 1994). Several 
investigations report an increase in these antioxidant enzymes in skeletal muscle, liver 
and heart following a single bout of acute exercise-induced oxidative stress in both 
animal and human studies (Ji and Fu, 1992; Ji et al., 1992; Sen, 1995; McArdle et al.,
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2001). The effect of regular endurance training has been demonstrated to increase the 
activity of SOD and GPX along with increased cellular glutathione concentrations in 
skeletal muscle (Powers et a l , 1999). Increased SOD activity was demonstrated in 
diaphragm muscle of rodents following a 12 week training protocol consisting of 90 min 
treadmill running at 75% V02max per day (Vincent et al., 1999). The improved 
antioxidant capacity resulted in a protective effect against contractile-induced oxidative 
stress of the diaphragm muscle with significantly lower levels of lipid peroxidation in 
the trained versus sedentary animals (Vincent et a l , 1999). This protective effect was 
also observed following short-term exercise training for five consecutive days (Vincent 
et a l,  2000). Up-regulation o f resting SOD and GPX activities has also been 
demonstrated in human erythrocytes following 12 weeks of high-intensity exercise 
training (Miyazaki et a l, 2001). In this investigation, lipid peroxidation and neutrophil 
superoxide production in response to incremental cycling to exhaustion were attenuated 
following the training period, indicating a protective effect of high-intensity exercise 
training.
The responses to acute and regular exercise are different due to adaptations which occur 
when exercise is undertaken frequently. Regular exercise training improves the 
antioxidant defence system and up-regulates the expression of protective proteins 
lowering the oxidant state of the body (Powers and Sen, 2000). This adaptation 
ameliorates oxidative stress caused during acute exercise when compared to the degree 
of oxidative stress induced prior to regular exercise training. However, even in well 
adapted individuals if the increase in free radical production following exercise is 
excessive and overwhelms the antioxidant defence system, oxidative stress will occur. 
Some people may further benefit from antioxidant supplementation to reduce exercise- 
induced oxidative stress if  training adaptations are not sufficient (Sen, 1995; Ashton et 
a l,  1998). As HO-1 is a marker o f oxidative stress, an alteration in redox balance will be 
reflected by changes in the expression of HO-1. In principle, the induction o f HO-1 
should be modulated by antioxidant availability and confirm both the oxidant-sensitive 
nature of the gene and the relative importance of any given antioxidant.
1. 7.2 Antioxidant compounds
Several non-enzymatic antioxidants are outlined in Table 1.6. Many of these compounds 
are synthesised in vivo or obtained from the diet. Glutathione serves multiple roles in 
cellular antioxidant defence and is involved in the reduction of vitamin E and vitamin C 
(Halliwell and Gutteridge, 1999). Bilirubin is a product of haem degradation, catalysed 
by HO-1, and has antioxidant properties (Stocker et a l ,  1987). Vitamins A, C, and E,
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carotenoids and flavonoids are found in a variety of fruits and vegetables. The 
localisation of an antioxidant within the body is dependent on its solubility with water- 
soluble compounds such as vitamin C, GSH and uric acid located in the cytosol, 
mitochondrial matrix and extracellular fluids. In contrast, the lipid-soluble compounds 
vitamin A, E, CoQ, carotenoids, polyphenols, and flavonoids are located in membranes, 
providing protection against oxidative damage to this compartment. A discussion on the 
protective effects of these antioxidants is beyond the scope of this literature review and 
the reader is referred to the following articles (Sies and Stahl, 1995; Traber, 2000; Sen, 
2001b; Jackson et a l , 2002).
In recent years, the purported protective effects of the carotenoid lycopene have 
attracted attention (Section 1.8). Lycopene is the principal antioxidant in tomatoes and 
there is strong evidence that tomato consumption is associated with reduced risk of 
cancer (Giovannucci et a l , 1995) and improvement in general health (Gey et a l , 1987). 
In particular, the consumption of a tomato-rich diet has been suggested to be a principle 
reason for lower cancer rates in the Mediterranean region (La Vecchia, 1998).
1.8 Lycopene
Lycopene is one of over 500 different carotenoids. The predominant feature of 
carotenoids is the long hydrocarbon chain consisting of a 40 carbon skeleton structure 
with conjugated double bonds flanked by two p-ionone rings, which provides 
provitamin A activity (Basu and Dickerson, 1996). This chain is referred to as the 
polyene chain and is responsible for the photochemical properties and chemical 
reactivity o f carotenoids. Carotenoids are found in all vegetables and fruits containing 
chlorophyll and are often red, yellow and orange in colour (Britton, 1995). The use of 
high-performance liquid chromatography (HPLC) analysis has revealed a total of about 
34 carotenoids in human serum, including lycopene and an oxidation product of 
lycopene known as 2,6-cyclolycopene-l,5-diol (Khachik et a l , 1997).
1.8.1 Lycopene Structure
Lycopene (C40H56) is an acyclic, open chain hydrocarbon containing 11 conjugated and 
two non-conjugated double bonds arranged in a linear array (Britton, 1995) (Figure 1.6). 
Lycopene like other carotenoids exists in cis and trans forms depending on the location 
of substituent groups, with the cw-isomer being generally less stable 
thermodynamically. The all-trans configuration is a linear, rigid molecule that is more
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difficult to absorb, solubilise and transport than the czs-isomer and for this reason, 
lycopene is found to exist predominantly as the all-trans form in nature. During 
chemical reactions, the double bonds are capable of undergoing isomerisation from 
trans to mono or poly-ds isomers. The most commonly identified forms o f lycopene are 
all-trans, 5-cis, 9-cis, 13-cis and 15-ds. Lycopene lacks the p-ionone ring structure and 
consequently provitamin A activity is absent from this molecule. It is now believed that 
the absence of this structure may in fact increase the antioxidant activity of the molecule 
(Stahl and Sies, 1996).
Figure 1.6 Molecular structure of lycopene
The half life of lycopene in human plasma is approximately 2-3 days (Stahl and Sies, 
1996). In plasma, the lycopene concentration is approximately 0.3-0.5 pM where it is an 
isomeric mixture with 50% total lycopene as cis isomers (Clinton et al., 1996). 
Lycopene tends to be found in the all-trans form in plant sources thus indicating that 
trans to cis isomerisation occurs in vivo (Sakomoto et a l,  1994), although very little is 
known about the in vivo metabolism o f lycopene.
Lycopene is incorporated into dietary lipid micelles and absorbed into the intestinal 
mucosal lining via passive diffusion. Chylomicrons containing lycopene are released 
into the lymphatic system for transport to the liver. Lycopene is concentrated in low- 
density lipoprotein (LDL) and very low-density lipoprotein (VLDL) fractions of the 
serum enabling transportation of lycopene through the membranes to the different 
organs (Stahl and Sies, 1996). The tissue distribution of dietary carotenoids is not 
uniform although it is known that lycopene can accumulate in tissues, with the inter­
individual variation in tissue lycopene levels about 100-fold (Rao and Agarwal, 1999). 
Lycopene is most concentrated in the adrenal glands, liver, prostate and testes (Table 
1.7), which is believed to be related to the large number o f lipoprotein receptors in these 
tissues.
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Table 1.7 Lycopene levels in human tissue














(Source: Rao & Agarwal, 1999).
1.8.2 Sources o f  lycopene and absorption
The most common sources of lycopene are fruits and vegetables that are red in colour, 
such as tomatoes, watermelon, apricots and papaya (Gross, 1987). When 
supplementation is via whole foods, it is important to note that the content of lycopene 
in tomatoes varies with different types of tomatoes and the extent o f ripeness (Scott and 
Hart, 1995). The form in which lycopene is given affects the bioavailability of this 
antioxidant as trans-cis isomerisation occurs during cooking and food processing 
(Tonucci et al., 1995), therefore there is minimal loss of actual lycopene content. The 
predominant form of lycopene in raw tomatoes is the all-trans isomer, however, the 
major contributors of lycopene in the Western diet are from tomato juice, ketchup, soup 
and spaghetti which contain czs-isomers (Table 1.8). These foods have one common 
factor in that they have been processed enabling trans-cis isomerisation. Heat treatment
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has been found to improve the bioavailability of lycopene causing lycopene release from 
the food matrix (Stahl and Sies, 1996; Gartner et a l,  1997).
Table 1.8 Lycopene contents of common fruits and vegetables______________________

















(Source: Rao and Agarwal, 1998).
The bioavailability of lycopene is enhanced from the food matrix in the presence of 
dietary lipids, processing and heat-induced isomerisation from all-trans to cis 
conformation (Stahl and Sies, 1992). Apart from matrix effects, lycopene absorption 
from foods is influenced by other factors, namely co-ingestion of high amounts of 
dietary fibre (Hoffman et al., 1999; Riedl et a l,  1999) or by co-ingestion of fat (Clark et 
al., 2000). Stahl and Sies (1992) demonstrated a 3-fold increase in serum lycopene 
levels following ingestion of cooked tomato juice in oil medium whereas the
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consumption of an equivalent amount of unprocessed tomato juice did not have any 
effect. Similarly, Gartner and colleagues (1997) found higher levels of lycopene in 
chylomicron fractions after consumption of tomato paste compared to fresh tomatoes, 
indicating that the cis isomeric form is more bioavailable than the trans in tomato paste 
compared to fresh tomatoes.
1.8.3 Lycopene function
Epidemiological studies examining normal and at risk populations have demonstrated a 
protective role of lycopene in the prevention of chronic diseases (Table 1.9). A recent 
review of the epidemiological literature and the relationship between plasma lycopene 
levels or tomato intake and the reduced risk of cancer has been conducted, finding an 
inverse relationship in 57 of the 72 studies identified (Giovannucci, 1999). Cancers of 
the prostate, lung and stomach showed the strongest benefit from lycopene/tomato 
intake.
Lycopene is a lipid-soluble antioxidant which scavenges both singlet oxygen (Sundquist 
et al., 1994; Tinkler et al., 1994) and peroxyl radicals at a faster rate than any other 
carotenoid including p-carotene (Di Mascio et a l,  1989; Woodall et al., 1997). 
Additionally, lycopene has been reported to protect lymphocytes from H2O2 and 
nitrogen dioxide radical damage, with protection induced by lycopene at least twice as 
effective as p-carotene (Bohm et a l,  1995). Lycopene has also been found to suppress 
growth of cancer cells in vitro more effectively than other carotenoids (Levy et a l,  
1995). In this study, a 4-fold and 10-fold relative increase in the concentration o f a- and 
p-carotene was required to produce similar growth suppression o f cancer cells as that 
found with lycopene. The findings from in vitro and epidemiological studies provide a 
strong theoretical relationship between lycopene intake and protection against chronic 
disease. This has led to an increase in the number of human trials investigating the 
protective effects of lycopene supplementation.
Table 1.9 The impact o f lycopene on chronic diseases in epidemiological studies
Reference n Outcome Notes
Giovannucci et al., (1995) 773 Dietary tomato-based products >10 vs. 1.5 servings/wk inversely related to prostate cancer risk 
Tomato sauce intake 2-4 vs. 0 servings/wk inversely related to prostate cancer risk
RR=0.65
RR=0.66
Kohlmeier et al., (1997) 1379 Inverse OR for MI by quintiles o f adipose tissue concentration 
Contrast between 10th and 90th percentile
OR=0.52
Gann et al., (1999) 578 cases 
1294 controls
Plasma LYC strongly associated with lower prostate cancer risk in PLA group OR=0.40
Slattery et al., (2000) 2410 Mean intake o f LYC 6.4 mg in both cases and controls 
no difference in LYC and colon cancer risk but inverse relationship with lutein
Lu et al., (2001) 65 cases 
132 controls
Inverse OR associated with prostate cancer 
Plasma LYC: 0.223 (cases) vs. 0.307 pM (controls)
OR=0.17
Polidori et al., (2001) 72 cases 
75 controls
Plasma LYC in controls was 85% greater than diabetics 
0.75 ± 0.25 vs. 0.11 ± 0.04 pM
Giovannucci et al., (2002) 47 365 LYC intake (>2/week vs. <1/month) associated with [  risk prostate cancer 
2481 individuals developed prostate cancer between 1986 and 1998
RR=0.77
Rissanen et al., (2003) 1028 Serum LYC concentration negatively correlated with mean CCA-IMT
Erhardt et al., (2003) 73 cases 
63 controls
Median plasma LYC lower in adenoma group than control group (52 p.g.1'1 vs. 80 pg.l'1) 
Plasma LYC < 70 pg.l’1 risk factor for colorectal cancer
RR: relative risk, OR: odds ratio, MI: myocardial infarction, LYC: lycopene, PLA: placebo, CCA-IMT: common carotid artery-intima media thickness.
oo
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1.8.4 Supplementation with lycopene
Several investigations have demonstrated protection to lymphocytes isolated from 
healthy human subjects supplemented with lycopene through a lycopene isolate or in the 
form of tomato-based products (Table 1.10). Plasma lycopene concentration increases 
following supplementation with different tomato products, oleoresin and lycopene 
beadlets, demonstrating an equal bioavailability of lycopene from these sources (Paetau 
et al., 1998). A recent study revealed the plasma response of lycopene following 
consumption of tomato sauce (21 mg/day) for three weeks was 65% greater than the 
plasma response observed in individuals consuming vegetable juice for three weeks (17 
mg/day) (Allen et al., 2003), suggesting that lycopene from tomato sauce is more 
bioavailable than from vegetable juice. New steady state plasma lycopene 
concentrations are found within two weeks of increased consumption of tomato products 
(Micozzi et al., 1992; Allen et al., 2003). Similarly, two weeks consumption of a 
lycopene free diet has been found to reduce plasma lycopene levels by 50% (Bohm and 
Bitsch, 1999).
Table 1.10 Lycopene supplementation protects against oxidative stress-induced damage
Reference n Supplementation per day Outcome
Rao and Agarwal (1998) 19 6 treatments, each 1 wk: 2 x SS (20.5/ 39 mg); TJ (50 
mg); OLR (75/150 mg); PLA, cross-over
LYC levels f  in dose-dependent manner in the SS and OLR 
I serum TBARS with SS,TJ, OLR
Paetau et al., (1998) 15 4 treatments each 4 wks: TJ (75 mg); OLR (75 mg); B 
(70 mg); PLA; each with 4.5 g butter, cross-over
t  plasma LYC following TJ, OLR and B 
Detected 2,6-cyclolycopene-l, 5-diol in plasma
Riso et al., (1999) 10 60 g tomato puree (16.5 mg LYC and 0.6 mg 13- 
carotene) for 3 wks with 10 g olive oil, cross-over
I L DNA damage by 33% to 500 pM H20 2
Neuman et al., (2000) 20 OLR (30 mg/day) for 1 wk, cross-over 55% patients protected against exercise-induced asthma 
Forced expiratory volume in 1 s improved by 10%
Porrini and Riso (2000) 9 25 g tomato puree (7 mg LYC and 0.3 mg p-carotene) 
for 2 wks with 5 g olive oil, cross-over
i  L DNA damage by 50% to 500 pM H20 2 
Inverse relationship between plasma LYC and DNA damage
Stahl et al., (2001) 19 40 g tomato paste (16 mg LYC) with 10 g olive oil for 
10 wks (9 treated, 10 controls)
Dorsal erythema formation was 40% lower in tomato paste 
group compared to control group
Rao and Shen (2002) 12 6 trials: 5,10, 20 mg LYC of OLR or Ketchup 
for 2 wks, cross-over
I TBARS and protein oxidation with all tomato treatments
Riso et al., (2004) 20 Tomato products taken with 10 g olive oil for 3 wks 
(8 mg LYC, 0.5 mg P-carotene, 11 mg vitamin C)
i  DNA damage by 24% following exposure to iron ions 
Trend towards I lipid peroxidation in L
SS: spaghetti sauce, TJ: tomato juice, OLR: oleoresin capsules, PLA: placebo, B: lycopene beadlets, LYC: lycopene, L: lymphocytes.
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Lycopene supplementation has been shown to increase plasma lycopene and the extent 
of the increase in tissue lycopene concentration is dependent on the dose of 
supplementation as well as the form in which lycopene is given (capsule, raw or 
processed foods). Although extremely high lycopene concentrations can act as a pro­
oxidant in vitro (Lowe et al., 1999) it seems that in humans it is not physiologically 
possible to reach these concentrations. Indeed, consumption of up to 150 mg lycopene 
from a variety o f sources (foods and capsules) for one week increased plasma lycopene 
levels to -0.75 pM (Rao and Agarwal, 1998), revealing that high lycopene 
concentrations (> 4 pM) cannot be achieved by consuming a diet rich in lycopene.
However, this study did demonstrate that one week supplementation of 20-150 mg 
lycopene per day was sufficient to increase plasma lycopene concentration 2-fold and 
was associated with reduced endogenous levels of oxidation of lipids, proteins, and 
DNA. Based on this, recommendations for a daily lycopene intake of 25-30 mg were 
suggested (Rao and Agarwal, 1998). Supplementation with 25 g tomato puree per day 
for two weeks increased plasma lycopene levels 3-fold, with a 2-fold increase in the 
lycopene concentration of lymphocytes (Porrini and Riso, 2000). Both plasma and 
lymphocyte lycopene concentrations following supplementation were inversely 
correlated with the level of oxidative DNA damage induced by treatment with H2O2, 
indicating that lycopene contributes to the protection of DNA from oxidative stress 
(Porrini and Riso, 2000). The amount of lycopene delivered in this study was 7 mg/day, 
although more importantly, this dose was delivered in a realistic quantity of a whole 
food product as previous research has observed protective effects from large quantities 
of foods or antioxidant isolates (Paetau et a l , 1998; Rao and Agarwal, 1998; Paetau et 
al., 1999; Torbergsen and Collins, 2000). This observation was supported by Rao and 
Shen (2002), demonstrating reduced levels of endogenous lipid peroxidation (TBARS) 
and protein damage (loss of reduced thiol groups) following two weeks of 
supplementation with different doses of lycopene (5, 10 and 20 mg/day) in the form of 
ketchup or oleoresin capsules. In this investigation, there were no differences in the 
reduction of lipid peroxidation or protein damage between treatments, leading to the 
conclusion that an intake of 5 to 10 mg lycopene per day is adequate to maintain serum 
lycopene level and reduce lipid peroxidation. However, this may not be sufficient in 
populations at high risk for chronic diseases, and the higher recommendation suggested 
by Rao and Agarwal (1998) may be more beneficial, as epidemiological evidence 
supports an association between intake of tomato products and the reduced risk of 
cancer (Giovannucci et al., 1995). Therefore, it is necessary that future investigations 
continue to examine the effects of lycopene supplementation in food products where the 
consumption is of manageable and realistic portion sizes.
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1.8.5 Antioxidant modulation o f HO-1
At the present time, there is no available information on the effect of lycopene 
supplementation on HO-1 expression in humans and it is only possible to draw parallels 
with other antioxidants. Generally, the literature indicates a suppressive effect of 
antioxidant supplementation on the expression of HO-1, and this has been observed in 
animal models, cell culture studies and in human trials (Table 1.11). For example, rats 
supplemented with ascorbic acid, bilirubin, P-carotene or a-tocopheral had reduced 
levels of hepatic HO-1 mRNA accumulation in response to stimulation (Ossola et al., 
1997; Yamaguchi et al., 1997).
Presently only two studies have investigated antioxidant supplementation and HO-1 
expression in human leukocytes. Niess and co-workers (2000) supplemented athletes 
with vitamin E for eight days and measured HO-1 protein expression before and after an 
exhaustive run. In the control trial o f this investigation, HO-1 protein expression 
increased a small amount in neutrophils and monocytes. Vitamin E supplementation did 
not affect HO-1 expression at baseline and a similar increase in neutrophil and 
monocyte HO-1 protein was demonstrated following exercise (Niess et al., 2000). 
Therefore, this study demonstrated that exercise-induced HO-1 protein induction was 
not modulated by vitamin E supplementation. It is possible that the exercise protocol 
was not demanding enough, as only small changes in HO-1 were observed. In contrast, 
larger changes in the cytoplasmic expression of HO-1 have been observed following 
prolonged running (Niess et al., 1999b), and it is likely that this form of exercise model 
would be more appropriate to investigate the impact of supplementation.
The second human study examined the effect of a mixed dietary supplement taken daily 
for five weeks on the expression of HSPs and HO-1 induction following exposure to the 
free radical generator, AAPH (2, 2 ’-Azobis-(2-amidinopropane)-dihydrochloride) (Peng 
et al., 2000). The expression of HSPs and HO-1 were differentially modulated with HSP 
synthesis increasing and HO-1 protein decreasing at the end of the supplementation 
period. The overall antioxidant capacity of erythrocytes increased leading to an 
attenuation of oxidative stress observed by reduced levels of MDA and protein 
cambonyl formation and a down-regulation in the expression of HO-1. The authors 
suggested that the reduced HO-1 response may be the result of inhibition of NF-kB 
activation as this transcription factor has been found to be inhibited by a number of 
antioxidants (Sen and Packer, 1996; Jackson et al., 1998).
Table 1.11 Antioxidant treatment and HO-1 expression
Reference n Treatment Outcome
Yamaguchi et al., (1997)# 66 2 groups (n=33), fed basal diet + AA, or basal diet 
Rats were deficient in AA synthesis
I hepatic HO-1 mRNA expression in AA gp 5 h after LPS stimulation 
(7-fold vs. 13-fold, respectively)
Ossola et al., (1997)# 9 Intraperitoneal administration of BR, a-tocopheral 
or BC 2 h prior to CuS04 treatment in rats
Hepatic HO activity j  significantly with BR and a-tocopheral, 
BC partially [ hepatic HO activity
Offord et al., (2002)* 2 GT-4 fibroblasts treated with 0.1-0.5 pM BC/LYC 
with 14 pM vitamin C
t HO-1 mRNA expression with BC/LYC following 500 kJ.nf2 UVA
Trekli et al., (2003)* 3-4 FEK4 fibroblasts treated with 2.3-21 pM BC Concentration-dependent I HO-1 mRNA following 250 kJ.m'2 UVA  
with BC (2-fold vs. 6-fold at 2.3 pM)
Basu-Modak et al., (2003)* 3 FEK4 fibroblasts treated with 30 pM epicatechin No effect on HO-1 mRNA at 50,100, 250 kJ.nf2 UVA 
f  HO-1 mRNA at 500 kJmf2 UVA (12-fold vs.3-fold, respectively)
Niess et al., (2000)f 13 Vitamin E (500 IU/day) for 8 days No difference in HO-1 protein expression before or after EE
Peng et al., (2000)| 32 Mixed antioxidant supplement (1 capsule/day for 
5 wks) 19 supplemented and 13 controls
Exposure to AAPH j MDA and protein carbonyl formation 
t  synthesis o f HSPs and J, HO-1 protein
# denotes animal study, * denotes in vitro study, |  denotes human study, AA: ascorbic acid, AAPH: 2, 2 ’-Azobis-(2-amidinopropane)-dihydrochloride.
BR: bilirubin, CuS04: copper sulphate, BC: P-carotene, EE: exhaustive exercise, LYC: lycopene, UVA: ultraviolet A irradiation.
u>
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In contrast to these findings, in vitro studies have demonstrated inconsistent results. Cell 
culture studies using fibroblast cell lines have demonstrated an increase in the 
expression of HO-1 mRNA following UVA irradiation (500 kJ.m'2) when cells were 
treated with low concentrations o f P-carotene or lycopene (Offord et a l , 2002). 
However, Trekli and colleagues (2003) observed a concentration-dependent suppression 
of UVA- (250 k J .m ') induced transcriptional activation o f HO-1 in fibroblast cells by (3- 
carotene. Furthermore, fibroblasts incubated with lycopene in the culture medium also 
demonstrated suppression of UVA-(100 and 250 kJ.m'2) induced HO-1 mRNA 
accumulation (Trekli, 2003).
The protective effect of tomato consumption is well established in the literature, 
although the effect of lycopene supplementation on HO-1 expression in humans has not 
been investigated. Oxidative stress is implicated in the causation and progression of 
chronic diseases with epidemiological evidence indicating that diets high in fruits and 
vegetables are associated with a lower risk of disease (Ames et al., 1993). It is now 
known that diets high in antioxidants have the potential to modulate the expression of 
oxidant-responsive genes and it is possible that lycopene is effective through a 
modulation of redox balance and the response to an oxidant challenge.
1.9 Aims
The research outlined in this thesis aimed to examine the impact o f lycopene 
supplementation on the expression of HO-1. The first part of this thesis aimed to 
develop models of oxidative stress that were sensitive, reproducible and physiologically 
relevant. The induction of HO-1 mRNA and protein was used as a marker of oxidative 
stress. Once an acceptable model was developed, the second stage of this work aimed to 






All experimental procedures involving subjects took place in the Applied Physiology 
Laboratory at the University of Bath. Each study received ethics approval from the NHS 
Local South West Research Ethics Committee (Bath). Treatments to, and analysis of 
human mononuclear cells (MNCs) were carried out in the Department o f Pharmacy and 
Pharmacology. This Chapter outlines the generic protocols that were used throughout 
this thesis. Methods which were used once only are described in the relevant Chapter.
In all studies, excluding Chapter 3, subjects were male volunteers (aged 18-40 years). In 
Chapter 3, three females volunteered to take part in the study. All subjects were 
provided with an information sheet detailing the requirements of each study. Subjects 
gave written informed consent to participate and were asked to complete a medical 
history questionnaire (Appendix 1). Information regarding physical activity levels were 
also collected (Appendix 2). Subjects taking regular prescribed medication and smokers 
were excluded from all studies.
2.2 Anthropometry
Height was measured using a fixed stadiometer (Holtain Ltd., UK) and recorded to the 
nearest cm. Body mass was measured using an Avery balance scale (Weylux, England) 
to the nearest 0.05 kg. Subjects were required to wear light clothing during this 
measurement.
Measurements of skinfold thickness was made in triplicate and measured to the nearest 
0.1 mm using skinfold calipers (Holtain Ltd., UK). Four different sites were measured: 
biceps, triceps, subscapular, and suprailiac. Skinfold thickness was reported as the sum 
of the four sites.
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2.3 Maximal oxygen uptake test
Maximal oxygen uptake (VC^max) of each subject was determined using a submaximal 
speed test followed by an incremental incline test to exhaustion on a treadmill ergometer 
(Woodway, ELG 70 Weiss, Germany). The submaximal running protocol consisted of 
four steady-state exercise stages, each lasting four min, with speed increasing by one 
km.h'1 with each stage. One-minute expired air samples were collected at the end of 
each stage of exercise using Douglas bags. Measures of heart rate (HR) (Vantage NV, 
Polar Electro OY, Finland) and rate of perceived exertion (RPE) using a 6-20 scale 
(Borg, 1973) were taken during the gas collection.
The percentage of oxygen and carbon dioxide (CO2) in expired air samples was 
determined using a paramagnetic O2 analyser (Series 1400, Servomex Ltd., Sussex, UK) 
and an infrared CO2 gas analyser (Series 1400, Servomex Ltd., Sussex, UK). Expired air 
volume was determined using a dry gas meter (Harvard Apparatus, Kent, UK) and 
corrected to standard temperature and pressure (dry gas). Expired minute ventilation, 
respiratory exchange ratio (RER), VO2 and carbon dioxide output (VCO2) were 
calculated for each expired air sample.
Following adequate recovery subjects completed the maximal incremental test, 
consisting o f three-minute exercise stages at gradients of 3, 6, 8.5, and 11% until 
volitional exhaustion. The initial speed for this test was determined by linear regression 
using HR and speed from the submaximal test, so that HR was approximately 160 
beats.min'1. Expired gas samples were collected in the final min of each stage along with 
HR and RPE. Peak HR was defined as the highest value recorded during this test. The 
criteria for a valid VC^max were a maximal RER value of 1.10 and/or maximal HR 
value within 5% of their age-predicted maximum.
In Chapter 3, the relationship between speed and VO2 was used to determine the average 
intensity at which each subject completed the half marathon race. In Chapter 5, the VO2 
values were used to calculate the running speeds required to obtain 65, 85 and 100% of 
VC^max.
2.4 Dietary Restrictions
Subjects arrived in the laboratory following an overnight fast on each occasion where a 
blood sample was taken. Participants in each study were required to report their food
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and fluid intake over a period of 72 h prior to each trial and were asked to refrain from 
consuming alcohol during this period. Each subject received a set of weighing scales 
(Model 3001, Salter, Kent, UK) to accurately fulfill this requirement. In Chapters 3 to 6, 
weighed food records were analyzed using the software COMP-EAT 4.0 (Nutrition 
Systems, UK), which is based on food composition tables.
2.5 Chemicals
All reagents were from Sigma-Aldrich (Poole, UK) unless otherwise specified. Routine 
tissue culture reagents were purchased from Gibco Invitrogen Ltd. (Paisley, UK). Foetal 
calf serum (FCS) and horse serum (HS) were purchased from PAA laboratories 
(Somerset, UK). LightCycler DNA Master SYBR Green I, propidium iodide, Annexin 
V and bovine serum albumin (BSA) standard solution were purchased from Roche 
Molecular Biochemicals (Lewes, UK). TRIZOL reagent and Superscript first-strand 
synthesis kit were purchased from Invitrogen Life Technologies (Paisley, UK). The 
mouse anti-HO-1 monoclonal antibody (Stressgen, Victoria, Canada) was purchased 
from Bioquote Ltd (York, UK). Ethanol, methanol and acetonitrile (HPLC grade) were 
purchased from Fisher Scientific (Loughborough, UK). Tetrahydrofuran (THF) and n- 
Hexane were purchased from BDH (Poole, UK). Phosphate-buffered saline (PBS) was 
purchased from Oxoid Ltd. (Basingstoke, UK). Hydrogen peroxide (H2O2) was 
purchased from Calbiochem (Poole, UK).
2.6 Blood Sampling
On the morning of a trial, subjects reported to the laboratory following an overnight fast. 
Subjects remained in a supine position for 15 min prior to blood sampling. Twenty-five 
ml o f whole blood was collected by venepuncture in the ante-cubital vein. In all studies, 
syringes were used and the blood dispensed into blood collection tubes (Sarstedt Ltd., 
Leicester, UK) containing ethylenediaminetetra acetic acid (EDTA) as the anti 
coagulant. Whole blood differential leukocyte counts, haemoglobin and haematocrit 
data were obtained using an automatic haematology system (SF-3000, Sysmex Ltd., 
Milton Keynes, UK).
Whole blood was centrifuged (3500 g, 10 min at 5 °C) to obtain plasma, which was 
dispensed into eppendorf tubes and immediately frozen at -70 °C. The remaining whole
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blood was diluted in RPMI media (containing 10% FCS) to its original volume before 
isolating peripheral blood mononuclear cells (MNCs) (Section 2.6.1).
In Chapter 5, finger prick samples were obtained before exercise and during the exercise 
trial, every 15 min, using a lancet (Accu-Check Softclix Pro, Roche, Lewes, UK). The 
first drop of blood was discarded using a tissue and 100 pi whole blood was collected 
using a microvette tube (CB300, Sarstedt Ltd., Leicester, UK) lined with EDTA. 
Samples were immediately analyzed using a lactate analyzer (2300 STAT Plus, YSI 
Incorporated, Yellow Springs, USA).
2.6.1 Leukocyte Separation
Peripheral blood MNCs were isolated using a one-step centrifugation technique 
developed by Boyum (1968). Twenty-five ml diluted whole blood, with the plasma 
compartment removed was carefully overlayered 12.5 ml Lymphoprep (Nycomed, 
Norway). The suspension was centrifuged for 20 min at 800 g  at 20 °C. The MNC layer 
formed a distinct band at the interface, which was removed and washed twice with PBS 
by centrifuging (250 g , 10 min at 20 °C). The cell pellet was collected and resuspended 
in 20 ml PBS. The total leukocyte cell count was obtained using the SF-3000 and the 
appropriate volume of cell suspension transferred to falcon tubes for analysis.
2.6.2 Analysis o f  Mononuclear Cells
In Chapters 3-6, approximately 1 x 106 cells were used for cytosolic extract preparation 
(Section 2.6.3) for the determination o f protein concentration (Section 2.6.4). In Chapter 
5, 3 x 106 cells were isolated for immunophenotyping and 1 x 106 cells for indirect 
immunofluorescence measurement (Chapters 4-6). In Chapter 5, the remaining cell 
suspension was resuspended in RPMI containing 1% FCS and transferred in to a 150 
cm3 flask and placed in a humidified atmosphere at 37 °C with 5% CO2 for 45 min. 
Following incubation, the flask was tapped and the supernatant, containing the 
lymphocyte population, transferred into a 50 ml falcon tube. Monocytes adhere to 
plastic and these were obtained for RNA extraction following lysis in TRIZOL (Section 
2.10). The lymphocyte population was counted and centrifuged (170 g, 5 min at room 
temperature) and lysed in TRIZOL (Section 2.10). In Chapter 3, the remaining 
suspension was pelleted and immediately lysed in TRIZOL. In Chapter’s 4 and 6, the 
cell suspension was prepared for treatment with H2O2 (Section 2.8.1).
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2.6.3 Cytosolic extract preparation
Approximately 1 x 106 cells suspended in PBS were centrifuged (200 g, 5min at 4 °C). 
The supernatant was aspirated and the cell pellet was resuspended in 50 jul Munroe lysis 
buffer containing 10 mM Hepes, pH 7.5; 3 mM MgCE; 40 pM KC1; 5% Glycerol and 
H2O and 10% NP40, 100 x protease inhibitors and pefabloc. The cell extract was 
centrifuged (200 g, 7 min at 4 °C) and the supernatant flash-frozen using ethanol and 
dry ice. This was transferred into 10 pi aliquots and stored at -70 °C until analysis of 
protein concentration.
2.6.4 Protein Measurement
Protein content of the samples was determined as described by Bradford (1976). Briefly, 
BSA standard solution (100 mg/ml) was diluted 1:100 in water and used at 
concentrations of 0, 2.5, 5, 7, 10, and 15 pg/ml. For the samples, 5 pi of the cell extract 
was transferred into an eppendorf containing 795 pi water. All samples and standards 
were vortexed to ensure thorough mixing of the Bradford reagent (BioRad, Hemel 
Hempstead, UK). The absorbance o f 100 pi aliquots o f all standards and samples was 
measured in triplicate at 550 nm using a microplate reader (MR5000, Dynatech 
Laboratories, West Sussex, UK).
2.7 Mammalian cell culture
TK6 cells, a B cell line, transfected with Epstein-Barr virus were initially used as they 
had been shown to over-express HO-1 mRNA (Applegate et al., 1991). These cells were 
cultured routinely at 37 °C in 5% CO2 in RPMI-1640 medium, supplemented with 50 
u/ml penicillin, 50 pg/ml streptomyocin, 0.2% sodium bicarbonate, and 10% horse 
serum. These cells were seeded at a density of 5 x 104 cells/ml in 75 cm3 flasks, and 
harvested at day two o f growth. The media was reserved and kept at 37 °C for use in ex 
vivo treatments. Conditioned media was used for the treatment in all experiments as 
addition of fresh medium instead of conditioned medium induces HO-1 providing 
incorrect estimates for basal levels o f HO-1 mRNA (Tyrrell and Basu-Modak, 1994).
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2.8 Treatment of mononuclear cells
In Chapters 4-6, cells were treated in PBS in 15 ml falcon tubes at a density o f 1 x 106 
cells/ml, based on cell viability assessed by the MTT assay following incubation in 
serum free media (SFM) or PBS immediately following treatment (Figure A.1, 
Appendix 4).
2.8.1 Hydrogen Peroxide Treatment
Mononuclear cell’s (~3 x 106 cells) were treated in 15 ml centrifuge tubes. Hydrogen 
peroxide was diluted in PBS to obtain a stock solution of 25 mM H2O2. In Chapter 6, 
stock solutions o f 25 and 45 mM H2O2 were used so that exposure was not altered by the 
volume of solution added. In all cases, isolated human MNCs were exposed to a final 
concentration of 50 pM H2O2 for 30 min at 37 °C. Following treatment, cells were 
washed once in PBS and then resuspended in conditioned media taken from TK6 cells, 
and replaced at 37 °C for 4, 6, 18, 24 or 48 h recovery. Following recovery, the cells 
were centrifuged (170 g, 5 min at room temperature) and placed in aliquots for analysis.
2.8.2 Cell Viability
In Chapters 4 and 5, cell viability was assessed using trypan blue staining. Briefly, 50 pi 
of sample was diluted 1:2 with PBS, and then 100 pi trypan blue was added. Trypan 
blue staining is based on the ability of cells with an intact membrane to exclude the dye, 
therefore it only assesses between live and dead cells and not the mode of death. The 
ratio o f unstained cells to total cell count was calculated and represents cell viability. In 
Chapter 6, cell viability was assessed by flow cytometry. The effect o f H2O2 on cell 
viability was assessed at concentrations o f 5, 10, 25, and 50 pM (Figure A.3, Appendix 
7) in addition to the effect of the recovery time following treatment (Figure A.4, 
Appendix 8).
2.9 Flow Cytometry-Indirect Immunofluorescence of HO-1
This technique allows quantification of cells expressing HO-1 protein on a single cell 
basis within a cell population. In Chapters 4-6, MNCs were analyzed by indirect 
immunofluorescence using a monoclonal mouse anti-HO-1 antibody IgGl. Following 
recovery from treatment, ~ 2 x 106 cells were centrifuged and fixed and permeabilised in 
2 ml 70% ice-cold ethanol. Samples were kept at 4 °C until subsequent analysis. Cells
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were washed twice in PBS and then blocked using 500 pi of a 2% BSA solution for 10 
min at 37 °C. Cells were centrifuged and the supernatant discarded. The HO-1 antibody 
(1:3 dilution used in chapter 4 and 5; 1: 100 dilution in chapter 6) was added directly to 
the cells and incubated in the dark on ice for 60 min. The cells were washed twice and 
then incubated in the dark at 4 °C for 45 min in the presence of fluorescein 
isothiocyanate (FITC) conjugated goat anti-mouse polyvalent immunoglobulins 
antibody. An isotype control was performed with FITC mouse IgGl antibody (DAKO, 
Glostrup, Denmark) and the same anti-mouse IgG-FITC secondary to determine 
background fluorescence. Cells were washed a further two times in PBS and 
resuspended in 300 pi PBS for analysis.
Cell analysis was performed in a Becton Dickinson FACScan (Cellquest version 3.3 
software, Belgium) calibration checked with Fluoresbrite beads (Polysciences, 
Pennsylvania, USA). Samples were analyzed using 488 nm excitation and detection in 
the green fluorescence channel (FL1-530 ± 30 nm Bandpass filter). The lymphocyte and 
monocyte populations were differentiated by size and granularity in the forward versus 
side scatter gram and gated. Background dead cells/debris was excluded by electronic 
threshold and data for 10,000 events of the lymphocyte population acquired. HO-1 
protein was expressed as the fold change in median fluorescence intensity (MFI) of the 
treated versus sham-treated controls. In exercise trials, the MFI of the post-exercise 
samples was normalised relative to the baseline pre-exercise sample. Percent positive 
cells (%) were also ascertained to determine similarities between trials.
2.10 Total RNA Preparation
For each sample, one ml TRIZOL reagent per 5 x 106 cells was dispensed into a 15 ml 
falcon tube and the cells were lysed by pipetting. The monocytes formed a cell 
monolayer in the culture flasks therefore lysis was performed by adding TRIZOL to the 
flasks. The lymphocyte and monocyte populations were stored in separate tubes at 
-70 °C until analysis.
Cells were thawed rapidly at 37 °C and glycogen was added to the lysates at a final 
concentration of 50 pg.m l'1 in order to increase RNA yields. Total cellular RNA was 
extracted according to the manufacturer’s protocol (Invitrogen Life Technologies). 
Briefly, following centrifugation with chloroform, the aqueous phase containing the 
RNA was extracted and transferred to an eppendorf tube containing isopropyl alcohol. 
The RNA was recovered by sequential precipitation with 75% cold-ethanol and re­
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suspended in RNase free water. The optical density of the isolated RNA was read on a 
spectrophotometer with an A 2 6o/28o ratio of 1.6-1.8. This equation is performed as:
(A26o x dilution factor x 40) / 1000 = RNA concentration (pg.ml'1)
2.10.1 Reverse-Transcription-PCR (RT-PCR)
A two-step RT-PCR approach using Superscript first strand synthesis kit was used to 
analyze HO-1 mRNA accumulation. Random hexamers were used for priming the 
reaction to obtain a better representation of the RNA population in the cDNA samples. 
Briefly, an RNA primer mix containing 2 pg total RNA, random hexamers (50 ng.pl'1), 
10 mM dNTP mix, and DEPC-treated water was denatured at 70 °C for 5 min and 
chilled immediately on ice. Reaction components for RT-positive and RT-negative 
samples were set up separately. Nine pi of the reaction mix (10 x reaction buffer, 25 
mM MgCl2, 0.1 M DTT, RNaseOUT (40 U .pl'1), was added to each RT sample and 
incubated at room temperature for 2 min. Superscript II (50 U .pl'1) was added to the 
positive RT samples and incubated for 10 min at room temperature. All samples were 
incubated at 42 °C for 50 min, then 70 °C for 15 min and immediately chilled on ice. 
RNase H (2 U .p l'1) was added to each positive RT sample and incubated at 37 °C for 
20 min. The newly synthesized cDNA was stored at -20 °C until required for real-time 
RT-PCR.
2.10.2 Real-Time RT-PCR
Real-Time RT-PCR was used for quantification of HO-1 mRNA in human mononuclear 
cells in both exercise studies (Chapters 3 and 5). Reactions were carried out in the 
LightCycler (Roche Molecular Biochemicals, Lewes, UK) using the fluorescent green 
dye SYBR Green I. The light cycler performs a quantification analysis by comparing the 
fluorescence o f a PCR product of unknown concentration with the fluorescence of 
several dilutions o f an external standard. SYBR Green I dye binds to all double-stranded 
DNA molecules regardless of their sequence and produces fluorescence proportional to 
the amount of amplified DNA. Fluorescence is acquired once per cycle generating a 
curve that increases in value with each cycle as the product accumulates (Figure 2.1). 
The use of relative quantification (RelQuant software, Roche Diagnostics, Lewes, UK) 
allows the result to be expressed as a relative ratio of the target of interest (HO-1) to a 
reference target (GAPDH) measured in the same sample material. This method has been 
described by Basu-Modak and colleagues (2003).
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Briefly, a 1:10 dilution of each cDNA was freshly prepared in PCR grade water before 
each run and 2 pi was used in each PCR reaction. The total volume for PCR reactions 
was 20 pi. This reaction included 3 mM MgCh in PCR grade water, 2 pi of SYBR 
Green I dye and primer pairs at a final concentration of 0.5 pM. The experimental 
protocol consisted of four programs including predenaturation, amplification, melting 
curve analysis and cooling (LightCycler 3 Run version 5.32). The temperature transition 
rate of 20 °C.s'1 was used in all programs unless specified.
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Figure 2.1 Representation of the LightCycler software analysis package. The software 
calculates the increase in fluorescence of SYBR Green I dye with increasing cycle 
number. Each sample was analysed in duplicate, with a calibrator and a no template 
control (NTC). Each colour represents a single sample. R: rest sample, E: exercise 
sample.
The primer sets had different amplicon sizes therefore the optimal amplification 
conditions were slightly different, and this meant that the gene of interest and the 
reference gene were analysed in separate runs (Figure 2.2). The parameters for HO-1 
(target) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (reference) are 
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Figure 2.2 Melting curve analysis for HO-1 (A) and GAPDH (B) accounting for the 
differences in run conditions.
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Table 2.1 Experimental protocol used for the different stages of Real-Time RT-PCR
HO-1 GAPDH
Predenaturation 1 cycle of 30 s at 95 °C
Amplification
40 cycles of: 40 cycles of: 
0 s at 95 °C 0 s at 95 °C 
5 s at 55 °C 5 s at 55 °C 
4 s at 72 °C 8 s at 72 °C
Melting Curve Analysis
1 cycle of:
0 s at 95 °C 
15 s a t 65 °C 
Gradual T to 95 °C (transition rate of 0.1 °C) with 
continuous fluorescence acquisition
Cooling Default parameters
The HO-1 primer pair 5’AAG AGG CCA AGA CTG TC-3’ (forward) and 5’-GGT 
GTC ATG GGT CAG CAG C-3’ (reverse) gave an amplicon size o f 74 bp in the human 
HO-1 cDNA sequence. The GAPDH primer pair 5’-GAC ATC AAG AAG GTG GTG 
AA-3’ (forward) and 5’-TGT CAT ACC AGG AAA TGA GC-3’ (reverse) had an 
amplicon size of 178 bp in the human GAPDH cDNA sequence. Desalted primers were 
obtained from Life Technologies (Paisley, UK) and used for PCR reactions without 
further purification.
An external standard curve was developed using serial dilutions in the range of 1:10 to 
1:3000 of a cDNA pool obtained following recovery from irradiation with 250 kJ.m' 
UVA. The concentration o f cDNA in this pool was used to generate separate standard 
curves for HO-1 and GAPDH. Triplicates of each dilution were used for the standard 
curve runs and the data from these runs were used to create a coefficient file in the 
Relative Quantification software.
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A calibrator was used in all light cycler runs and consisted of cDNA with a relatively 
high HO-1 signal. This was diluted 1:10 in PCR grade water and run in duplicate for 
each set of sample runs. RelQuant software was used to analyze the data file of each run. 
These files were exported and the ratio concentrations were determined using the dual 
colour mode with efficiency correction. The normalised HO-1 mRNA values in the 
post-exercise samples were expressed as a fold increase of the pre-exercise, control 
sample. The reproducibility of the reverse-transcriptions were assessed in addition to the 
reproducibility of the light cycler runs, by repeating three RT’s and running the cDNA 
samples in the light cycler (Figure A.2 (A), Appendix 5) and by running the same cDNA 
sample in the light cycler for three separate runs for HO-1 and GAPDH (Figure A.2 (B), 
Appendix 5).
2.11 Cytokines
Plasma interleukin- 6  (IL-6 ) and interleukin-10 (IL-10) were determined in some 
Chapter’s using a commercially available solid phase enzyme linked immunosorbent 
assay (ELISA). In Chapter 3, a high sensitivity kit for IL-6  was used (Quantikine, R and 
D systems Inc., Abingdon, UK) with the minimum detectable concentration claimed by 
the manufacturer to be 0.016 to 0.110 pg.ml'1. In Chapter 5, plasma IL-6  and IL-10 
concentrations were analysed using high sensitivity kits (Quantikine, R and D systems 
Inc., Abingdon, UK) with the minimum detectable concentration for IL-10 claimed to be 
less than 0.5 pg.ml'1. Samples were analysed in duplicate in a microplate reader and read 
at 450 nm with wavelength correction at 690 nm (Anthos HT-III, Labtech International 
Ltd., Ringmer, East Sussex).
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CHAPTER 3
HO-1 mRNA EXPRESSION IN HUMAN MONONUCLEAR 
CELLS FOLLOWING A HALF MARATHON RACE
3.1 Introduction
There is a wealth of evidence relating the benefits o f regular exercise to health, with 
associations of increased risk to disease and decreased longevity with sedentary 
behaviour. Although the rewards of regular exercise greatly outweigh the costs, it is 
widely accepted that an acute bout o f demanding or non-familiar exercise leads to 
oxidative stress (Jackson, 2000). The induction of the antioxidant enzyme haem 
oxygenase-1 (HO-1) is a general response to oxidant stress in mammalian cells (Keyse 
and Tyrrell, 1989) and has been shown to be up-regulated in response to a wide variety 
of inducers (Morse and Choi, 2002). Haem oxygenase-1 is an appropriate gene to 
monitor oxidative stress (Offord et al., 2000) although, for it to be validated as a marker 
o f oxidative stress in vivo, the response needs to be characterised further.
The first evidence reporting an induction of HO-1 in leukocytes following exercise was 
by Niess and co-workers (1999b). In this investigation, flow cytometric analysis of 
leukocytes revealed an elevation in HO-1 protein expression immediately after a 
competitive half marathon. In a later study by the same group, HO-1 protein expression 
was greater following a half marathon in comparison to a short exhaustive run and an 
eccentric exercise protocol (Fehrenbach et a l , 2003a), supporting the use of prolonged 
endurance exercise in the investigation of exercise-induced HO-1. An increase in human 
lymphocyte HO-1 mRNA following exercise has only recently been reported 
(Thompson et a l , 2005). In this study, the induction of HO-1 mRNA was accompanied 
by an increase in HO-1 protein 2 h following prolonged exercise at 70% V0 2 max for 75 
min. The induction of HO-1 has been shown to be cytoprotective (Vile et al., 1994) as 
well as anti-inflammatory (Willis et a l , 1996) and, as acute exercise causes both 
oxidative stress and inflammation in vivo, the induction of HO-1 may have important 
implications for leukocyte function.
Although a half marathon race is assumed to be more physically demanding than the 
prolonged run used by Thompson and colleagues (2005), the intensity of exercise was 
not assessed by Niess and co-workers (1999b) and it is possible that the induction of
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HO-1 mRNA in response to a half marathon is greater than the level observed by 
Thompson and co-workers (2005) following running for 75 min at 70% VC>2max. Both 
protocols have shown HO-1 protein induction, and if HO-1 mRNA expression is higher 
in response to a half marathon, then this type o f exercise may be a useful model of 
exercise-induced oxidative stress. Therefore, the aim of the present investigation was to 
examine changes in HO-1 expression, at both the mRNA and protein level, in response 
to a competitive half marathon race.
3.2 Methods
3.2.1 Subjects
Nine students, six males and three females, volunteered to participate in this study 
(Table 3.1). All participants had entered the Bath half marathon race and had trained, for 
this event in particular, for at least three months prior to the race. Four individuals had 
never attempted the distance. Physical activity was assessed by questionnaire (Appendix 
2). All subjects reported to the laboratory for preliminary measurements to be taken two 
weeks prior to the race.
Table 3.1 Subject characteristics
Age Height Mass V02max E 4 Skinfolds Weekly
(yrs) (cm) (kg) (ml.kg .min ) (mm) exercise
0 0
24.1 ± 1.6 170 ± 10 64.2 ± 7.2 61 ±7 26 ± 8 8.0 ±7.6
Values are mean ± S.D. (n=9).
3.2.2 Experimental design and procedures
Subjects kept a record of their food and fluid intake for three days prior to the race 
(Chapter 2.4) and refrained from strenuous physical activity for at least 48 h before 
racing. On the day of the competition, subjects arrived at the laboratory following an 
overnight fast. A resting blood sample was taken by venepuncture from a forearm vein 
after the subject had been seated for 15 min (2 h prior to the race; Pre-exercise), and 
then at 1 h, 3 h and 24 h following completion of the race (Figure 3.1). Heart rate was 
monitored continuously throughout the race by short-range telemetry (Vantage NV, 
Polar Electro OY, Finland). The time to complete the event was noted to determine 







25 ml venous blood sample Half marathon race
Figure 3.1 Schematic design of the half marathon race day.
Complete blood cell counts including haemoglobin and haematocrit and differential 
leukocyte counts were assessed using an automated haematology counter (Chapter 2.6). 
Plasma aliquots were stored at -70 °C for subsequent analysis o f cytokines (Chapter 
2.11). Mononuclear cells were harvested and isolated (Chapter 2.6.1) for the analysis of 
HO-1 mRNA using real-time RT-PCR (Chapter 2.10) and HO-1 protein expression.
Western blotting was used to determine HO-1 protein induction following protein 
measurement (Chapter 2.6.4) of the cytosolic extract (Chapter 2.6.3). Equal amounts of 
protein (40 pg) were diluted with 3 x loading buffer (180 mM Tris, pH 6.8, 3% SDS, 
150 mM 1,4-dithio-DL-threitol (DTT), 30% glycerol, 0.0015% bromophenol blue, 0.53 
ml milliQ water) and boiled for 5 min. A 12.5% polyacrylamide gel was used for protein 
separation by electrophoresis at 80 V for 2 h (Mini-protean 3, BioRad, Hemel 
Hempstead, UK). Samples were transferred onto nitrocellulose membranes for 1 h at 
100 V (Trans-blot cell system, BioRad, UK) that were blocked overnight at 4 °C in 
blocking solution (3% milk powder, 0.05% Tween-20 in PBS for HO-1 antibody and 
with 3% milk powder, 3% BSA, 0.1% Tween-20 in PBS for the actin antibody). After 
blocking, blots were probed with a monoclonal mouse anti-HO-1 antibody or 
monoclonal mouse anti-actin antibody (Amersham Biosciences, Bucks, UK) at 1:200 
dilution in blocking solution containing 0.05% Tween-PBS for 1 h at room temperature. 
Following incubation with the primary antibody, blots were washed three times with 
Tween-PBS. Both proteins were detected with a rabbit anti-mouse IgG-HRP conjugate 
at a dilution of 1:1000, incubated for 1 h at room temperature. Immunoreactive bands 











Biosciences, Bucks, UK). HO-1 was normalised to P-actin and expressed relative to 
baseline samples.
3.2.3 Statistical Analysis
A one-way analysis of variance (ANOVA) with repeated measures was used to analyse 
the changes in white blood cell populations and both protein and RNA yield and HO-1 
mRNA expression across time. The data was not normally distributed therefore a natural 
log transformation was applied. Post hoc analysis using a paired t statistic was used to 
determine at which time points a significant effect was observed. Significance was 
accepted at the 5% level. Values are expressed as mean ± standard deviation (S.D.). 
Data was analysed using SPSS version 10 (SPSS Inc., Chicago, USA).
Effect size statistics (ES) were calculated using the ratio o f the mean difference to the 
grouped standard deviation for the baseline and post-exercise time points for all 
parameters (Equation 3.1). Small, moderate and large effect sizes were indicated by 
ratios of 0.2-0.49, 0.5-0.79, and 0.8 upwards, respectively (Cohen, 1988).
ES (d) = (Mi-M2)/ cooled w hereapooied = V[(a1 2+ a 2 2)/2] [Equation 3.1]
The relationship between the fold increase in plasma IL- 6  concentration and peak HO-1 
mRNA expression following the half marathon was determined using Pearson’s product 
moment correlation coefficient (r). All the results from the blood analysis for HO-1 are 
the mean of eight rather than nine subjects, as difficulties were encountered with the 
extraction procedures for one subject.
3.3 Results
Race Data
Mean HR during the race was 176 ± 7 b.min ' 1 (n=9). The time for completion of the race 
ranged from 80 min to 121 min with the mean time for these individuals being 103 ±13  
min. The mean exercise intensity at which the individuals completed the race was 
73 ± 5% V 0 2max.
Dietary information was collected over a three-day period prior to the race (Table 3.2). 
The large variation in energy intake is a result o f a mixed population, as it is
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acknowledged that energy intake is greater in males (3293 ± 660 kcal; n=6 ) compared to 
females (2035 ± 400 kcal; n=3).
Table 3.2 Daily dietary composition assessed 72 h prior to the race
Energy Intake Carbohydrate Protein Fat
(kcal) (%) (%) (%)
2874 ±841 56 ± 6 15 ± 1 29 ± 6
Values are mean ± S.D. (n=9).
Exercise-Induced Leukocyte Cell Changes
The differential leukocyte counts changed following the half marathon (Table 3.3). 
Neutrophils and monocytes increased significantly at 1 h (ES = 1.7, P  = 0.001 and 
ES = 1.5, P  = 0.001 in neutrophils and monocytes, respectively) and 3 h following the 
half marathon (ES = 1.75, P = 0.000 and ES = 1.44, P  = 0.015 for neutrophils and 
monocytes, respectively), with the largest increase in the neutrophil population 
accounting for the significant change in total white blood cell number. In contrast, the 
number of lymphocytes was lower 1 h (ES = -1.34, P  = 0.002) and 3 h (ES = -1.14, 
P  = 0.048) following completion of the race. At 24 h, the cell populations tended to be 
above baseline resting values, although this was not statistically significant.
Table 3.3 Differential leukocyte counts at rest, 1, 3, and 24 h after the half marathon 
White blood cells Neutrophils Lymphocytes Monocytes
Baseline 4.64 ± 0.97 2.47 ± 0.58 1.63 ±0.41 0.31 ±0.11
1 h 15.39 ±4.48** 13.57 + 4.38** 1.04 ±0.22** 0.70 ±0.21**
3 h 14.28 ± 3.44** 12.47 ±3.51** 1.18 ± 0 .2 2 * 0.57 ±0.14*
24 h 5.87 ± 1.41 3.45 ± 1.31 1.83 ±0.38 0.40 ±0.12
Units are cell number (x 109.1-1). Values are means ± S.D. ** denotes significant 
changes compared to resting values (P < 0.01), * (P<  0.05). (n=8 ).
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RNA yield
The total RNA yield at 1 h post-race was significantly greater compared to pre-race 








Figure 3.2 RNA yield (pg/106 cells) in MNCs, at rest before the race and 1, 3, and 24 h 
following the race. Pre: pre-exercise. * denotes a significant difference from pre-race 
values (P < 0.01). Values are expressed as mean ± S.D. (n=8).
HO-1 mRNA expression
In five o f the eight subjects, HO-1 mRNA expression in MNCs changed relative to their 
respective pre-exercise sample by 1.5-fold at the 1 h and 3 h post-race time points. 
However, the magnitude of change of HO-1 mRNA induction following the half 
marathon varied dramatically among the individuals (Figure 3.3), which gave an overall 
non-significant effect o f HO-1 mRNA induction over time (P = 0.408). HO-1 mRNA 
expression was greatest in subject 7 at 3 h post-race and returned to resting values 24 h 
later. The peak level of HO-1 mRNA expression in subjects 3 and 5 was at 1 h post-race 
with the level at 3 h falling below resting values. Subject 1 had an increase in HO-1 
mRNA at 1 h post-race that had returned to the baseline level by 3 h post-race. Although 
the mean change in H O -1 mRNA induction was not significant, effect size statistics at 1 






Figure 3.3 HO-1 mRNA expression in human MNCs prior to the half marathon at rest, 
and 1, 3 and 24 h post-race in eight individuals. HO-1 mRNA is expressed relative to 
GAPDH. Data is expressed as the fold change compared to each individual baseline 
(resting) sample. For subject 2, data was unavailable 24 h post-race.
Table 3.4 The fold change in HO-1 mRNA at 1, 3, and 24 h post-exercise and associated 
effect size statistic
Time post-exercise (h) Mean S.D. ES
1 1.27 0.43 0.74
3 1.15 1.05 0.19
24 0.91 0.26 -1.02
The ES of 0.74 and -1.02 indicate a moderate and large effect at 1 and 24 h 
post-exercise, respectively. (n=8 at 1 and 3 h post-exercise; n=7 at 24 h post-exercise).
The variability in the MNC induction of HO-1 mRNA is clearly demonstrated in Figure
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Figure 3.4 Peak exercise-induced fold change in HO-1 mRNA expressed against the 
baseline level (resting sample). The peak time point was at 1 h post-race for subjects 1, 3 
and 5 and at 3 h post-race for subject’s 7 and 8.
In order to explore whether variability in the induction of HO-1 was related to basal 
expression of HO-1, a comparison of each individuals’ basal expression and induction 
of HO-1 mRNA following exercise was performed (Figure 3.5). In addition, the basal 
expression of HO-1 mRNA in these subjects was also compared to the resting level of 
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Figure 3.5 Comparison of the basal level and peak fold induction of HO-1 mRNA 
following a half marathon race. Bars represent the basal expression of HO-1 mRNA 
with triangles representing the peak fold change. The black line at 1 on the right hand 
scale indicates the resting value of HO-1 mRNA which is used for normalising the data, 
therefore solid triangles above this line show increased HO-1 mRNA induction.
It appears that basal expression of HO-1 was not related to the extent of peak induction 
of HO-1 mRNA following a half marathon (r = -0.295, P = 0.478).
In Figure 3.6 it is clearly demonstrated that resting levels of HO-1 mRNA in samples 
1-8 (taken from subjects before the half marathon), were higher than in samples 10-17 
(taken from subjects performing a rest trial). Basal HO-1 mRNA in samples 10-17 were 
very different to those of 1-8, with the mean HO-1 mRNA expression o f samples 1-8 
significantly higher than the mean HO-1 mRNA expression o f samples 10-17 
(ES = 1.46, P = 0.004). The second group of subjects refrained from exercise and 
drinking alcohol for two days prior to the trial. These subjects were taking part in a rest 
trial similar to that described in Chapter 5. For this second group of individuals, mean 
age, height, body mass and sum of skinfolds were 21 ± 1 yrs, 179 ± 1 cm, 73.9 ± 2.4 kg, 
26 ± 2 mm (mean ± S.D.), respectively. Mean V 0 2 max was 64 ± 2 ml.kg"1.min"1. All 
subjects in this group were male, therefore, the only difference in these two groups of 
subjects was gender.
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□  Pre-half marathon samples
□  Mean for samples 1-8
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Figure 3.6 Comparison of basal HO-1 mRNA expression in human MNCs in 16 
individuals. Each code represents the subject number. Samples 1-8 were taken prior to a 
half marathon race whereas samples 10-17 were taken from eight different subjects 
participating in a rest trial. All venous samples were taken in the morning. The 
means ± S.D. are also included. * denotes a significant difference between the two 
groups in the HO-1 mRNA basal levels (P < 0.01). Subject characteristics for samples 
10-17 are detailed on page 75.
Protein Expression
The protein concentration of MNC extracts varied among the individuals and no 
significant differences were observed over time (P = 0.240). Technical difficulties were 
encountered when performing western blot analysis o f the cell extracts resulting in no 
available data for HO-1 protein expression.
Cytokines
Plasma interleukin-6 (IL-6) concentration 1 h post-exercise was significantly greater 
than pre-exercise values (ES = 1.73, P = 0.000) (Figure 3.7). A positive relationship 
between the fold increase in plasma IL-6 concentration and the peak fold increase in 








Figure 3.7 Plasma IL-6 concentration (pg.m l'1) following a half marathon race. Pre: pre­
exercise, Post: 1 h post-exercise. * denotes a significant difference in IL-6 concentration 
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Figure 3.8 The relationship between the peak fold increase in plasma IL-6 concentration 
and peak HO-1 mRNA expression in MNCs following a half marathon race. (n=8).
78
3.4 Discussion
In the present investigation, exercise in the form of a competitive half marathon was 
used as the stimulus to induce HO-1 mRNA in human MNCs. The findings from this 
study reveal a large degree of inter-individual variability in the magnitude and time of 
peak HO-1 expression, which is consistent with previous reports assessing lymphocyte 
HO-1 mRNA expression following exercise (Thompson et al., 2005). In the current 
investigation, an up-regulation of HO-1 mRNA at either 1 or 3 h following the race was 
observed in five out of the eight subjects. Although the subjects recruited for this 
investigation had been training specifically for this race for at least three months, their 
individual training history differed. This may account for reported differences in the 
basal regulation of HO-1 mRNA as previous studies reported endurance-trained 
individuals exhibited a lower HO-1 protein expression at rest (Niess et a l , 1999b). As 
training status could have an impact upon the resting level o f HO-1, a comparison 
between the expression of HO-1 mRNA at rest with the peak fold change following 
exercise was made. From this it was possible to establish whether the magnitude of the 
response following exercise was affected by the expression o f the gene at rest, and 
therefore contribute as a factor affecting inter-individual variability.
Thompson and colleagues (2005) reported an accumulation of lymphocyte HO-1 mRNA 
following a 75 min run at 70% V02max, accompanied by an increase in HO-1 protein 
supporting the findings of Niess and co-workers (1999b). The differences between these 
two studies include the exercise protocol, the inclusion of a rest trial in one study, the 
determination of HO-1 mRNA and the use of western blotting compared to flow 
cytometry for HO-1 protein determination. Firstly, when using a competitive race as the 
exercise protocol the intensity and duration will be different for each subject. In 
contrast, a laboratory environment enables each subject to complete the exercise for the 
same duration and relative intensity. In the study conducted by Niess and colleagues 
(1999b), no information regarding the intensity of exercise was provided, therefore 
making comparisons with other exercise protocols difficult. In the present investigation, 
heart rate data was collected during the race in order to quantify the intensity at which 
subjects were exercising. In this study, the half marathon was completed in a mean time 
of 103 min at an intensity equivalent to 73% VC^max, indicating a prolonged and 
intense bout of exercise. The increase in HO-1 mRNA following exercise was not 
significant because a large inter-individual difference in the small sample population 
was found; although a moderate effect size was reported 1 h post-exercise.
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In the present study, subjects had been training specifically for the competitive half 
marathon in the preceding months. It is possible that this could affect basal HO-1 either 
through an adaptation to training or through anticipation on the day o f the event. This is 
an important finding as the elevated level at rest may have potentially masked any affect 
caused by the exercise itself since the basal level o f certain genes is inversely related to 
their inducibility (Boshoff et al., 2000). It is possible that a competitive event is likely to 
increase anxiety and circulating levels of hormones such as catecholamines and cortisol. 
Therefore, one of the major conclusions from the present study is that although the 
metabolic and immune responses to exercise in field or laboratory environments are 
generally the same, a competitive event may increase a number of stressors known to 
induce HO-1 prior to the event. Hence, competitive field-based races may be unsuitable 
when investigating gene up-regulation.
Intense physical exercise causes increases in the blood concentration of a number of 
stress hormones, including adrenaline, noradrenaline and cortisol (Hoffman-Goetz and 
Pedersen, 1994). In the current study, changes in the cell number of leukocytes were 
measured following exercise. Lymphocytes continuously recirculate throughout the 
body (Hay and Hobbs, 1977) and it is hypothesised that lymphocytes are recruited to the 
circulation from the spleen, lymph nodes and gastro-intestinal tract, with the extent of 
recruitment determined by the intensity of the stimulus (Pedersen and Hoffman-Goetz, 
2000). In the present work, lymphocyte cell numbers fell below pre-exercise values 
during recovery, accompanied by large increases in neutrophil numbers with a smaller 
increase in monocytes. Changes to lymphocyte subsets were not examined and this 
should be taken into account in future work. It appears that catecholamines play an 
important role in the mediation of immuno-suppressive effects of exercise and could be 
the reason for apoptosis and the decline in cell number in lymphocytes. As the total 
lymphocyte concentration declines after exercise, the total in vivo lymphocyte function 
in the blood can be considered as ‘suppressed’ at this time (Pedersen and Hoffman- 
Goetz, 2000). Because of this decline, the modest but variable changes in the expression 
of HO-1 in lymphocytes may have an important role in the function of these cells.
An acute bout of exercise results in an inflammatory response, with the release of pro- 
inflammatory cytokines followed by regulatory anti-inflammatory cytokines (Pyne, 
1994; Cannon and Blumberg, 2000; Moldoveanu et a l ,  2001). The finding of markedly 
elevated levels of IL-6 after exercise in the current study is consistent with earlier 
investigations (Ostrowski et a l,  1998; Niess et al., 1999b; Ostrowski et al., 1999; 
Suzuki et al., 1999; Moldoveanu et al., 2000; Suzuki et al., 2003; Thompson et al., 
2005). This inflammatory response is likely to compound oxidative stress initiated
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during the exercise itself (Pyne, 1994). Both the previous studies that investigated HO-1 
up-regulation following exercise reported changes in pro-inflammatory cytokines 
immediately post-exercise. A 4-fold change in IL-6 was observed by Thompson and co­
workers (2005) with changes in IL-8 and TNF-a concentrations reported by Niess and 
colleagues (1999b). Furthermore, plasma levels of IL-8 were correlated with HO-1 
expression in lymphocytes and neutrophils directly after exercise (Niess et al., 1999b). 
In the present investigation, plasma IL-6 concentration was significantly greater than 
pre-exercise values and was positively correlated with peak HO-1 mRNA expression. 
However, the increase in plasma IL-6 concentration, from 1.2 to 6.7 pg.ml'1 was 
relatively small compared to the change in IL-6 reported following other prolonged 
running events (Jeukendrup et al., 2000; Nieman et al., 2000; Suzuki et a l,  2003). 
Cytokines can induce HO-1 (Cantoni et al., 1991) and it is possible that the induction of 
HO-1 could be the result of inflammatory-mediated production of reactive intermediates 
rather than a direct result o f oxidative stress associated with mitochondrial respiration.
In conclusion, the main finding from this investigation is that HO-1 mRNA induction 
following intense exercise is highly variable between individuals. This variability was 
not explained by variation in the basal levels of HO-1 mRNA since there was no 
relationship between resting HO-1 and peak HO-1 induction. It is possible these 
responses reflect differences in antioxidant defences. Basal HO-1 mRNA expression 
seems to be elevated pre-competition and this could be either a specific response to 
preparatory training or a pre-competition elevation in HO-1. The induction of HO-1 
seems to be related to an inflammatory response. The lack of response to exercise- 
induced oxidative stress is interesting and it is important to establish whether this is due 




REPRODUCIBILITY OF HO-1 PROTEIN INDUCTION IN HUMAN 
MONONUCLEAR CELLS FOLLOWING HYDROGEN PEROXIDE TREATMENT
4.1 Introduction
Haem oxygenase-1 is a marker of oxidative stress as it is up-regulated in response to a 
wide range of treatments causing oxidative stress. The exercise-induced expression of 
HO-1 is highly variable between individuals (Chapter 3) making it difficult to 
characterise the response to exercise and to use this as a model o f oxidative stress. This 
may be a result o f adaptations to regular exercise (Niess et a l,  1999b) or the presence of 
an HO-1 polymorphism (Yamada et a l,  2000). Adaptations to regular exercise enhance 
the antioxidant defence system and therefore the degree of oxidative stress encountered 
by individuals may vary and differ depending on the type of training that has been 
undertaken. However, it is not known whether lymphocytes from different individuals 
treated with an oxidant challenge ex vivo would respond in a similar manner.
The development of an ex vivo lymphocyte model may allow the HO-1 response to be 
better characterised, as a known concentration of an oxidant can be delivered directly to 
the cells o f interest in contrast to a whole body stressor like exercise. It has been 
suggested that human lymphocytes provide an appropriate and convenient tool to use as 
an experimental model of oxidative stress (Rothfuss et a l , 1998; Rao et al., 2003). 
Hydrogen peroxide (Khassaf et al., 2003), hyperbaric oxygen treatment (HBO) 
(Rothfuss et a l , 1998), and heavy metals (Menzel et a l , 1998) have been used ex vivo to 
investigate oxidative stress in human lymphocytes. Haem oxygenase-1 is induced in 
lymphocytes in response to H2O2 treatment in vitro (Applegate et a l , 1991) and ex vivo 
(Marini et al., 1996a; Rothfuss et al., 2001). Furthermore, lymphocytes have been 
shown to be protected against H202-induced DNA damage 24 h after exposure to HBO 
treatment, indicating an adaptive response to prior oxidative stress (Speit et a l , 2000).
Marini and colleagues (1996a) observed that the level of protein expression of HO-1 in 
human lymphocytes following H2O2 treatment was not consistent between subjects. 
Before being able to employ this as a model o f oxidative stress it is important to 
understand whether these differences are true inter-individual differences or related to 
day-to-day, random variation. To our knowledge, the intra-subject variation has not yet
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been examined. Therefore, the aims of this study were to develop an ex vivo model of 
oxidative stress using H2O2 in order to (i) determine the time course o f HO-1 protein 
expression in freshly isolated lymphocytes and monocytes, and (ii) determine the 
reproducibility of the HO-1 protein response to H2O2 treatment.
4.2 Methods
4.2.1 Subjects
Ten males participated in this study (Table 4.1). Physical activity was assessed by 
questionnaire (Appendix 2). Subjects were habitually active and completed 7 ± 2 h of 
physical activity per week (comprising both endurance and resistance exercise).
Table 4.1 Subject characteristics
Age Height Mass 2 Skinfolds
(yrs) (cm) (kg) (mm)
25.9 ±3.9 177 ±2 80.0 ±3.2 32 ±6
Values are mean ± S.D. (n=10).
4.2.2 Experimental design
All subjects completed two trials, with each trial separated by two weeks (Figure 4.1). 
Subjects refrained from exercising and were not permitted to drink alcohol for 72 h prior 
to the trial day. During this time, subjects kept a record of their food and fluid intake 
(Chapter 2.4). This allowed subjects to repeat the diet recorded prior to the first trial in 
the 72 h prior to the second trial day, so that any changes were not a result o f differences 
in diet. Daily energy intake was 2445 ± 494 kcal, with a macronutrient composition of 
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Figure 4.1 Experimental design of the ex vivo H2O2 treatment model. A venous sample 
was taken on two separate occasions, separated by two weeks. Mononuclear cells were 
harvested and treated ex vivo with H2O2 (30 min). Cells were left to recover for 4, 6, 24, 
and 48 h before determination of HO-1 protein.
4.2.3 Blood sampling and treatment
On the morning of the trial, subjects reported to the laboratory following an overnight 
fast. Subjects remained in a supine position for 15 min prior to blood sampling (Chapter 
2.6). Twenty-five ml o f whole blood was collected by venepuncture in the ante-cubital 
vein and placed in aliquots in EDTA coated tubes. Whole blood differential leukocyte 
counts, haemoglobin and haematocrit data were obtained using an automated 
haematology analyser (SF-3000, Sysmex UK Ltd., UK). Mononuclear cells were 
isolated and treated with H2 O2 (Chapter 2.8.1) and recovered from incubation 4, 6, 24 
and 48 h following treatment for analysis of HO-1 protein by flow cytometry (Chapter 
2.9). Cell viability was assessed at these time points (Chapter 2.8.2) and protein 
concentration was determined using the Bradford assay (Chapter 2.6.4).
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4.2.4 Statistical Analysis
The standard error of the measurement (SEM) is a practical index of measurement error 
(Bland and Altman, 1996b; 1996a) and is proposed as the most useful estimate of 
reproducibility for individual-level applications (McHomey and Tarlov, 1995). For each 
data set, pair-wise plots of each subject’s difference score (trial 1 minus trial 2) were 
plotted against the mean for the two trials (Bland and Altman, 1986). The plots were 
visually inspected for heteroscedasticity and the data analysed using the Shapiro-Wilks 
test of normality. These both showed that the data were not normally distributed and 
positively skewed. Therefore, a natural logarithm transformation was applied to all data 
points prior to analysis to normalise and stabilise the variance. The data were then back- 
transformed to provide information about the actual measurements (Bland and Altman, 
1986).
The within-subject variation was derived using the SEM and the change in the mean. 
The SEM is the random error that arises from testing the same individual on two or 
more different occasions, and is calculated by dividing the standard deviation of the 
difference scores (SDdifr) by V2. The typical percentage error can be determined and is 
expressed as the percentage coefficient of variation (%CV) (Equation 4.1). This allows 
direct comparisons of reproducibility of measures irrespective of scaling (Hopkins, 
2000a). The SEM expressed as a %CV was calculated using the formula:
%CV =100 (es -1), where s = SEM [Equation 4.1]
The change in the mean is referred to as the bias and is estimated by the mean difference 
between trials. Systematic bias was assessed using a paired t statistic on each set of data. 
Where P  < 0.05, there is evidence of systematic bias, implying that the difference 
between trial 1 and trial 2 may be consistently smaller or greater in the second trial.
In addition to calculating the SEM, re-test correlation was also determined (Pearson’s 
product moment) for each pair of observations, indicating the reproducibility o f the rank 
order of each subject’s result. The fold change in HO-1 protein was expressed as the 
median fluorescence intensity (MFI) of the treated samples normalised to the MFI of the 
control samples. In order to examine whether differences between mean values existed 
between trials and over the time course, a two-way ANOVA was performed. A paired t 
statistic was performed in order to determine at which time point there were differences. 
Statistical significance was accepted at P  < 0.05. Statistical calculations were performed 
using SPSS Version 11 (SPSS Inc., Chicago, USA) and a pre-formatted spreadsheet 
(Hopkins, 2000b). Values are expressed as mean ± S.D.
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4.3 Results
Time course o f  HO-1 protein induction
There was no difference in HO-1 protein induction between trial one and trial two 
(P = 0.317), although an effect of time was observed (P = 0.010). The time course of 
HO-1 protein induction showed that maximal HO-1 protein expression in response to 
H2O2 treatment occurred at 48 h following recovery (Figure 4.2). This was consistent in 
both trials with a mean fold change in lymphocyte HO-1 protein o f 2.1 ± 0.9 (P = 0.000) 
and 1.9 ± 1.0 (P = 0.008) in trials 1 and 2, respectively. In trial 1, all ten subjects had 
maximum levels of HO-1 protein at 48 h with a mean fold change of 2.1 ± 0.9 
(P = 0.000), whereas in trial 2, seven out of the ten subjects peaked at 48 h with a peak 
mean fold change of 2.0 ± 0.9 (P = 0.000). O f the three subjects whose response differed 
in trial 2, maximal fold change in HO-1 was at 24 h in two individuals and at 6 h in the 
other.
In monocytes, the effect of time and the response to H2O2 was similar to lymphocytes 
but less pronounced (P = 0.051) (Figure 4.2). At 48 h following treatment, the fold 
change in HO-1 protein was 1.3 ± 0.4 in trial 1 (P = 0.022) and 1.5 ± 0.6 in trial 2 
(P = 0.018). Six individuals had maximum levels of HO-1 in monocytes at 48 h in trial 1 
compared to five in trial 2. In trial 1, the number of individuals with maximum HO-1 
expression at 24 h was two, increasing to five in trial 2, whereas two individuals had 
maximum monocyte HO-1 induction at 6 h in trial 1 alone. The maximum fold change 
in monocytes, irrespective of time, was 1.4 ± 0.3 (P = 0.002) and 1.6 ± 0.5 (P = 0.000) 
in trials 1 and 2, respectively.
The magnitude o f the maximal HO-1 response in lymphocytes differed between subjects 
ranging from a 1.4-fold change to a 4.6-fold change from control values. An example of 
this range is depicted in Figure 4.3. Inter-individual differences were less pronounced in 
monocytes, ranging from a 1.2-fold change to a 2.6-fold change in maximal HO-1 
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Figure 4.2 The time course of HO-1 protein induction following H2O2 treatment in 
lymphocytes (A) and monocytes (B). The fold change is the MFI o f the treated samples 
normalised to the MFI o f the sham-treated controls. 0 h: untreated control. ** denotes a 
significant difference between time and untreated control (P < 0.01), * (P < 0.05). 
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Figure 4.3 A representative flow cytometric analysis o f HO-1 protein induction in 
human lymphocytes at 48 h in two different subjects illustrating the varied response to 
H2 O2 treatment. A 4.6-fold change is shown in (A) with a 1.6-fold change observed in 
(B). I represents the isotype control, S represents the sham-treated sample and T 
represents H2 O2 treatment.
Reproducibility analyses
Total leukocyte population number was analysed in both trials with a small systematic 
bias in both lymphocyte and monocyte populations. The SEM as a %CV was 5% and 
11% in the lymphocyte and monocyte populations, respectively (Table 4.2).
Table 4.2 Reproducibility data for total leukocyte and differential population cell counts 
(xlO9.!-1) taken from venous blood for trials 1 and 2
Population
(xio’.r1)




WBC 4.5 ± 1.0 4.5 ± 1.0 -2 (-7 to 3) 6 (4 to 11)
Neutrophils 2.3 ±0.8 2.2 ±0.8 -4 (-13 to 7) 11 (8 to 22)
Lymphocytes 1.8 ±0.3 1.7 ±0.2 -3 (-7 to 2) 5 (3 to 9)
Monocytes 0.4 ±0.1 0.4 ±0.1 -5 (-14 to 6) 11 (8 to 23)
WBC: total white blood cells. Values are mean ± S.D. (n=10).
The reproducibility of the HO-1 protein response between trials was assessed at all time 
points. There was no significant difference between the mean HO-1 protein for any of 
the pairs of trials, in either lymphocytes or monocytes, showing negligible systematic 
bias between trials 1 and 2 (Figure 4.4). Systematic bias was largest following 4 h 
recovery and tended to be smaller in lymphocytes than in monocytes (Tables 4.3 and 
4.4). The SEM (%CV) represents the variability o f measurements for individual subjects 
in a population. Table 4.3 shows that the SEM varied across the recovery time following 
H2O2 treatment. In general, the SEM was similar in both lymphocytes and monocytes at 
each recovery time. The SEM was largest following 6 h recovery at 44% and 49% in 
lymphocytes and monocytes, respectively. However, the SEM decreased to 30% and 
29% at 48 h in lymphocytes and monocytes, respectively. The maximum fold change in 
HO-1, irrespective of time, showed good reproducibility with a SEM of 14% in 
lymphocytes and 18% in monocytes.
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Figure 4.4 Reproducibility plots of peak HO-1 protein induction in lymphocytes (A) and 
monocytes (B). The data represents the difference score in HO-1 protein between trials 1 
and 2 against the mean fold change in HO-1 protein for each subject. (n=10).
Table 4.3 Reproducibility data for lymphocyte HO-1 protein expression at basal levels, peak induction and 4, 6, 24 and 48 h following H2 O2
treatment
Parameter Trial 1 Trial 2 % change in mean 
(95 % Cl)





Peak 2.1 ± 0 .9 2.0 ± 0 .9 -2 (-14 to 12) 14 (10 to 30) 0.92**
48 h 2.1 ± 0 .9 1.9 ± 1.0 -12 (-32 to 15) 30 (23 to 73) 0.92**
24 h 1.1 ±0.3 1.3 ±0.3 17 (-1 to 42) 20 (15 to 43) 0.84**
6 h 1.0 ±0.3 1.1 ±0.3 16 (-19 to 70) 44 (36 to 124) -0.28
4 h 0.9 ± 0.2 1.1 ± 0 .2 22 (-1 to 55) 25 (19 to 57) 0.37
Basal 1.0 ± 0 .2 0.9 ±0.1 -9 (-21 to 4) 11 (7 to 27) 0.57
** denotes a significant correlation coefficient (P  < 0.01). Values are mean ± S.D. (n=10 for all time points other than basal, where n=6).
Table 4.4 Reproducibility data for monocyte HO-1 protein expression at basal levels, peak induction and 4, 6, 24 and 48 h following H2O2
treatment
Parameter Trial 1 Trial 2 % change in mean 
(95 % Cl)





Peak 1 .410 .3 1 .610 .5 13 (-3 to 34) 18 (13 to 38) 0.66*
48 h 1 .3 1 0 .4 1 .510 .6 12 (-14 to 49) 29 (21 to 73) 0.56
24 h 1 .010 .3 1 .110 .3 15 (-8 to 46) 25 (19 to 59) 0.46
6 h 0 .9 1  0.4 0 .9 1 0 .3 1 (-32 to 52) 49 (40 to 146) 0.05
4 h 0.8 1 0 .2 1 .010 .2 23 (0 to 59) 26 (19 to 60) 0.24
Basal 1 .11 0 .2 1.110.1 -6 (-17 to 6) 10 (7 to 24) 0.59
* denotes a significant correlation coefficient (P  < 0.05). Values are mean ± S.D. (n=10 for all time points other than basal, where n=6).
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Re-test correlation for peak HO-1 induction was statistically significant in lymphocytes 
(r = 0.92, P = 0.000) and in monocytes (r = 0.66, P = 0.036) (Tables 4.3 and 4.4). This 
was similar at 48 h in lymphocytes (r = 0.84, P = 0.002) and smaller in monocytes 
(r = 0.46, P = 0.214).
The basal level of HO-1 protein was also determined although due to technical 
difficulties, the basal level of HO-1 protein in both trials was only available for six 
subjects. In lymphocytes and monocytes (n=6), the %CV was -9% ± 11% and 
-6% ± 10%, respectively (Tables 4.3 and 4.4). This indicates that the basal levels of 
HO-1 protein are reproducible when individuals refrain from physical activity and 
follow a replicated diet for 72 h prior to measurement.
Cell Viability
Cell viability following H2O2 treatment was measured at all time points (Figure 4.5). As 
expected, H2O2 treatment resulted in reduced cell viability in comparison to the 
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Figure 4.5 Cell viability of MNCs before treatment and 4, 6, 24 and 48 h following 
H 2O2 . 0 h: untreated control. Values are mean ± S.D. (n=10). * In trials 1 and 2, values 
following H2O2 are different to 0 h (P < 0.01), # In trials 1 and 2, values for viability 
following H202are different to sham-treated control in respective trial {P < 0.01).
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The change in the mean and the SEM, as a %CV, increased with time and was larger in 
the treated samples than the sham-treated controls (Table 4.5).
Table 4.5 Reproducibility data for mononuclear cell viability at 4, 6, 24 and 48 h following H2O2 treatment
Parameter Trial 1 (%) Trial 2 (%) % change in mean 
(95 % Cl)




4 h sham 92 ±5 93 ±5 2 {-A to 8) 6 (4 to 12) -0.05
4 h treated 78 ± 10 78 ±7 2 (-9 to 14) 12 (9 to 25) 0.00
6 h sham 84 ± 10 90 ± 6 8 (-1 to 19) 10(7 to 19) 0.28
6 h treated 72 ± 9 72 ± 10 0.2 (-15 to 17) 17 (12 to 36) -0.38
24 h sham 73 ± 1 81 ±7 12 (-3 to 31) 16 (12 to 34) -0.18
24 h treated 49 ± 12 61 ± 10 28 (5 to 67) 26 (19 to 59) 0.21
48 h sham 65+16 73 ±8 15 (-3 to 38) 19 (14 to 42) 0.29
48 h treated 46 ± 17 58 ± 11 30 (6 to 73) 27 (21 to 65) 0.24




The present study supports previous research showing an ex vivo up-regulation of HO-1 
protein in lymphocytes following H2O2 treatment (Marini et al., 1996a). This is the first 
work investigating the within-subject variation of the HO-1 protein response to H2O2. In 
addition, it confirms reports of large inter-individual variations in the ability to increase 
lymphocyte HO-1 protein in response to oxidants (Marini et al., 1996a; Menzel et al., 
1998). The main finding is that maximal expression of HO-1 protein is a reproducible 
measure for reporting the response of this enzyme to H2O2 treatment.
The physiological concentration o f H2O2 in human plasma has been reported to be 
4-5 pM (Yamamoto et al., 1987) and this increases under inflammatory conditions. 
Some studies have found levels of H2O2 in human urine as high as 100 pM (Long et al., 
1999a), with many common beverages containing H2O2 at concentrations greater than 
100 pM (Long et al., 1999b). In the present investigation, MNCs were treated with a 
concentration of 50 pM H2O2. The concentration of H2O2 used was sufficient to up- 
regulate HO-1 protein in a time-dependent manner with increased levels of the protein 
from 24 h. Maximum levels of HO-1 protein expression were observed 48 h following 
H2O2 treatment in lymphocytes and were equivalent to a 2-fold increase.
Previous studies have demonstrated an increase in HO-1 protein in lymphocytes as early 
as 6 h, with HO-1 expression maintained at least 18 h following H2O2 treatment (Marini 
et al., 1996a). Other investigators have shown that in human lymphocytes using a non- 
genotoxic HBO treatment as the model o f oxidative stress, induction of HO-1 protein 
increases in a time-dependent manner and was maximum at 24 h (Speit et al., 2000; 
Rothfuss and Speit, 2002). Furthermore, these authors showed that increased HO-1 
induction protected lymphocytes from oxidative DNA damage induced by a repeated 
HBO exposure or by treatment with H2O2, supporting the role of HO-1 as 
cytoprotective. However, in contrast to these findings, some authors have reported that 
HO-1 protein was not detectable in vivo in lymphocytes at basal level or following 
different types of oxidative stress (Yachie et al., 2003). Although in the present study, 
monocytes showed a similar response to treatment as lymphocytes, with the induction of 
HO-1 protein greatest 48 h following the stimulus. There is little evidence in the 
literature investigating H2O2 treatment and HO-1 protein induction in monocytes, 
however, treatment of monocytes with alternative oxidants has shown increased levels 
of HO-1 protein (Pinot et al., 1997; Bomman et al., 1999). The present findings 
demonstrate a delayed induction of HO-1 protein in comparison to other studies
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investigating HO-1 protein induction in lymphocytes (Marini et a l ,  1996a). However, 
this time point for maximal HO-1 protein induction has been reported in osteoarthritic 
chondrocytes (Fernandez et al., 2003) and mouse peritoneal macrophages (Vicente et 
al., 2003a). These authors suggest that the delayed induction of HO-1 may reflect an 
autocrine response to oxidative stress (Fernandez et al., 2003; Vicente et a l, 2003a), 
although there is little direct evidence to support this contention at the present time.
Several studies have shown a large inter-individual variation in the induction of HO-1 
protein in humans (Marini et al., 1996a; Menzel et a l ,  1998). It is possible that the 
variation in the induction of HO-1 is a result of the presence of a polymorphism in the 
gene associated with susceptibility to oxidative-stress mediated diseases (Hirai et a l, 
2003). For example, the microsatellite polymorphism GT (n) repeat is present in the 
human HO-1 gene promoter and is associated with increased risk of emphysema 
(Yamada et a l,  2000). Undoubtedly, the presence of a polymorphism in the human 
HO-1 gene could cause inter-individual variation of HO-1 activity, with the absence of 
the GT (n) repeat in rat and mouse HO-1 genes accounting for the interspecies variation 
in the regulation of HO-1 expression (Shibahara et a l ,  2002). Alternatively, the 
variation could be attributed to a number of factors such as health status, exercise, 
general stress and diet, although they are more likely to have implications for the within- 
subject variation and these factors were tightly controlled in the current investigation. 
Ultimately, from an experimental perspective, it is the ability to reproduce the response 
on different days that is critical.
Re-test correlation reflects the reproducibility of the rank order of the subjects on re­
testing. In lymphocytes and monocytes this was statistically significant (r = 0.92, 
P  = 0.000 and r = 0.67, P = 0.036 in lymphocytes and monocytes, respectively). 
Therefore, those subjects who responded highest in trial 1 remained high in trial 2 and 
were placed in a similar positioning in terms of order. Although re-test correlation is a 
good measure of reproducibility, it comprises both between-subject and within-subject 
variation (Hopkins et a l,  1999) and is only applicable to individuals similar to those 
sampled. The within-subject error is a better measure of reproducibility as it can be 
estimated from a sample of individuals not representative of a population (Hopkins, 
2000a).
In the present study, the within-subject variation of the HO-1 response to H2O2 
treatment decreased in a time-dependent manner. There was no significant difference 
between the two trials at any time point, thus suggesting negligible systematic bias. The 
number of responders to the treatment at 4 and 6 h was very small and not consistent
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among the sample population increasing both the systematic bias and the SEM. The 
SEM is usually larger than the bias and represents the random error due to biological or 
mechanical factors inherent in the measurement tool (Hopkins, 2000a). An ideal 
measure would have both a small systematic bias and a small SEM. The number of 
individuals mounting a response to the treatment through increased HO-1 up-regulation 
increased with time of recovery, therefore minimising the within-subject variation in the 
lymphocyte HO-1 response to treatment. All ten subjects had a maximum induction of 
HO-1 protein at 48 h in trial 1 and seven o f these in trial 2. At 48 h, the change in the 
mean ± SEM, as a %CV, was -12% ± 30% and 12% ± 29% in lymphocytes and 
monocytes, respectively. Additionally, as the majority of subjects experienced maximal 
HO-1 protein induction at this time in both cell populations, this would be the most 
appropriate time point to use in further investigations. The change in the mean ± SEM 
can be expressed in raw values as a fold change. At 48 h, this was -0.16 ± 0.39 fold 
change and 0.21 ± 0.37 fold change in lymphocytes and monocytes, respectively. 
Therefore, if  this time point is used in future investigations where an intervention is 
employed, the researcher can estimate that any change in HO-1 protein expression that 
is greater than 30% or 0.40 fold change, with regards to the change in the mean between 
the two trials, is related to the treatment and not to random error.
The peak response had the smallest change in the mean and SEM, as a %CV, 
(-2% ± 14% and 13% ± 18% in lymphocytes and monocytes, respectively). There was a 
negligible change in the mean and relatively small random error in lymphocytes which 
was -0.03 ± 0.26 when expressed as a fold change. In monocytes, the change in the 
mean was larger and the SEM was the same as in lymphocytes (0.20 ± 0.26 fold 
change). Altered gene expression is a sensitive marker of oxidative stress in vitro 
(Tyrrell and Basu-Modak, 1994; Griffiths et al., 2002) and mononuclear cell HO-1 
protein expression fulfils the criteria as a valid biomarker o f oxidative stress since the 
measured product is specific, sensitive and reproducible (Offord et a l , 2000; Griffiths et 
a l , 2002). Accordingly, the results presented here confirm that the induction of HO-1 
protein is a reproducible measure of the response to oxidative stress in lymphocytes.
In conclusion, the present investigation has provided the first evidence detailing the 
within-subject variation o f HO-1 protein induction in response to H2O2 treatment. This 
study shows that the reproducibility of the response changes over time and is most 
reproducible when there is maximum induction of the gene. This method is, therefore, a 
suitable model to use following exposure to (i) a prior stimulus known to induce HO-1, 
or (ii) a modifying factor which may alter the basal level of HO-1 and, hence, the pattern 
of expression of the enzyme upon further treatment. In the next chapter, this model is
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applied before and after demanding exercise in order to establish whether prior exercise 
affects the ability of lymphocytes to respond to a subsequent oxidant challenge.
99
CHAPTER 5
THE EFFECT OF EXERCISE ON EXPRESSION OF HO-1 IN HUMAN 
MONONUCLEAR CELLS IN RESPONSE TO SUBSEQUENT OXIDATIVE STRESS
5.1 Introduction
Lymphocytes are immune cells that are continually exposed to ROS, and therefore, the 
manner in which they react to ROS is important in their ability to function. Strenuous 
long duration exercise causes oxidative damage to tissues resulting in an increase in 
plasma lipid hydroperoxides (Alessio et a l,  2000; Davison et a l ,  2002; Nieman et a l, 
2003), lymphocyte DNA damage (Tsai et a l ,  2001; Mastaloudis et a l ,  2004b), and 
increased plasma protein carbonyls following exercise (Radak et a l ,  1997; Lee et a l,  
2002).
Acute exercise induces a transient inflammatory response and this may serve as an 
important secondary source of free radical production during the recovery period 
following heavy exercise (Ji, 1999). This response is characterised by the release of pro- 
inflammatory cytokines with plasma IL-6 concentrations peaking immediately post­
exercise (Pedersen and Toft, 2000; Nieman et a l ,  2001; 2003). High-intensity exercise 
induces apoptosis in lymphocytes (Mars et a l,  1998) and there are conflicting findings 
regarding whether apoptosis is implicated in the decline in lymphocyte concentration in 
the hours following exercise (Mars et a l ,  1998; Steensberg et a l ,  2002). Furthermore, 
lymphocyte proliferation is depressed 2 h post-exercise (MacNeil et a l ,  1991; Nielsen 
and Pedersen, 1997; Mitchell et a l ,  2002). Consequently, the damage caused by 
strenuous exercise may have important implications for lymphocyte function in the 
hours following exercise, particularly for individuals who engage in successive exercise 
sessions.
Therefore, demanding exercise may have a negative impact on lymphocytes as it causes 
an excessive increase in the production of ROS. The oxidative damage induced 
following exercise may increase the susceptibility to subsequent oxidative stress and this 
has led to suggestions that individuals participating in these activities may benefit from 
antioxidant supplementation (Sen, 1995; Ashton et a l,  1998). This scenario could 
provide an ideal model to manipulate the response to oxidative stress using antioxidants. 
Superimposing the ex vivo model (Chapter 4) upon exercise-induced oxidative stress
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provides a method for examining the response of lymphocytes to subsequent oxidative 
stress, replicating the process that may occur following acute exercise in vivo. Hence, 
the aim of the present investigation was to determine whether (i) HO-1 is induced by 
demanding exercise and (ii) exercise increases the susceptibility o f lymphocytes to 




Eight male students participated in this study (Table 5.1). Physical activity was assessed 
by questionnaire (Appendix 2). The exercise was intermittent in nature and all subjects 
recruited were familiar with intermittent activities such as football, squash and rugby, 
completing on average 3 ± 1 h of activity per week (mean ± S.D.) Subjects were 
excluded from the investigation if they smoked, took regular prescribed medication or 
food supplements or were endurance-trained.













24.5 ±3.8 180 ± 6 78.8 ±8 .9 58 ± 6 200 ± 9 41 ± 13
Values are mean ± S.D. (n=8).
5.2.2 Experimental design
Each subject completed two trials, one exercise (Ex) and one control (Rest), separated 
by two weeks with the order o f the trials randomised. Subjects were asked to record 
their food and fluid intake during the 72 h prior to the main trial, which was replicated 
prior to the second trial (Chapter 2.4). Prior to the main trials, all individuals completed 
preliminary testing to establish their VC^max (Chapter 2.3) and to determine their 
individual running speeds for the intermittent exercise protocol (IEP). The IEP consisted 
of a 60 min run divided into four 15 min blocks comprised of bouts of speeds equivalent 
to 65, 85 and 100% VC^max (Figure 5.1). This protocol was developed so that a high- 
intensity exercise could be used as a model to induce changes in HO-1 mRNA that are 
greater than levels previously demonstrated with other protocols. As intermittent
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exercise performed at the same average work rate as continuous exercise has been 
associated with increased physiological strain (Edwards et al., 1973) it was hypothesised 
that this model would elicit greater changes in HO-1 mRNA in response to acute 
exercise. Pilot data revealed that individuals who were endurance-trained were not able 
to complete the protocol for 60 min, stopping after approximately 20-40 min (Table A .l, 
Appendix 6).
0 15 30 45 60
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2 min 85% V02max
■□
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2 min rest
Figure 5.1 Schematic design of the intermittent exercise protocol. Each block lasts 15 
min with a two-min rest interval between blocks.
The overall intensity o f this protocol was equivalent to 75% VC^max for 60 min with a 
total rest time of six min. Heart rate was measured every 15 s during exercise using 
short-range telemetry (Vantage NV, Polar Electro OY, Finland) and retrieved upon 
completion of the exercise. During the 12th min of each block o f activity, subjective 
ratings of perceived exertion were recorded using a 6-20 scale (Borg, 1973) and expired 
gas samples were collected. Upon completion of each block, a finger prick capillary 
sample was taken for blood glucose and lactate concentration. Subjects consumed water 
ad libitum throughout exercise, and the volume consumed was recorded.
Subjects completed a five min warm up on the treadmill at a speed equivalent to 50% 
V02max, following a resting venous sample (Section 5.2.3). On completion of the 
protocol, all subjects sat in a supine position for 15 min prior to the post-exercise blood 
sample being taken. Venous blood was taken 2, 4 and 6 h post-exercise, with two 
additional samples at 24 and 48 h post-exercise (Figure 5.2). Subjects were given a 
standardised meal following the 0 h post-exercise sample, and again between the 2 and 4
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h samples (1771 kcal, 62% carbohydrate, 12% protein and 26% fat). This diet was 
replicated in the control trial, during which subjects sat in the lab resting for 60 min, 
with gas samples and capillary blood being collected at the same times as in the exercise 
trial.
5.2.3 Blood sampling and treatment
On the day of a main trial, subjects reported to the laboratory following an overnight 
fast. A resting venous sample was taken from the ante-cubital vein following rest in a 
supine position for 15 min (Chapter 2.6). Approximately 25 ml of blood was collected 
and placed in aliquots in EDTA coated tubes (Chapter 2.6). Plasma was removed and 
stored at -70 °C prior to analysis of plasma interleukin-6 (IL-6) and interleukin-10 
(IL-10) concentrations (Chapter 2.11). Mononuclear cells were harvested and incubated 
for 45 min to separate monocytes and lymphocytes before lysis in TRIZOL (Chapter 
2.10). HO-1 mRNA was determined using real-time RT-PCR (Chapter 2.10.2). 
Approximately 12 x 106 cells were resuspended in PBS for treatment with H2O2 and left 
to recover for 6 and 48 h (Chapter 2.8.1). Following recovery from H2O2 cells were 
pelleted and fixed in 70% ice cold ethanol and left at 4 °C for three days prior to 
analysis of HO-1 by flow cytometry (Chapter 2.9). Approximately 12 x 106 cells were 
set aside for immunophenotyping. Cell viability was assessed after the MNC separation 
procedure (Chapter 2.8.2) along with the determination of protein concentration 
(Chapter 2.6.4). The ex vivo treatment was performed prior to exercise and rest and 0, 2, 
4, 6, 24, and 48 h post-exercise and post-rest (Figure 5.2).
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The direct immunofluorescence method of staining was used to determine lymphocyte 
subsets from a MNC population using a dual combination o f monoclonal antibodies 
conjugated to FITC or R-phycoerythrin (PE). Samples were analyzed using 488 nm 
excitation and detection in the green fluorescence channel for FITC (FL1: 530 ± 30 nm 
bandpass filter) and orange fluorescence channel for PE (FL2: 585 ± 42 nm bandpass 
filter). Electronic compensation was set to correct for spectral overlap in both FITC and 
PE emissions. When the cells are correctly compensated the population medians of 
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Figure 5.3 Dual parameter dot plot of FL2 versus FL1, determining the percentage of 
CD4 (A) and CD8 (B) T cells in a MNC population. T cells are positive for CD3/CD4 
and are located in the upper right quadrant o f (A), with CD3/CD8 cells located in the 
upper right quadrant of (B).
Briefly, 1 x 106 cells were incubated with 20 pi of conjugate (CD3-FITC/CD4-PE; 
CD3-FITC/CD8-PE) in the dark for 30 min at room temperature. After incubation, 2 ml 
diluent was added and the cells centrifuged (170 g, 5 min at room temperature). The 
supernatant was aspirated and the cell pellet suspended in a fixative solution of 2% 
paraformaldehyde in PBS. An isotype control was performed with FITC mouse IgGl 
and PE mouse IgG2a monoclonal antibodies to determine background fluorescence. 
Cells were kept on ice until analysis by flow cytometry. Ten thousand events of the 
lymphocyte population were collected using a Becton Dickinson FACScan (Cellquest 
version 3.3 software, Belgium). Gates based on cell size and granularity were used to 
distinguish between lymphocyte and monocyte populations for fluorescence analysis.
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The data was analysed using two-dimensional dot plots of FL2 versus FL1 fluorescent 
profiles.
5.2.5 Statistical Analysis
Haem oxygenase-1 mRNA and protein in response to exercise (Ex) or rest were 
normalised to the pre-trial time point. In the ex vivo model, HO-1 protein in the treated 
sample was normalised to the respective sham-treated control, and then expressed 
relative to the pre-trial time point. For each trial, the change in HO-1 mRNA and protein 
expression was determined at each time point following exercise/rest in relation to the 
pre-exercise/rest sample to produce a change score for each subject [ChangeExO -  
ChangeRestO = (0 h post-Ex minus pre-Ex) minus (0 h post-rest minus pre-rest), where 
0 represents the 0 h post-trial time point]. Paired t statistics of the change scores for each 
parameter were performed.
The data were not normally distributed, therefore, a natural log transformation was 
applied. This was followed by back-transformation o f the log effects into factors. The 
difference in the mean of the exercise and rest trials change scores was calculated using 
effect size (ES) (Chapter 3.2.3), using the control trial SD as the denominator. This 
provided additional information regarding the practical significance as the ES represents 
the magnitude of the difference between the change score (ChangeEx minus 
ChangeRest) over the time course. Values lying between 0.2 to 0.49, and 0.5 to 0.79 
were considered small and moderate effects, whereas ES greater than 0.8 indicated large 
differences (Cohen, 1988).
The clinical significance of the change in HO-1 expression was assessed from Q value 
calculations. This statistic represents the probability that the true effect of HO-1 
induction with exercise was at least as great as the minimum worthwhile effect 
(Froehlich, 1999). This was derived from testing a hypothesis of an arbitrary minimum 
effect rather than a hypothesis of no effect as in a t test (Equation 5.1) (Froehlich, 1999). 
In this study, the minimum worthwhile effect (6) (smallest worthwhile difference) was 
regarded at an ES of 0.2, in order to estimate the % chance that the true value was at 
least a ‘small’ effect. In this Chapter, the term ‘clinical’ significance will be referred to 
as ‘biological’ significance because the ‘clinical’ utility of this measurement is not 
known.
te = [ 6 - ( M r M 2) ] / S E [Equation 5.1]
Where, Q = probability that T > tq SE = standard error
Traditionally, when clinical significance is employed, the % chance that the true value is 
at least as great as the minimum worthwhile effect is defined as a positive, trivial or 
negative change. In this Chapter, a positive or negative change will be defined as an 
increase or decrease, respectively. This can be interpreted in both a quantitative and 
qualitative form (very unlikely: < 5%, unlikely: < 25%, possible: < 75%, likely: < 95%, 
very certain: > 95%). For a change to be practically significant, the estimate that the % 
chance was greater than or equal to 75% was accepted, indicating a ‘likely’ or 
‘probable’ chance that the observed effect was true.
Pearson’s product moment correlations were calculated comparing the peak fold 
increase in IL-6 and IL-10 concentration with the peak fold increase in HO-1 mRNA in 
the exercise trial. The statistical calculations described were performed using a pre­
formatted spreadsheet (Hopkins, 2003) in addition to SPSS version 11 (SPSS Inc., 
Chicago, USA). Significance was accepted at the 5% level. Values are presented as 
mean ± S.D. The data represent values for eight subjects, except in the ex vivo model at 
48 h where values represent seven subjects due to problems with the pre-trial ex vivo 
treatment in one subject.
5.3 Results
Exercise Protocol
The overall intensity o f the IEP was predicted to be 75% VC^max. During exercise, 
expired air samples could only be collected once per block in the 65% VC^max stage to 
ensure the actual intensity of the protocol was equivalent to 65%. This was 67 ± 2% in 
block one, increasing to 69 ± 4% in block four. During these lower intensity phases, the 
exercise resulted in an 11-fold increase in oxygen consumption when compared to all 
resting values (Table 5.2). As expected, the exercise produced significantly different 
changes in blood lactate and blood glucose concentrations, oxygen consumption and 
heart rate when compared to the resting trial (P < 0.05) (Table 5.2).
Table 5.2 A comparison of the changes in blood lactate and blood glucose concentrations, heart rate and oxygen consumption at rest vs. exercise



















Rest 4.0 ± 0.8 3.8 ±0.8
1 0.8 ± 0.3 4.4 ± 0.3 61 ±4 3.6 ± 1.5 4.5 ± 1.3** 4.4 ± 0.4 157± 15** 38.3 ±3.7**#
2 0.8 ± 0.3 4.2 ± 0.2 60 ±4 3.3 ±0.9 4.7 ± 2.0** 4.8 ± 0.7 166 ± 13**+ 38.6 ±3.7**#
3 0.7 ± 0.2 4.2 ± 0.3 61 ±4 3.3 ± 1.1 5.0 ± 1.7** 4.7 ± 1.2 171± 13*** 39.9 ±5.1**#
4 0.9 ± 0.6 3.9 ± 0.7 62 + 5 3.6 ±0.5 5.5 ± 1.5** 4.8 ±0.8 170 ± 11*** 39.7 ±3.9**#
Block numbers 1 to 4 equate to 15 min bouts o f intermittent exercise or rest. ** denotes a significant difference to the corresponding block in the 
resting trial (P < 0.01). # denotes a significant difference to the rest value in the exercise trial (P < 0.01). * denotes a significant difference to 
block 1 in the exercise trial (P < 0.01). Values are means ± S.D. (n=8).
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Leukocyte Changes
Exercise-induced changes to the blood leukocyte populations increased immediately 
after the IEP, peaking at 2 h post-exercise, with the largest change occurring in the 
neutrophil population (Figure 5.4). Total leukocyte count 2 h after the 60 min trial 
period was 9.2 ± 2.0 x 109.l ' cells in the exercise trial compared to 4.6 ± 1.2 x 109.r ' 
cells in the rest trial (ES = 4.74, P = 0.000). This remained elevated for 6 h returning to 
resting values 24 h post-exercise. An increase in the monocyte population at 2 h post­
exercise (ES = 1.87, P = 0.006) was accompanied by a decline in lymphocytes 
(ES = -1.11, P = 0.047) when compared to the corresponding time in the rest trial. The 
cell counts did not change significantly for any leukocyte subpopulation in the rest trial.
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Figure 5.4 Neutrophil, lymphocyte and monocyte cell count (x lO9.!"1) during the 
exercise and rest trial. Pre: pre-trial. ** denotes a significant difference between the 
change score in neutrophil cell count in the exercise trial compared to the change score 
at the same time point in the rest trial [ChangeEx minus ChangeRest] (P < 0.01), 
* (P < 0.05). t  denotes a significant difference in the change score in the monocyte 
population in the exercise trial compared to the change score at the same time point in 
the rest trial (P < 0.01), # denotes a significant difference in the change score in the 
lymphocyte population in the exercise trial compared to the change score at the same 
time point in the rest trial (P < 0.05). Values are mean ± S.D. (n=8).
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Immunophenotyping of lymphocyte subpopulations CD3/4 and CD3/8 revealed no 
differences in distribution following exercise (Table 5.3) or with the time of day in the 
rest trial. The distribution of T cells remained between 73% and 75% over the 48 h 
period in both trials with B cell proportion remaining consistently between 21% and 
24%.
Table 5.3 Immunophenotyping of lymphocyte subpopulations following 60 min intermittent exercise or rest
Time (h)
Trial Baseline 0 2 4 6 24 48
Rest
C D 3 / C D 4 4 1 . 3  ±  7 . 0 4 5 . 6  ±  6 . 1 4 5 . 0  ±  5 . 5 4 7 . 6  ±  4 . 5 4 2 . 1  ±  6 . 6 4 5 . 0  ±  4 . 5 4 3 . 1  ±  6 . 8
C D 3 / C D 8 2 9 . 7  ±  9 . 8 2 6 . 4  ±  3 . 8 2 8 . 3  ±  7 . 3 2 8 . 3  ±  4 . 4 2 8 . 3  ±  5 . 4 2 7 . 3  ±  3 . 6 2 7 . 6  ±  3 . 8
T cells 7 6 . 0  ±  7 . 9 7 3 . 7  ±  3 . 5 7 3 . 6  ±  3 . 7 7 4 . 5  ±  4 . 7 7 4 . 4  ±  2 . 2 7 4 . 1  ±  4 . 2 7 4 . 3  ±  5 . 3
B cells 2 3 . 0  ±  6 . 0 2 3 . 0  ±  3 . 3 2 3 . 5  ±  2 . 9 2 2 . 6  ±  3 . 6 2 3 . 0  ±  2 . 3 2 3 . 8  ±  1 . 9 2 3 . 3  ±  3 . 9
Exercise
C D 3 / C D 4 4 5 . 0  ±  5 . 2 4 5 . 4  ±  2 . 8 4 6 . 1  ±  3 . 3 4 5 . 6  ±  7 . 4 4 6 . 2  ±  5 . 1 4 5 . 1  ±  4 . 6 4 4 . 7  ±  5 . 9
C D 3 / C D 8 2 8 . 0  ±  5 . 3 2 5 . 9  ±  3 . 4 2 6 . 0  ±  2 . 5 2 5 . 7  ±  2 . 5 2 8 . 1  ±  5 . 3 2 6 . 5  ±  3 . 3 2 8 . 5  ±  6 . 3
T cells 7 3 . 6  ±  5 . 6 7 3 . 6  ±  5 . 1 7 3 . 5  ±  5 . 3 7 6 . 9  ±  2 . 2 7 4 . 0  ±  4 . 1 7 5 . 1  ±  4 . 8 7 4 . 7  ±  2 . 4
B cells 2 3 . 6  ±  5 . 8 2 3 . 3  ±  4 . 4 2 3 . 8  ±  6 . 2 2 1 . 0  ±  3 . 0 2 3 . 5  ±  3 . 6 2 3 . 0  ±  5 . 9 2 3 . 0  ±  2 . 3
Values are percentages, expressed as mean ± S.D. (n=8).
I l l
HO-1 mRNA expression
The change in lymphocyte HO-1 mRNA following exercise was variable between 
subjects, with increases in HO-1 mRNA induction observed in some subjects and a lack 
of response in others (Figure 5.5). At 2 h post-exercise, four individuals had increased 
levels of HO-1 mRNA above 2-fold. The largest induction found was a 5-fold change at 
2 h following exercise when compared to the corresponding time point in the control 
trial. Although the difference in HO-1 mRNA expression following exercise compared 
to rest was not statistically significant at any time point, an ES of 0.9 was observed at 
the 2 h post-trial time point indicating a large effect. The probability that the observed 
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Figure 5.5 The fold change in lymphocyte HO-1 mRNA expression pre-exercise, 
immediately post-exercise, 2, 4, 6, 24, and 48 h after exercise in eight individuals. HO-1 
mRNA was normalised to the baseline value in each trial and expressed as the fold 
change in HO-1 mRNA in the exercising trial relative to the fold change in HO-1 




















Figure 5.6 Estimates of the probability that the true values o f the difference in the mean 
lymphocyte HO-1 mRNA expression (ChangeEx minus ChangeRest) over time are 
important. The smallest worthwhile effect was set a priori at an ES o f 0.2. (n=8).
Where the percent likelihood is referred to as an increase, a greater change in HO-1 
mRNA in the exercise trial compared to the change in HO-1 mRNA expression in the 
resting trial is observed. Therefore, at 2 h post-exercise it is 75% likely that the increase 
in HO-1 mRNA with exercise is greater than the change in HO-1 mRNA with rest. In 
contrast, at 24 h, the decrease indicates the change in HO-1 mRNA with exercise is less 
than the change in HO-1 mRNA observed at rest, indicating a down-regulation in HO-1 
mRNA at this time point. The trivial effect at 4 h represents no difference between the 
change in HO-1 mRNA in either trial.
The basal level of HO-1 mRNA in lymphocytes was determined in each subject in both 
trials (Figure 5.7). In seven out o f the eight subjects, HO-1 mRNA expression was 
higher in the exercise trial than in the rest trial. When this was data was grouped, a 
significantly higher level of HO-1 mRNA at baseline was evident in the exercise trial 
with a value o f 7.2 ± 2.1 arbitrary units (A.u) compared to 5.6 ± 2.0 A.u in the rest trial 
(mean ± S.D., n=8) (ES = -0.8, P = 0.043). Trial order was randomised and there were 
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Figure 5.7 Basal expression of lymphocyte HO-1 mRNA in the exercise and rest trial in 
eight individuals including the mean ± S.D. HO-1 mRNA is expressed relative to 
GAPDH in arbitrary units (A.u). * denotes a significant difference compared to the rest 
trial (.P < 0.05).
The basal level of HO-1 mRNA expression was not related to the peak fold increase in 
HO-1 mRNA following acute intermittent exercise (r = -0.33, P  = 0.425).
HO-1 Protein
HO-1 protein did not change with exercise or rest (Table 5.4). A moderate decrease in 
monocyte HO-1 protein following exercise was observed at 2 h post-exercise when 
compared to the rest trial (ES = -0.7, P  = 0.126). This was associated with an 87% 
chance (decrease) that the true value was greater than the smallest worthwhile effect 
indicating the reduction in monocyte H O -1 protein following exercise compared to rest.
Table 5.4 The fold change in HO-1 protein expression at baseline, 0, 2,4,  6, 24 and 48 h following 60 min exercise or rest
Time (h)
Trial Baseline 0 2 4 6 24 48
Lymphocytes
Rest 1.00 ±0.00 0.94 ±0.13 0.98 ±0.14 0.97 ± 0.09 0.99 ± 0.20 0.95 ±0.10 1.01 ±0.25
Exercise 1.00 ±0.00 1.01 ±0.19 0.97 ± 0.25 0.95 ± 0.24 1.02 ±0.23 1.01 ±0.21 1.00 ±0.15
Monocytes
Rest 1.00 ±0.00 1.16 ±0.40 1.18 ±0.33 1.14 ±0.45 1.17 ±0.67 1.14 ±0.32 1.28 ±0.74
Exercise 1.00 ±0.00 1.05 ±0.30 1.03 ±0.38 1.02 ±0.29 1.09 ±0.41 1.18 ±0.35 1.16 ±0.28
Values are mean ± S.D. (n=8).
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Hydrogen peroxide treatment
At the 6 h recovery time point following H2O2 treatment, there were no differences 
between lymphocyte or monocyte HO-1 protein induction following exercise or rest at 
any time. There were large effects in the difference in the mean at 0 h, 2 h, and 24 h 
post-exercise, suggesting a reduced lymphocyte HO-1 protein induction following H2O2 
treatment when compared to the rest trial (Table 5.5). In monocytes, a large ES was 
observed 2 h post-exercise. Exercise resulted in a decreased monocyte HO-1 protein 
expression when compared with rest.
Table 5.5 The induction of HO-1 protein in human lymphocytes after exercise or rest following 6 h and 48 h recovery from H2O2 treatment
Time post-exercise (h)
Trial Baseline 0 2 4 6 24 48
6 h
Rest 1.15 ±0.29 1.28 ±0.10 1.17 ±0.24 1.10 ±0.20 1.43 ±0.31 1.43 ±0.23 1.46 ±0.25
Exercise 1.30 ±0.27 1.29 ±0.32 1.14 ±0.33 1.21 ±0.30 1.45 ±0.26 1.34 ±0.36 1.49 ±0.34
Change -0.14 ±0.30* 0.27 ± 0.46* -0.03 ± 0.32 -0.13 ±0.38 -0.23 ± 0.42* -0.11 ±0.34
48 h
Rest 1.36 ±0.28 1.24 ±0.61 1.78 ±0.33 1.43 ±0.39 1.88 ±0.62 1.77 ±0.73 1.62 ±0.61
Exercise 1.54 ±0.57 1.24 ±0.54 1.25 ±0.34 1.49 ±0.40 1.53 ±0.32 1.90 ±0.83 1.57 ±0.94
Change -0.17 ±0.46 -0.71 ±0.62*# -0.11 ±0.43 -0.53 ± 0.54 -0.05 ±0.61 -0.22 ± 0.63
Values are mean ± S.D. The symbols for ES and P  values indicate significance o f the change score relative to baseline [Change = (2 h post­
exercise minus baseline) minus (2 h post-rest minus baseline)]. * denotes a large ES of the change score. # denotes a significant difference 
between exercise and rest trials (P < 0.05). (n = 8 for 6 h recovery, n = 7 for 48 h recovery).
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At 2 h post-exercise, the expression of HO-1 48 h after recovery from H2O2 was 
significantly lower than the HO-1 protein induction at the same time point in the rest 
trial (ES = -2.6, P = 0.044) (Figure 5.8). In monocytes, a moderate effect was seen at the 





























Figure 5.8 The individual change in lymphocyte HO-1 protein 48 h after H2O2 treatment 
2 h post-exercise or 2 h post-rest (2 h post-exercise minus pre-exercise or 2 h post-rest 
minus pre-rest). The mean ± S.D is included (n=7 for rest; n=8 for exercise). There was 
a missing value for subject one’s rest trial as a result o f a problem with the pre-rest 
treatment.
Likelihoods of the probability that the true value was greater than the smallest 
worthwhile effect were calculated for lymphocytes and monocytes at both 6 h and 48 h 
after H2 O2 treatment, showing that the difference in the mean between exercise and rest 


















Figure 5.9 Estimates of the probability that the true values of the difference in the mean 
for lymphocyte HO-1 protein expression (ChangeEx minus ChangeRest) over time are 
important at 6 h recovery (A) and 48 h recovery (B). The smallest worthwhile effect was 
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Figure 5.10 Estimates of the probability that the true values o f the difference in the mean 
for monocyte HO-1 protein expression (ChangeEx minus ChangeRest) over time are 
important at 6 h recovery (A) and 48 h recovery (B). The smallest worthwhile effect was 
set at an ES of 0.2.
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Cytokines
Plasma levels of interleukin-6 (IL-6) and interleukin-10 (IL-10) increased immediately 
following the exercise trial (Figure 5.11). There were no differences between IL-6 or 
IL-10 concentrations in the rest trial (ES = -0.22, P  = 0.310 and ES = 0.02, P  = 0.697 
for IL-6 and IL-10, respectively). The difference in the change in the mean (ChangeEx 
minus ChangeRest) was significant for both plasma IL-6 and IL-10 concentrations 
(ES = 2.44, P = 0.000 and ES = 2.03, P = 0.002 for IL-6 and IL-10, respectively).
There was a positive relationship between the peak fold increase in plasma IL-6 
concentration and peak fold increase in HO-1 mRNA expression in the exercise trial 
{r = 0.723, P  = 0.045) (Figure 5.12). The peak fold change in plasma IL-10 
concentration and peak fold increase in HO-1 mRNA expression in the exercise trial 
displayed a similar relationship, although was not statistically significant (r = 0.577, 




































Figure 5.11 Plasma interleukin-6 concentrations (A) and interleukin-10 concentrations 
(B) in rest and exercise trials. Pre: pre-trial, Post: 0 h post-trial. ** denotes a significant 
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Figure 5.12 The relationship between the peak increase in HO-1 mRNA expression in 
mononuclear cells and the peak fold increase in plasma IL-6 concentration (A) and 
IL-10 concentration (B) following the intermittent exercise protocol. (n=8).
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Cell Viability
Cell viability immediately following the isolation procedure was 97 ± 2% 
(mean ± S.D.). Cell viability did not change with time or trial. Following H2O2 
treatment, significant differences were observed between the sham-controls and H2O2- 
treated samples at all time points in both the exercise and rest trials, for 6 and 48 h 
recovery (P < 0.01) (Table 5.6). An ES less than 0.2 was found when the difference in 
ChangeEx minus ChangeRest was calculated at all time points, therefore cell viability 
was unaffected by prior exercise.
Table 5.6 Cell viability (%) following recovery at 6 h and 48 h after H2O2 treatment, 
assessed over a time course post-exercise and post-rest___________________________
Time post-rest or exercise (h)
Baseline 0 2 4 6 24 48
Rest (6 h following H2O2 treatment)
Sham
H20 2
94 + 4 
84  + 5 **
94 ± 4 93 ± 3 94 ± 3 93 ± 3 
81 ±5** 80 ±5** 79 ±4** 81 + 5**
92 ±3 
76 ± 8 **
94 ±2
8 i ± 8 **




82 ± 8 **
95 ± 2 95 ± 3 94 ± 3 94 ± 5 










83 ± 6  82 + 6 78 ±7  81 ± 6  
58 ± 6 ** 57 ±5** 57 + 3** 57 ±4**
79 ± 10 
59 ± 6 **
85 ±7 
55 ±3**
Exercise (48 h following H20 2 treatment)
Sham
H20 2
80 + 7 
58 ± 7 **
80 + 6 78 ±5 80 ± 6  81 ± 6  





** denotes a significant difference when compared to the sham-treated sample at the
same respective time point (P < 0.01). Values are mean ± S.D. (n=8).
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5.4 Discussion
In this investigation, lymphocytes harvested 2 h after an acute bout of demanding 
exercise demonstrated a reduced up-regulation of HO-1 protein expression in response 
to a second oxidant challenge. This was also the time point where the increase in 
lymphocyte HO-1 mRNA was greatest. This is the first investigation that demonstrates 
altered lymphocyte HO-1 protein response to exogenous oxidant treatment following 
acute exercise.
The exercise protocol used in this study was intermittent in order to achieve a higher 
overall intensity of exercise. The increases in blood lactate, heart rate and oxygen 
consumption confirm the demanding nature o f the exercise. Interestingly, the increase in 
total leukocytes and neutrophils following exercise was smaller than that observed 
following a half marathon (Chapter 3), which may reflect the shorter duration of 
exercise. Additionally, the proportion o f T cells and B cells did not change post­
exercise. The intensity of the protocol used in this study was equivalent to 
approximately 75% VC^max. Although it was shorter in duration than the prolonged 
protocols previously shown to induce HO-1 (Niess et a l , 1999b; Thompson et a l , 
2005), it was hypothesised that higher intensity bouts of exercise would increase the 
demands of the cardiovascular system associated with overall greater oxygen 
consumption. In particular, the present protocol involves subjects completing four bouts 
of sustained work at 100% maximal O2 consumption. A single incremental maximal 
exercise test that terminates at an equivalent to 100% maximal O2 consumption 
markedly increases free radical concentration in blood (Ashton et a l , 1998). During 
mitochondrial oxidative phosphorylation there is a reduction of molecular oxygen, with 
2-10% oxygen undergoing incomplete reduction leading to the generation of superoxide 
(Halliwell and Gutteridge, 1999). Although still not frilly resolved, it is generally 
accepted that the quantity of superoxide will increase in proportion to oxygen uptake. In 
the current investigation, an 11-fold increase in oxygen consumption above resting 
values was observed during the lowest intensity phases of the intermittent protocol.
Previous studies have demonstrated both prolonged and high-intensity exercise induces 
HO-1 mRNA in skeletal muscle (Pilegaard et al., 2000) and leukocytes (Thompson et 
a l , 2005). In human skeletal muscle, levels of HO-1 mRNA were shown to increase 11- 
fold above control levels 2 h after an exhaustive one-legged knee extensor exercise 
equivalent to 70% of each individual’s two min maximal resistance load (Pilegaard et 
a l,  2000). In comparison, a 4 h cycle at 60% V02max resulted in only a 4-fold increase 
in HO-1 mRNA which remained elevated for 4 h (Pilegaard et a l ,  2000). Therefore,
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high-intensity eccentric type exercise is more effective in up-regulating HO-1 mRNA 
levels in skeletal muscle. The exercise protocol used in the present study involved high- 
intensity intermittent running as it was hypothesised this would induce a greater 
expression of HO-1 mRNA in lymphocytes than prolonged running. The intermittent 
exercise used in the current study increased endogenous HO-1 mRNA levels 2 h post­
exercise when compared to the corresponding time point in the control trial. The 
expression of HO-1 mRNA did not change in the resting trial. There was a trend for an 
increase in lymphocyte HO-1 mRNA post-exercise as indicated by the large effect size 
and likelihood values. However, the induction of HO-1 mRNA was variable between 
individuals with some subjects showing a down-regulated response to exercise. The 
maximal induction of HO-1 mRNA in the current study was a 5-fold increase 2 h post­
exercise with a total of five subjects having a 2-fold change in HO-1 mRNA between 0 
and 6 h following exercise. The basal level of protective genes has been suggested to 
reflect the inducibility o f the gene in response to stress (Boshoff et al, 2000), with low 
basal expression reflected by high induction and vice versa. In the present investigation, 
no relationship between basal HO-1 mRNA expression and the peak induction of HO-1 
mRNA expression was evident (r = -0.33, P  = 0.425). In the current study, individuals 
with either low or high basal expression of HO-1 mRNA were able to induce the gene.
Presently, an up-regulation in lymphocyte HO-1 mRNA has been demonstrated 
following prolonged exercise equivalent to 70% V02max lasting 75 min (Thompson et 
al., 2005). Although the protocol used in the current investigation was completed at a 
higher overall intensity than the prolonged running by Thompson and co-workers 
(2005), the duration was 15 min shorter and there was a total of six min rest from 
exercise. The exercise-induced increase in HO-1 mRNA observed by Thompson and 
colleagues (2005) was larger than the response to the intermittent protocol. Exhaustive 
exercise has been shown to alter intracellular calcium signalling of lymphocytes leading 
to changes in the mitochondrial membrane potential (Mooren et a l , 2001). It is possible 
that the rest periods in the exercise protocol were sufficient for calcium disturbances 
within the mitochondria to recover and, coupled with the re-synthesis of antioxidant 
compounds such as glutathione, result in an attenuation of overall oxidative stress. 
Therefore, it would appear that the HO-1 mRNA response in skeletal muscle and 
lymphocytes differ depending on the exercise mode and intensity with prolonged 
running the more effective protocol for up-regulating HO-1 mRNA in human 
lymphocytes.
Inflammatory processes play a role in the generation of free radicals and resulting 
oxidative stress. In the current study, an increase in leukocyte counts was observed with
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the greatest changes to the neutrophil population at 2 h post-exercise. This increase in 
total leukocyte cell count was accompanied by an increase in monocyte cell number and 
a decline in lymphocyte cell number. Neutrophils and monocytes have the capability to 
produce superoxide, migrating to damaged muscles where they function to remove the 
injured tissue and aid the repair process (Pyne, 1994). The release of pro-inflammatory 
cytokines amplifies ROS formation and augments oxidative stress (Niess et a l ,  1999a). 
In the present investigation, the plasma concentration o f the pro-inflammatory cytokine 
IL-6 significantly increased immediately following exercise and the fold change in IL-6 
was positively correlated with the peak fold increase in HO-1 mRNA expression after 
exercise. The anti-inflammatory cytokine IL-10 also increased following intermittent 
exercise. Increased plasma IL-6 concentration was observed following prolonged 
running (Thompson et al., 2005), although the concentration of plasma IL-6 in this 
investigation was higher than the levels found in the current study. Previously, a 
correlation between IL-8 and HO-1 protein expression has been found in human 
lymphocytes and neutrophils following a half marathon race (Niess et al., 1999b). 
Collectively, these findings support a possible relationship between pro-inflammatory 
cytokine concentration and HO-1 expression.
In contrast to expectations, the acute exercise protocol used in the present study did not 
lead to an increase in HO-1 protein expression. Furthermore, in monocytes there was a 
moderate reduction in HO-1 protein expression 2 h post-exercise. In contrast to the 
findings of the present study, other investigations have demonstrated increases in HO-1 
protein expression post-exercise (Niess et al., 1999b; Thompson et al., 2005). The 
conflicting results observed in this study may be due to differences in the exercise 
protocols and/or methods of analysis. Flow cytometric analysis of MNCs in this 
investigation used the median fluorescence intensity to calculate fold changes in HO-1 
protein expression. Where significant increases in HO-1 protein expression have been 
demonstrated with this method, percent positive cells and the mean fluorescence 
intensity have been the parameters used for analysis (Niess et al., 1999b; Fehrenbach et 
al., 2003a). Although this may partially explain the discrepancy in results, it is 
noteworthy that the exercise protocols employed in earlier investigations have also been 
longer in duration. Therefore, it is possible that the discrepancy in results regarding 
exercise-induced HO-1 protein may be due to the duration and intensity of the exercise 
protocols employed, with HO-1 protein increasing in response to prolonged continuous 
exercise and not to demanding intermittent exercise that incorporates rest periods.
Previously, HO-1 protein induction has been found to be maximal 48 h following 
treatment with H2O2 (Chapter 4). In the present study, lymphocyte HO-1 protein
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induction increased approximately 1.5-fold 48 h following H2O2 treatment prior to 
exercising or resting for 60 min. Following the intermittent exercise, a decrease in the 
ability of lymphocytes to respond to H2O2 was evident as the induction of HO-1 protein 
was smaller when compared to pre-exercise values. The HO-1 protein response to H2O2 
treatment is a reproducible measure (Chapter 4) and therefore the decrease in HO-1 
protein observed 2 h post-exercise is the result of changes due to exercise. Increased 
HO-1 mRNA expression was found at this time point after exercise; although this was 
not accompanied by an increase in HO-1 protein at this point or any later time. The 
reduction in the HO-1 response to H2O2 treatment may reflect an inability to respond to 
subsequent oxidative stress. This could represent a maladaptive response of prior 
demanding exercise as lymphocytes were unable to induce the gene. However, it is 
noteworthy that this response was not accompanied by a decrease in cell viability. 
Furthermore, this was only a transient response and 4 h after exercise the ability to 
respond to H2O2 had returned to pre-exercise levels.
It is possible that the lack of induction of HO-1 to H2O2 treatment post-exercise is a 
reflection of the many other changes induced by an acute bout of exercise. Acute 
exercise is known to increase the expression of HSPs and antioxidant enzymes in 
lymphocytes (Fehrenbach et a l , 2000a; Elosua et a l , 2003; Tauler et a l , 2003). 
Therefore, one explanation for the lack of increase in HO-1 protein following ex vivo 
treatment may potentially be a consequence of increases in HSP and endogenous 
antioxidants and indicate an adaptive response to exercise. If this were subsequently 
proved to be the case this would potentially have important implications since 
lymphocytes are continuously exposed to ROS and are often found at sites of 
inflammation where further ROS are generated. Several investigations have shown an 
adaptive response to subsequent oxidative stress using a variety o f initial stressors which 
induce HO-1 (Noel and Tyrrell, 1997; Speit et al., 2000; Rothfuss and Speit, 2002; 
McArdle et a l , 2004). The time for this adaptive response has varied from 4 h (McArdle 
et a l , 2004) to 48 h following the initial exposure (Noel and Tyrrell, 1997), whereas in 
the present investigation the decrease in HO-1 induction following ex vivo treatment was 
observed 2 h post-exercise. The reduced ability of lymphocytes to induce HO-1 protein 
to subsequent oxidant challenge was a transient effect as the response had returned to 
resting levels 4 h following exercise. Furthermore, the reduced HO-1 response to H2O2 
treatment 2 h following exercise was not mediated by HO-1 as the acute exercise 
employed in the present investigation did not increase HO-1 protein.
An alternative explanation for the lack of induction of HO-1 following prior exercise is 
explained by the concept of ‘refractoriness’. Noel and Tyrrell (1997) investigated the
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adaptive response to a second challenge of oxidative stress in skin fibroblasts using 
UVA irradiation and reported an absence o f HO-1 mRNA accumulation with a 
treatment 48 h following the first irradiation. The down-regulated HO-1 response 
following prior induction has been described as refractoriness, and it is proposed that 
this may represent a pathway that has evolved to maintain haem synthesis (Noel and 
Tyrrell, 1997). This led to the proposal that a haem intermediate was involved in the 
refractory response (Noel and Tyrrell, 1997) with later investigations confirming this in 
the identification of the HO-1 repressor, the haem-binding protein Bach-1 (Shibahara et 
al., 2003). When haem binds to Bach-1, the repressor function is prevented (Ogawa et 
a l , 2002) allowing induction of HO-1. The continuous re-induction o f HO-1 would lead 
to local accumulation of CO, bilirubin and iron which individually are cytotoxic at high 
concentrations. The effects of unwanted gene activation was illustrated in cells where 
HO-1 is highly over-expressed, reversing the cyto-protective effects associated with 
increased HO-1 expression (Suttner and Dennery, 1999). The continuous re-induction of 
HO-1 would prevent the replacement of crucial haem-containing proteins and, therefore, 
repression of HO-1 could be a safety mechanism preventing unnecessary gene 
activation. An alternative proposal for the repression of HO-1 is that down-regulation of 
the gene might be a mechanism to reduce energy expenditure for haem catabolism and 
prevent accumulation of its by-products (Shibahara et al., 2003). A final possibility is 
that the basal expression of HO-1 may have been adequate for the level of oxidative 
stress encountered during exercise, thus increased protection was not necessary. 
According to this explanation, the preconditioning stimulus in the present study may 
have been sufficient to modestly alter transcription but this was not sufficient to increase 
protein synthesis.
In summary, the findings from this investigation confirm that an acute bout of exercise 
induces HO-1 mRNA accumulation in lymphocytes. However, in contrast to 
expectations, the increase was generally modest and was not associated with an increase 
in HO-1 protein. The degree of these changes limits the scope o f this particular form of 
exercise to serve as a model for subsequent modulation with lycopene supplementation. 
In spite of the modest change in HO-1, there was a decrease in the ability o f 
lymphocytes to respond to H2O2 treatment following an acute bout o f exercise. It is 
possible that this reflects either an adaptive response to prior oxidative stress (e.g., due 
to increases in antioxidant enzymes), refractoriness of HO-1 or some form of 
maladaptation and failure to respond when required.
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CHAPTER 6
THE IMPACT OF LYCOPENE SUPPLEMENTATION VIA WHOLE FOODS 
ON MODULATION OF HO-1 EXPRESSION AND CELL VIABILITY IN HUMAN
MONONUCLEAR CELLS
6.1 Introduction
Dietary supplementation with antioxidants can enhance the body’s natural defence 
system and therefore has the potential to modify the response to oxidative stress. The 
carotenoid lycopene is a powerful free radical scavenger and there is a wealth of 
epidemiological evidence supporting a protective effect of lycopene against certain 
types of cancers (Gann et al., 1999; Giovannucci, 1999; Lu et al., 2001), atherosclerosis 
and cardiovascular disease (Kohlmeier et al., 1997; Klipstein-Grobusch et al., 2000; 
Rissanen et al., 2003). However, investigations using dietary supplementation o f this 
antioxidant have, like many other exogenous antioxidants, resulted in conflicting 
findings regarding a protective role for lycopene (Riso et al., 1999; Astley et al., 2004; 
Riso et al., 2004).
Lycopene is the predominant antioxidant found in tomatoes and supplementation studies 
have often provided this carotenoid in the form of tomato-based products. The 
bioavailability o f lycopene from processed tomato products is greater than that found in 
fresh tomatoes (Stahl and Sies, 1992; Gartner et al., 1997; Stahl et al., 2002). 
Collectively, the evidence supports a protective effect from lycopene supplementation in 
whole food products (Rao and Agarwal, 1998; Gann and Khachik, 2003).
In the previous chapter, the HO-1 mRNA response to an acute bout of exercise was 
inconsistent between subjects with an increase in HO-1 mRNA observed post-exercise 
in four individuals with the remaining four subjects experiencing a down-regulation in 
HO-1 mRNA post-exercise (Chapter 5). This finding makes the exercise and combined 
ex vivo model inappropriate to use in further investigations in conjunction with lycopene 
supplementation. Since lymphocyte treatment with H2O2 ex vivo up-regulated HO-1 
protein in all individuals (Chapter 4) this represents a more appropriate model for 
intervention than the previous exercise model. In addition, several investigations have 
demonstrated that human lymphocytes treated ex vivo with H2O2 induces DNA damage
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(Marini et al., 1996b; RothfUss et al., 1998) and cell death by apoptosis (Marini et al., 
1996a; Fenech et al., 1999) and that antioxidant supplementation modulates this 
response. Indeed, antioxidant treatment prior to H2O2 exposure in vitro has been shown 
to reduce both apoptotic cell death and DNA damage (Crott and Fenech, 1999; Lowe et 
al., 1999). Furthermore, lycopene supplementation via a range of tomato products 
reduces DNA damage following H2O2 treatment ex vivo (Porrini and Riso, 2000; Porrini 
et al., 2005). The effect of lycopene supplementation in vivo and the apoptotic response 
of lymphocytes to ex vivo H2O2 treatment have not previously been examined. Although 
findings from cell culture and animal studies suggest that HO-1 induction would be 
suppressed, further evidence regarding the effect of antioxidant supplementation and 
modulation of HO-1 gene expression and the mode of cell death ex vivo are required.
Physical activity recommendations suggest that thirty minutes o f moderate activity on 
five or more days o f the week is sufficient to maintain health (Pate et al., 1995). 
Because habitual physical activity has the capacity to modulate endogenous antioxidants 
and therefore the response to oxidative stress, physical activity assessment should be 
incorporated to explore the role of habitual physical activity in HO-1 induction and cell 
death. Therefore, the primary aim of the present study is to investigate the impact of 
lycopene, using tomato supplementation, on modulation of the HO-1 response to 
oxidative stress and mode of cell death in response to H2O2 treatment. A secondary aim 
is to examine the relationship between these parameters and physical activity in order to 
(i) examine whether individuals participating in regular physical activity had different 




Twenty-four male volunteers took part in this study (Table 6.1). All participants were 
non-smokers and not taking regular prescribed medication. Participants with a range of 
physical activity levels were recruited.
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Table 6.1 Subject characteristics
Age (yrs) Height (cm) Mass (kg) Z Skinfolds (mm)
26.3 ±4.0 180 ± 10 76.9 ± 10.8 36 ± 12
Values are mean ± S.D. (n=24).
6.2.2 Experimental design and procedures
Anthropometric data was collected on the first visit (Chapter 2.2) and physical activity 
was assessed during the wash-out period (Section 6.2.5). During this investigation, 
participants were asked to refrain from consuming foods containing lycopene for eight- 
weeks (Appendix 3). The study design consisted of two, three-week supplementation 
periods separated by a two-week wash-out period (Figure 6.1). The supplementation 
periods consisted of (a) 170 g passata sauce (containing approximately 7 mg lycopene 
and 0.3 mg p-carotene) (H.J. Heinz, UK) taken with 10 g butter (Anchor, Aria foods, 
UK) or (b) 10 g butter alone. The tomato product was consumed with butter to ensure 
there was no loss in the bioavailability of lycopene from ingestion to absorption (Stahl 
and Sies, 1992; Van het Hof et al., 2000; Stahl et al., 2001) and was obtained from the 
same batch of tomatoes. A cross-over design was used with subjects acting as their own 
control, therefore in the control condition, no tomato products were consumed. The 
order of supplementation was randomised.
Subjects were asked to maintain a food and fluid record for three days of each week 
during the supplementation periods (Chapter 2.4). These days were any three days out of 
seven and were used as a tool by the experimenter to monitor adherence to the 
intervention. In the final week leading up to the next blood sample, subjects were 
instructed to report the three days immediately prior to the sample and were then asked 
to replicate these foods prior to visit five (Table 6.2). During the wash-out time, subjects 
did not weigh their foods and maintained a near to normal diet, still avoiding foods 
containing lycopene.
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Table 6.2 Daily dietary composition assessed over three days prior to each trial day
Energy CHO Protein Fat Vitamin C Vitamin E |3-carotene
Intake (%) (%) (%) (mg) (mg) (mg)
(kcal)
2619 ±791 49 ±6 17 ± 6 34 ±8 183 ±273 8 ± 3 1 ± 1.4
In the tomato supplemented trial, lycopene intake was ~7 mg.day'1. The lycopene 
content of foods was determined using an updated database of U.S foods (Holden et a l,  
1999). CHO: carbohydrate. Values are mean ± S.D. (n=24).
Subjects reported to the laboratory following an overnight fast, on five occasions 
(Figure 6.1). A resting blood sample (10-50 ml) was taken from a forearm vein 
following 15 min in a supine position (Chapter 2.6). On visits one, two, and four, 10 ml 
of venous blood was collected. For visits three and five (at the end of each three-week 
supplementation period) 25-50 ml blood was collected to obtain a final yield of a 
minimum of approximately 40 x 106 MNCs. Plasma was collected for carotenoid 
analysis (Section 6.2.4) at each occasion and stored in aliquots at -70 °C. Mononuclear 
cells were isolated (Chapter 2.6.1) and basal values for HO-1 protein (Chapter 2.9) and 
determination of percent apoptosis and necrosis (Section 6.2.3) were taken on four of 
the five visits. Following visits three and five, MNC’s were treated with H2O2 (Chapter 
2.8.1) and levels o f HO-1 protein, apoptosis and necrosis were determined at 18 and 
48 h following the initial treatment. Previous work showed similar levels of apoptosis in 
freshly harvested lymphocytes at 6, 12 and 18 h following treatment with 50 pM H2O2 
(Figure A.4, Appendix 8). Therefore, the 18 h time point was chosen as the induction of 
HO-1 is delayed. The 48 h time point corresponds to the maximal induction of HO-1 
protein (Chapter 4).
1
Supplementation period: non-tomato based
1
14 day washout period Supplementation period: tomato based
Supplementation period: tomato based ------------------C > Supplementation period: non-tomato based









C Control treated sample
T H2O2 treated sample
Day 22 
Day 22/ 57
C T C T






C T C T
I I 1 I
18 and 48 h Recovery
V V
i HO-1 APOPTOSIS HO-1 APOPTOSIS
Blood sample PROTEIN NECROSIS PROTEIN NECROSIS
Figure 6.1 Experimental design o f  the tomato supplementation vs. no tomato condition. Each subject acts as their own control with the order o f  
supplementation randomised. Each supplementation period lasts three weeks and is separated by a two week wash-out phase.
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6.2.3 Determination o f  apoptosis and necrosis
The use of flow cytometry allows for the quantification of live, apoptotic and necrotic 
cells on a single-cell basis within cell populations. The combination of a specific marker 
of apoptosis and a DNA stain can be used to distinguish between apoptotic and necrotic 
cell death. Markers of apoptosis and necrosis were FITC-conjugated Annexin V (AV) 
and the DNA stain propidium iodide (PI). Annexin V is a Ca2+-dependent phospholipid 
binding protein with a high affinity for phosphatidylserine (PS). It stains specifically 
externalized PS in the plasma membrane of apoptotic cells (Vermes et al., 2000). As 
necrotic cells also expose PS, these cells are distinguished by simultaneous staining with 
PI.
Cells were stained with AV and PI as described in the manufacturer’s protocol (Roche 
Applied Science, Lewes, UK). Briefly, MNCs were washed with PBS following 
incubation and resuspended in 100 pi incubation buffer (10 mM Hepes/NaOH, pH 7.4, 5 
M NaCl, 100 mM CaCh) containing AV (20 p l.m f1) and PI (20 p l.m f1). Cells were 
incubated in the dark for 15 min at room temperature. Following this, 400 pi incubation 
buffer was added to each sample before analysis in a Becton Dickinson FACScan 
(Cellquest version 3.3 software, Belgium). Samples were analysed using 488 nm 
excitation and detection in the FL1 channel for AV (530 ± 30 nm bandpass filter for 
fluorescein) and FL3 channel (650 nm longpass filter) for PI, using electronic 
compensation to correct for spectral overlap. The data were analysed using two- 
dimensional dot plots of FL3 versus FL1 fluorescent profiles (Figure 6.2). Live 
(AV'/PT), apoptotic (AV+/PT) and necrotic (total PI*) cell populations were determined 
in a total o f 10,000 cells and expressed as a percent. The apoptotic and necrotic cells in 
sham-treated samples were subtracted from the corresponding populations in H2O2- 
treated samples to exclude the low levels o f death unrelated to H2O2.
Figure 6.2 Dual parameter dot plot of FL3 versus FL1 fluorescent profiles in an 
untreated sample. Live cells are located in the lower left quadrant (AV’/PF), with 
apoptotic cells in the lower right quadrant (AV+/PF). The upper left and right quadrants 
reflect necrotic cell death (total PI+).
6.2.4 Detection o f  lycopene
Human plasma was thawed and vortexed to disperse possible precipitates. In 5 ml tubes, 
250 pi of plasma was added to 250 pi distilled water, followed by 500 pi ethanol 
containing butylated hydroxytoluene (BHT) (0.2g.r') to deproteinise the sample. The 
suspension was mixed for approximately 20 s on a vortex mixer. The extraction was 
completed by adding 2 ml rc-hexane, and samples were mixed for 90 s prior to 
centrifugation (2500 g, 5 min at room temperature). The upper phase was extracted into 
a glass tube and dried in a N 2 current. The residue was re-dissolved in 250 pi ethanol 
(containing BHT) and placed in aliquots in glass amber vials prior to analysis by HPLC.
High-performance liquid chromatography was performed using a modified protocol 
described by Tauler and colleagues (2002). The HPLC system consisted of a pump 
(JASCO PU-1580, Japan), an ultraviolet/visible light detector (JASCO UV-1575, 
Japan), and an autosampler (JASCO 851-AS, Japan), coupled to an integrator (Hewlett- 
Packard, model 3395) with a C l8, 4.6 x 150 mm column. The mobile phase was 
pumped at a rate o f 1 ml.min'1 and consisted of 550:370:80 
acetonitrile:terahydrofuran:water. Sample volumes of 40 pi were injected into the HPLC 
system and lycopene was measured as a single peak using an absorbance detector set at 
460 nm. The run time was approximately 18 minutes. The retention time for lycopene 
was 9 min, considered to be all-trans lycopene, with lutein and zeaxanthin, 
cryptoxanthin and p-carotene at 2.2, 5 and 15 min respectively (Figure 6.3). Carotenoid
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Figure 6.3 Chromatogram o f carotenoid separation from human plasma samples.
6.2.5 Assessment o f  Physical Activity
The level o f physical activity and total energy expenditure was assessed using a 
combined accelerometer and heart rate monitor (Actiheart, Cambridge Neurotechnology 
Ltd., Cambridge, UK). This tool was worn for seven continuous days, collecting data 
measurements every minute during both day and night. The data was downloaded and 
analysed providing an estimate of daily energy expenditure and activity patterns 
(Actiheart 2.0, Cambridge Neurotechnology, Cambridge, UK). The software package 
produced two plots with data for basal metabolic rate (BMR) and active energy 
expenditure (AEE) (Figure 6.4). The data was transferred into an excel spreadsheet for 
further analysis. Basal metabolic rate (BMR) was calculated by the software using the 
Schofield equation (1985) with energy expenditure above sleeping heart rate (10th 
lowest point during sleep) contributing to AEE. This was calculated using branched 
equation models for heart rate and activity data, allowing total energy expenditure 
(TEE) to be determined.
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Figure 6.4 An example of the data analysis package used with the Actiheart monitors. 
The top figure is a plot of activity (kcal.min'1) and HR (beats.min'1) against time, with 
the shading representing activity and the line indicating HR. The bottom figure is a plot 
of AEE against time.
The combination of heart rate and accelerometry data in a branched equation model 
improves the estimate of physical activity energy expenditure compared with either 
method used alone or if the traditional non-branched combination is used (Brage et al., 
2004). In addition, branched modelling avoids individual calibration of these monitors 
(Brage et al., 2004). The data output was provided as two separate plots of energy 
expenditure or heart rate against time and transferred to an excel file. A spreadsheet was 
used to calculate the TEE (AEE + BMR) as well as determine the number of min each 
subject spent above threshold values for 3, 6, 9, and 12 metabolic equivalents (METS) 
over the seven day testing period, providing daily and weekly estimates of TEE. 
Physical activity at an intensity less than 3, between 3 and 6, and greater than 6 METS 
reflected low, moderate and vigorous physical activity, respectively, as described by 
Pate and colleagues (1995). The data was analysed in kcal.min'1 and kcal. kg '1.m in'1.
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Physical activity recommendations recognise an accumulation of 10 min bouts of 
moderate activity to contribute to total daily activity, therefore only periods of 10 min or 
more were included in the duration at each intensity where HR was greater than 55% 
age-predicted maximum (Pollock et a l , 1998). Physical activity levels (PAL’s) were 
calculated by dividing TEE by BMR providing another measure of physical activity. An 
example of the software analysis print out illustrates the differences in energy 
expenditure in subjects who are sedentary compared to very active (Figure A.5, 
Appendix 9).
6.2.6 Statistical Analysis
A repeated-measures ANOVA was used to compare results between the tomato- 
supplemented trial and no tomato trial, with a between-subjects factor of order of 
treatment. This was to ensure that there was no period effect from eating the tomato or 
no tomato diet first (Riso et a l , 1999). Effect size was calculated determining the 
magnitude of the change (Chapter 3.2.3).
Spearman’s rank order correlation (rho) was used to determine whether relationships 
existed between physical activity and levels of HO-1 protein expression and cell 
viability at baseline and following treatment. The relationship between plasma lycopene 
concentration and HO-1 protein expression and cell death were examined. The data 
were divided into the top 50% (n=12) and the lower 50% (n=12) based on activity 
duration (total activity time, moderate activity, and vigorous activity). A paired t statistic 
was calculated to examine whether there were differences between activity duration and 
basal levels of HO-1 protein and cell death, as well as the HO-1 and cell death response 
to treatment. In order to determine the effect of duration of activity (total activity, 
moderate activity only, or vigorous activity only) threshold values o f 60 and 120 min 
per week were set and differences in the basal HO-1 protein and cell death at these 
limits were calculated using an unpaired t statistic.
Post-trial H202-induced HO-1 was expressed as the fold change in MFI of the treated 
samples against the MFI of the sham-treated samples. Cell viability data was expressed 
as a percent. Values for HO-1 protein and cell viability following treatment were log- 
transformed as the data were not normally distributed. Significance was accepted at the 
5% level. Values are presented as mean ± S.D. (n=24). Data were analysed using SPSS 




Plasma carotenoid concentrations changed following supplementation with tomatoes 
(Figure 6.5). In the tomato trial, plasma lycopene and P-carotene concentrations 
increased significantly compared to the no tomato trials (ES = 1.38, P = 0.000 and 
ES = 0.17, P = 0.004 lycopene and P-carotene, respectively). Small differences in the 
levels of cryptoxanthin (ES = 0.28, P = 0.034) and canthaxanthin (ES = 0.36, P = 0.021) 
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Figure 6.5 Plasma carotenoid concentration in the no tomato and tomato supplemented 
trials (p g .f1 plasma). ** denotes a significant difference in plasma concentrations 
between the tomato and control trials (P < 0.01),* (P < 0.05). Values are mean ± S.D. 
(n=24).
HO-1 protein expression
There was no difference in H O-1 protein expression in response to H2O2 treatment with 
18 or 48 h recovery following the tomato supplemented or no tomato condition in both 
lymphocytes (ES = 0.12, P  = 0.713 and ES = 0.16, P = 0.881 for 18 and 48 h 
respectively) and monocytes (ES = 0.02, P = 0.715 and ES = 0.20, P = 0.572 for 18 and 
48 h respectively) (Figure 6.6). The level o f HO-1 protein induction following 18 and 
48 h recovery was significantly different to 0 h in both trials in lymphocytes 
(P = 0.000). In monocytes this was not significant following 18 h (P = 0.929 and 
P = 0.729 in the no tomato and tomato conditions, respectively) or 48 h recovery from
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Figure 6.6 Fold change in lymphocyte (A) and monocyte (B) HO-1 protein expression at 
18 h and 48 h following H20 2 treatment. Values are mean ± S.D. (n=24).
There was no difference in the basal level o f H O -1 protein in lymphocytes or monocytes 
in the tomato or no tomato condition (ES = 0.18, P = 0.969 and ES = 0.39, P = 0.842 for 
lymphocytes and monocytes, respectively) (Figure 6.7). However, a modest positive 
trend, assessed by Spearman’s rank correlation (rho), between plasma lycopene
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concentration and basal lymphocyte HO-1 protein was evident in both the no tomato 
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Figure 6.7 Basal level of HO-1 protein in lymphocytes and monocytes did not change 
following three weeks of tomato supplementation or no tomatoes. Values are 
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Figure 6.8 The relationship between plasma lycopene concentration and basal HO-1 
protein expression in lymphocytes in the tomato supplemented (rho = 0.356, P = 0.088) 
and no tomato trials (rho = 0.250, P = 0.250). (n=24). NT: no tomato trial, T: tomato 
trial.
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Lymphocyte apoptosis and necrosis
When lymphocytes were treated with H2O2 there was no difference in the percentage of 
live, apoptotic, and necrotic cells at 18 h (ES = 0.11, P = 0.173; ES = 0.15, P = 0.275 
and ES = 0.13, P = 0.353 for live, apoptotic and necrotic cells, respectively) or 48 h 
recovery from treatment (ES = 0.04, P = 0.876; ES = 0.01, P = 0.619 and ES = 0.19, 
P = 0.648 for live, apoptotic and necrotic cells, respectively), following the tomato 















Figure 6.9 Percent live, apoptotic and necrotic cells in human lymphocytes at 18 h (A) 
and 48 h (B) following H2O2 treatment in tomato supplemented (T) and no tomato (NT) 
trials. Values are mean ± S.D. (n=24 for 18 h, n=19 for 48 h).
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A positive correlation was observed between plasma lycopene concentration and 
lymphocyte necrosis 18 h following H2O2 in both the tomato supplemented 
(rho = 0.438, P  = 0.032) and no tomato trials (rho = 0.444, P  = 0.030), respectively. In 
addition, a modest inverse relationship was found between plasma lycopene 
concentration and the proportion of live cells 18 h following H2O2 in both the tomato 
and no tomato trials (rho = -0.454, P  = 0.026 and rho = -0.496, P  = 0.014 for tomato 
and no tomato trials, respectively) (Figure 6.10). Figure 6.10 illustrates a shift to the 
right o f the data points from the tomato trial with respect to the no tomato trial; therefore 
the tomato supplement did not have a protective effect on recovery from H2O2 treatment 
with no effect on the nature of the relationship. Similar trends were demonstrated 
following 48 h recovery from treatment in both the tomato (rho = -0.528, P  = 0.020, 
rho = 0.358, P  = 0.132 and rho = 0.451, P= 0.053 for live, apoptotic and necrotic cells, 
respectively) and no tomato trials (rho = -0.307, P  = 0.201, rho = 0.293, P = 0.223 and 
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Figure 6.10 The relationship between plasma lycopene concentration and the proportion 
o f live cells (A) apoptosis (B) and necrosis (C) 18 h following H2O2 treatment in the 
tomato supplemented (T) and no tomato trials (NT) (n=24).
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In the untreated samples, the basal level o f live cells increased with the tomato 
supplement (ES = 0.61, P = 0.029) and was accompanied by a reduction in the 
proportion of apoptotic cells (ES = 0.59, P = 0.006) (Figure 6.11). The proportion of 
necrotic cells in untreated lymphocytes in the tomato trial also reduced although this 
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Figure 6.11 Basal level of live, apoptotic and necrotic lymphocytes following three 
weeks of tomato supplementation or no tomatoes. ** denotes a significant difference 
between the no tomato and tomato trial (P < 0.01), * (P < 0.05). Values are 
mean ± S.D. (n=24).
Physical activity and energy expenditure
Daily total energy expenditure (TEE) was 3909 ± 530 kcal (mean ± S.D.) with estimated 
basal metabolic rate (BMR) ranging from 1535 kcal.day’1 to 2168 kcal.day’1 (Table 6.3). 
The duration of activity at moderate intensity or above (greater than three METS) was 
calculated for each person with the weekly duration of physical activity ranging from 10 
min to 471 min (Figure 6.12).
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Table 6.3 Daily total energy expenditure analysed as BMR, active energy expenditure 
(AEE) and physical activity level (PAL)
BMR AEE TEE PAL
(kcal.day'1) (kcal.day'1) (kcal.day'1)
1847± 168 2099 ± 425 3909 ± 530 2.1 ±0.2
(1535-2168) (1393-2854) (3019 to 5022) (1.6 to 2.6)
PAL represents the ratio between TEE and BMR. Values are mean ± S.D. (Range). 
(n=24).
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Figure 6.12 Weekly duration o f physical activity at moderate intensity exercise or 
above, in subjects 1 to 24. M: mean ± S.D. Bouts of physical activity were only included 
when they exceeded 10 min at a HR greater than 55% age-predicted maximum in 
accordance with current ACSM exercise recommendations (Pollock et al., 1998).
Physical activity recommendations o f a minimum of 30 accumulated min o f moderate 
intensity exercise at least five times a week is equivalent to 150 min of physical activity 
at three or more METS. The mean weekly exercise duration spent at or above moderate 
intensity was 210 ± 124 min (Table 6.4). Eight individuals failed to meet exercise 
recommendations with seven subjects participating in 300 min or more exercise a week.
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Table 6.4 Duration of weekly activity (min) at differing intensity levels
Intensity Moderate Vigorous --------- ►
METS 3-6 6-9 9-12 > 12
Time (min) 87 ±85 53 ±38 60 ±48 10 ±33
Values are mean ± S.D. (n=24).
The proportion of each subject’s time spent at different intensities was calculated with 
moderate intensity activity accounting for 43 ± 29% of the weekly physical activity time 
(Figure 6.13). The amount of time spent participating in vigorous activities (intensity 
greater than six METS) accumulated to 57% of the total exercise duration.
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Figure 6.13 Proportion o f weekly time engaged in moderate physical activity or above 
(> 3 METS). Values are mean ± S.D. (n=24).
The data were analysed to determine whether there was a relationship between the 
weekly duration o f exercise and basal levels o f HO-1 protein, live, apoptotic and 
necrotic cells, and the responses to H2O2 treatment in human lymphocytes and 
monocytes. There was a positive relationship between the baseline basal measures of 
HO-1 protein and the time spent engaged in vigorous physical activity in both 
lymphocytes and monocytes. Additionally, it appears there may be a positive 
relationship between cell viability following H2O2 treatment and the amount of time
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engaged in physical activity, however no other parameters measured showed consistent 
relationships across the different levels of physical activity (Table A.2, Appendix 10).
The baseline measure of basal HO-1 protein in lymphocytes and monocytes was 
modestly correlated with duration of time engaged in vigorous activity (intensity greater 
than six METS) (rho = 0.351, P = 0.093 and rho = 0.413, P  = 0.045, in lymphocytes and 
monocytes, respectively) (Table A.2, Appendix 10). The sample was divided into two 
groups based on the amount of time spent engaged in vigorous activity (top and bottom 
50%). The mean activity in the top 50% was 193 ± 59 min vigorous physical activity 
compared to 61 ± 3 9  min for the lower 50%. The basal level o f HO-1 protein in 
lymphocytes and monocytes at baseline was also examined using threshold duration of 
vigorous physical activity set at arbitrary limits of 60 and 120 min (Figure 6.14). 
Significantly higher levels of basal HO-1 protein were found in lymphocytes and 
monocytes of individuals who engaged in more than 120 min vigorous activity 
(P = 0.011 and P  = 0.007 for lymphocytes and monocytes, respectively) or were in the 
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Figure 6.14 Threshold exercise duration o f vigorous physical activity (intensity greater 
than six METS) associated with basal HO-1 protein in lymphocytes and monocytes. 
Thresholds o f 60 min (A), and 120 min (B) were analysed. Groups relating to physical 
activity duration were formed with the top 12 durations in the high group (high) and the 
lowest 12 durations in the low group (low) (C). ** denotes a significant difference 
between basal HO-1 expression and threshold duration o f vigorous exercise (P < 0.01), 
* (P < 0.05). Values are mean ± S.D. (n=24).
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6.4 Discussion
In the present investigation, three weeks of intervention (tomato supplementation versus 
no tomatoes) resulted in an approximately three-fold higher level of plasma lycopene in 
the tomato supplementation condition demonstrating that plasma lycopene levels were 
successfully modulated. The HO-1 protein response to H2O2 treatment and the basal 
level of HO-1 protein were not affected by the intervention and, therefore, increased 
plasma lycopene concentration does not modulate HO-1 protein expression in 
lymphocytes and monocytes. Additionally, tomato supplementation did not alter cell 
viability following H2O2 treatment, although a significant reduction in apoptosis was 
found at basal levels in the tomato supplemented trial.
Epidemiological studies demonstrate an inverse relationship between tomato 
consumption and risk of cancer (Giovannucci, 1999; Lu et al., 2001; Giovannucci et al.,
2002). Rao and Agarwal (1998) used a variety of tomato products providing up to 150 
mg lycopene per day and demonstrated a reduction in lipid peroxidation (TBARS), 
protein thiols and DNA damage. Based on these findings, recommendations for a daily 
lycopene intake of 25-30 mg were made (Rao and Agarwal, 1999). Recently these 
observations have been demonstrated using low dose supplementation and an intake of 5 
to 10 mg is recommended (Rao and Shen, 2002). In the present investigation, subjects 
were supplemented with 7 mg lycopene daily. This resulted in a 3-fold higher plasma 
lycopene concentration in the tomato trial. Other studies using between 5 and 30 mg 
lycopene daily have observed a 3-fold increase in plasma lycopene concentration 
(Gartner et al., 1997; Chen et al., 2001). Lycopene concentration of lymphocytes was 
not measured in the present investigation, although in a different study using the same 
amount of supplemented lycopene (and p-carotene), lymphocyte lycopene concentration 
increased ~2-fold (Porrini and Riso, 2000).
There is limited research examining changes in HO-1 expression following lycopene 
supplementation, although many studies have demonstrated that supplementation with 
other antioxidants has a suppressive effect on HO-1 induction (Ossola et al., 1997; Pinot 
et al., 1997; Yamaguchi et al., 1997; Bomman et al., 1999; Peng et al., 2000). In the 
present investigation, tomato supplementation did not affect HO-1 protein induction in 
response to treatment with H2O2. As shown previously (Chapter 4), HO-1 protein 
induction increased significantly 48 h following recovery from treatment in both the 
tomato and no tomato trials. As the plasma lycopene concentration increased and did not
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alter the HO-1 protein response to treatment, the findings from the present investigation 
show that HO-1 protein induction is not modulated by three weeks supplementation with 
tomatoes.
At present, only one human supplementation trial has reported a down-regulated 
expression of HO-1 protein in lymphocytes following oxidative stress (Peng et a l , 
2000). In this investigation, subjects were supplemented daily with a mixed antioxidant, 
taken for five weeks. In the supplemented group, total plasma antioxidant status 
increased and was accompanied by reduced levels o f MDA and protein carbonyl 
formation, reflecting an attenuation of oxidative stress. In the antioxidant supplemented 
group, exposure of lymphocytes to a free radical generator (AAPH) following initial 
heat shock, resulted in enhanced HSP synthesis and reduced HO-1 protein induction 
when compared to the responses of individuals prescribed the placebo. The findings 
from this study demonstrate that antioxidant status differentially modulates the synthesis 
of stress proteins. Khassaf and co-workers (2003) demonstrated lymphocytes from 
vitamin C supplemented individuals had a reduced induction of HSP60 and HSP70 
synthesis in response to H2O2 treatment. This finding was supported by an increased 
expression of basal HSP60 and SOD and CAT activities in vitamin C supplemented 
subjects. According to the inducibility relationship presented by Boshoff and colleagues 
(2000), the increase in basal expression of HSP60 following supplementation may 
account for the decrease in its induction in response to H2O2 treatment. In the present 
investigation, tomato supplementation did not alter HO-1 protein induction following 
H2O2 treatment or the basal expression of HO-1 protein in lymphocytes or monocytes. 
The basal level of HO-1 protein was not reported in the study conducted by Peng et a l
(2000) and so it is difficult to know whether the reduced induction of HO-1 that these 
authors observed with antioxidant supplementation was accompanied and/or explained 
by altered basal HO-1. Although previous research has shown that oxidant-responsive 
proteins can be altered through antioxidant supplementation, the findings from the 
present study did not observe any change in the level of HO-1 protein at baseline. 
Furthermore, this finding was supported by the lack of modulation of HO-1 protein 
induction following H2O2 treatment. Collectively, the current investigation demonstrates 
that three weeks of tomato supplementation does not modulate any aspect of HO-1 
protein expression.
The findings reported from in vitro studies provide conflicting evidence regarding the 
effects of antioxidant supplementation and HO-1 expression. The addition of lycopene 
to the culture medium over a range of concentrations (0.1 to 8 .8  pM) led to a 
suppression of UVA-induced HO-1 mRNA at 100 and 250 kJ.m ' 2 (Trekli, 2003). In
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contrast, incubation with 0.5 pM lycopene led to an increased induction of HO-1 mRNA 
in skin fibroblasts following UVA irradiation (500 kJ.m'2) (Offord et al., 2002). As the 
doses of UVA used in these investigations were not the same, the discrepancy in the 
results may be explained by this factor. Interestingly, skin fibroblasts treated with 
epicatechin did not show differences in UVA-induced expression of HO-1 mRNA at 
intermediate doses although at high UVA doses (500 k J .m '), epicatechin significantly 
increased HO-1 mRNA accumulation (Basu-Modak et al., 2003). This increase in HO-1 
mRNA may reflect an increase in oxidative stress with antioxidant treatment. It is 
possible that antioxidants provide protection against modest oxidative stress, whereas 
during more severe oxidative stress antioxidants may interact with oxidants to 
exacerbate oxidative stress. According to this contention, antioxidant treatments with 
stimuli that induce a high degree of oxidative stress may not be protective and could 
lead to augmented oxidative stress. Within this context it is noteworthy that in the 
present investigation, a non-lethal dose of H2O2 was used to induce HO-1 and this was 
unaffected by tomato supplementation.
Apoptosis is induced in human lymphocytes following ex vivo treatment with H2O2 
(Marini et al., 1996a). In the present investigation, apoptosis was induced in human 
lymphocytes 18 h following recovery from ex vivo treatment with H2O2. Lycopene 
supplementation provides protection against H2 0 2 -induced DNA damage (Riso et al., 
1999; Porrini and Riso, 2000) and therefore may modulate cell viability following H2O2 
treatment. In the present study, tomato supplementation did not affect the proportion of 
live, apoptotic and necrotic lymphocytes in response to treatment with H2O2. Although 
plasma lycopene concentrations increased, the degree of oxidative stress induced by 
H2O2 treatment was the same in both trials as HO-1 protein was induced to the same 
level. Therefore, the present findings demonstrate that tomato supplementation does not 
modulate the mode of cell death in response to H2O2 treatment and that this may 
represent the failure of lycopene to successfully modulate the degree of oxidative stress 
induced by hydrogen peroxide treatment.
Interestingly, in basal conditions, there was a significant increase in the proportion of 
live lymphocytes and a decrease in the percentage of apoptotic lymphocytes after three 
weeks of tomato supplementation. It is not clear what explains these results, although, 
because HO-1 remained unchanged, it seems unlikely that this was through an oxidant- 
mediated mechanism. Many hormones and growth factors are capable of inducing and 
facilitating apoptosis under physiological or pathological conditions, or both (Kiess and 
Gallaher, 1998). The protection afforded by lycopene may involve hormonal and 
immune system modulation (Rao and Agarwal, 1999). Previous research has
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demonstrated lycopene interferes with autocrine/paracrine loop by down-regulating sex 
steroid hormones and growth factor activation and signalling in the prostate (Siler et al., 
2004). Hence, in the present study, it is possible that reductions in the level of 
circulating hormones such as insulin-like growth factor-1 (IGF-1) may be the cause of 
the decrease in apoptosis at basal levels. Apoptosis is essential to normal development 
and removes dysfunctional cells. A reduction in apoptosis may not necessarily be a 
beneficial process; however, current therapies shown to improve patient outcomes in 
atherosclerosis reduce apoptosis in atherosclerosis as part of their action (Stoneman and 
Bennett, 2004). As lymphocytes play an important role in early atherosclerosis it is 
possible that lowered lymphocyte apoptosis is beneficial. However, based on the 
findings reported in this thesis, it is not possible to either explain the reduction in 
apoptosis or draw conclusions about the significance of this finding.
In the present investigation, the level of physical activity undertaken by each subject 
was estimated over a one week period using a combined heart rate monitor and 
accelerometer. People who are regularly active obtain beneficial adaptations from 
exercising which protect them against the risk of disease. These adaptations include an 
increase in the level of endogenous antioxidant enzymes, lowering the pro-oxidant state 
of the body (Powers et al., 1999; Powers and Sen, 2000; Miyazaki et al., 2001). 
Therefore, individuals who take part in regular exercise may respond to oxidative stress 
in a different manner to those individuals who are inactive. Furthermore, if  individuals 
have gained adaptations to exercise, they may respond differently to antioxidant 
supplementation. In the present investigation, the duration of weekly physical activity 
ranged from 10 min of moderate intensity activity to 471 min of activity consisting of 
moderate and high-intensity work. Current exercise recommendations suggest a 
minimum of 30 min accumulated moderate intensity activity at least five times a week 
(Brooks et al., 2004; DoH, 2004). In the current study, eight people did not fulfil the 
recommended criteria, participating in less than 150 min of moderate intensity exercise 
per week.
Previous research has shown that highly trained athletes have a lower basal level of 
HO-1 protein (Niess et al., 1999b) and a higher level of apoptosis at rest (Mooren et a l ,
2004). In the present study, individuals that engaged in more than 120 min of vigorous 
physical activity per week had significantly higher levels o f basal HO-1 protein in both 
lymphocytes and monocytes. Interestingly, five consecutive days of one-legged knee 
extensor exercise increased basal HO-1 mRNA in skeletal muscle by 2-fold when 
compared to the control leg (Pilegaard et al., 2000). This finding demonstrates that the 
exercised leg was exposed to oxidative stress resulting in an increase in HO-1.
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Consequently, this may represent an adaptation to regular exercise or be related to the 
last acute bout of exercise. Fehrenbach and colleagues (2003a) demonstrated that the 
basal level of HO-1 protein was different in two groups of endurance exercisers. In a 
previous investigation, the same group showed that basal HO-1 protein was lower in 
trained athletes prior to participating in a half marathon (Niess et al., 1999b). In contrast, 
the second paper by this group showed that trained endurance athletes in the eccentric 
exercise group did not show lower basal HO-1 protein when compared to the untrained 
group (Fehrenbach et a l , 2003a). Interestingly, the untrained group participated in less 
then 3 h physical activity per week (Fehrenbach et al., 2003a) and, in the present 
investigation, it was demonstrated that 2  h vigorous physical activity per week was 
sufficient to increase basal HO-1 protein. Additionally, the amount of time in which 
subjects refrained from exercise differed in these studies, ranging from three days in the 
present investigation up to one week (Fehrenbach et al., 2003a). Ultimately, this could 
affect basal HO-1 protein as the length of time required for the acute responses to 
exercise to return to ‘normal’ conditions is not known and this needs to be investigated 
in order to be able to effectively compare the basal level o f HO-1 protein in groups of 
active individuals.
The present work did not find any other relationships between physical activity and cell 
viability or the responses to H2O2 treatment. However, in the current study the subjects 
recruited were mostly active and it may be possible that tomato supplementation of 
physically active people does not affect their responses versus no supplementation, as 
these individuals already benefit from increased antioxidant protection afforded through 
regular exercise. It is plausible that antioxidant supplementation of habitually active 
people is ineffective because of adaptations (Clarkson and Thompson, 2000). 
Alternatively, antioxidant supplementation could also simply replace endogenous 
defences and this would probably not be justified. However, sedentary people do not 
benefit from these adaptations and may benefit from supplementation if  they are not 
convinced to become more active. Therefore, future work should look at 
supplementation in sedentary populations who have not benefited from the adaptations 
to regular exercise.
In summary, tomato supplementation increases plasma lycopene concentration although 
this does not modulate the level of basal or induced HO-1 protein in human lymphocytes 
and monocytes. In addition, the mode of cell death in response to H2O2 treatment was 
unaffected by tomato supplementation. However, basal levels of lymphocyte apoptosis 
were significantly reduced in the tomato supplemented trial. This finding appears to be 
mediated by a non-oxidative mechanism of lycopene since the expression of the
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oxidant-sensitive protein HO-1 was unchanged. Individuals engaging in more than 120 
min of vigorous physical activity had higher basal levels of HO-1 expression. As the 
level of physical activity of the subjects used in this trial was high, this may have 
affected the response to tomato supplementation. The WHO (2002) estimate that 
approximately 60% of the global population do not achieve current physical activity 
guidelines. This large inactive population are more at risk of developing chronic 
diseases and therefore, future investigations should examine whether antioxidant 
supplementation is effective in modulating the expression of oxidant-responsive genes 
in this group of people. Furthermore, because of the effect o f regular exercise on 
antioxidant defences, it is recommended that researchers should not look at antioxidant 




A common element of all inducers of haem oxygenase-1 (HO-1) is their ability to 
induce oxidative stress (Morse and Choi, 2002). Consequently, HO-1 expression is a 
marker o f oxidative stress (Tyrrell and Basu-Modak, 1994; Offord et al., 2000). 
Conditions which disturb the balance between free radicals and antioxidants will result 
in oxidative stress and, therefore, affect the expression of HO-1. In this thesis, two 
models of oxidative stress were employed in human mononuclear cells; (i) a ‘whole 
body’ approach using acute exercise and (ii) ex vivo H2O2 treatment. The ex vivo model 
was superimposed upon the exercise model to determine whether an acute bout of 
demanding exercise alters the response to an exogenous oxidant challenge. The ex vivo 
treatment model was judged to be a better inducer of HO-1 protein when compared to 
acute exercise and therefore this model was subsequently used with tomato 
supplementation to investigate whether it was possible to modulate the induction of 
HO-1.
The main findings reported in each Chapter of this thesis are listed below:
• HO-1 mRNA induction in mononuclear cells is variable following a half marathon
race (Chapter 3).
• The basal level of HO-1 mRNA is higher prior to exercise than rest (Chapter 3).
• The induction of HO-1 protein in human lymphocytes ex vivo is maximal 48 h 
following exogenous H2O2 treatment and this is a reproducible response (Chapter 4).
• The induction of HO-1 mRNA following intermittent exercise is variable and was 
not accompanied by an increase in HO-1 protein (Chapter 5).
• At 2 h post-exercise, there is a reduced ability of lymphocytes to induce HO-1
protein induction 48 h following ex vivo H2O2 treatment (Chapter 5).
• Tomato supplementation increased plasma lycopene concentration and did not alter 
any aspect of HO-1 protein expression (Chapter 6 ).
• In basal conditions, the proportion of live lymphocytes increased and the percentage 
of apoptotic lymphocytes decreased following tomato supplementation (Chapter 6 ).
• Individuals who engaged in vigorous physical activity levels had higher basal HO-1 
protein levels at baseline (Chapter 6 ).
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The exercise-induced increase in HO-1 mRNA in human mononuclear cells appears to 
be a variable response (Chapters 3 and 5). This observation was also demonstrated by 
Thompson and colleagues (2005) following continuous running at 70% V0 2 max where 
one subject had a pronounced response of a 20-fold increase in HO-1 mRNA 24 h post­
exercise. There are several possible explanations why individuals respond differently to 
exercise. The subjects used in the current investigations had either been training 
specifically for a half marathon race (Chapter 3) or habitually participated in intermittent 
activities in their leisure time (Chapter 5). Inevitably, the absolute amount o f training 
and the quality of training varied between individuals and it is possible that the varied 
HO-1 response to an acute bout of exercise is partly explained by differences in training. 
Regular exercise leads to adaptations including increased levels of antioxidant enzymes 
(Powers and Sen, 2000) and antioxidant molecules such as vitamin C (Robertson et a l , 
1991) and this may lead to differences in the degree of oxidative stress induced by an 
acute bout of exercise. Alternatively, there may be a genetic explanation for these 
differences. Recently, a polymorphism in the promoter region o f the HO-1 gene has 
been discovered (Yamada et al., 2000; Kaneda et al., 2002; Hirai et a l , 2003; Exner et 
a l , 2004) and this has been shown to influence the inducibility of the HO-1 response.
Interestingly, the results presented in this thesis further confirm the variability in HO-1 
induction since, although HO-1 induction 48 h following H2O2 treatment was a 
reproducible response, there was considerable inter-individual variability with the fold 
increase in HO-1 protein in lymphocytes ranging from 1.4 fold to 4.6-fold (Chapter 4). 
Inter-individual variability in lymphocyte HO-1 protein induction has been shown in 
several investigations using H2O2 (Marini et a l , 1996a), heavy metals (Menzel et a l , 
1998) and HBO (Speit et a l , 2000). This variability in HO-1 induction may be a useful 
property in that this clearly shows that people respond to oxidative stress in differing 
degrees. However, it is not known to what degree variations in the ability to induce HO- 
1 are related to differences in the degree of oxidative stress experienced by tissues or 
other factors such as genotype. It is possible that the variability in HO-1 induction may 
affect the use o f this gene as a marker of oxidative stress in cross-sectional studies 
where it may be used as a stand alone measurement taken on a single occasion. 
Consequently, a measure of HO-1 induction in isolation may be meaningless and this 
should be investigated further to strengthen the application of HO-1 in these types of 
studies. However, HO-1 provides a useful marker of oxidative stress in trials of a cross­
over design such as those employed in the present thesis where people act as their own 
controls.
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Acute exercise initiates oxidative stress and an inflammatory response. In principle, it is 
possible that the increase in HO-1 mRNA may be directly mediated by exercise-induced 
oxidative stress during the exercise itself or that HO-1 induction is a response to 
oxidative stress caused by exercise-induced inflammation. Previous investigations have 
shown prolonged exercise induces HO-1 mRNA (Thompson et al ,  2005) and HO-1 
protein (Niess et al., 1999b; Thompson et al., 2005) in human lymphocytes. Both these 
studies demonstrated an increase in pro-inflammatory cytokines, with one of these 
investigations reporting a positive relationship between plasma IL-8 concentration and 
HO-1 protein induction (Niess et al., 1999b). In the present thesis, both acute exercise 
protocols demonstrated significant increases in plasma IL-6 concentration post-exercise 
(Chapters 3 and 5). Interestingly, a positive relationship was observed between the fold 
increase in plasma IL-6 and the peak fold increase in HO-1 mRNA accumulation 
following a half marathon race and intermittent running. When the results for both trials 
are pooled, a modest positive relationship was found between the fold change in peak 
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Figure 7.1 The relationship between the peak fold increase in IL-6 concentration and the 
peak fold increase in HO-1 mRNA expression following acute exercise (r = 0.536, 
P  = 0.032) (n=16, pooled data from Chapter 3 and Chapter 5).
Although a positive relationship between the anti-inflammatory cytokine IL-10 and 
HO-1 mRNA expression was demonstrated, this was not statistically significant 
(Chapter 5). Collectively, these results tentatively suggest that induction of HO-1 in 
lymphocytes following exercise may be related to the pro-inflammatory effect of an 
acute bout o f exercise. With this in mind, it is also possible that the delayed induction of 
HO-1 protein in the ex vivo model could be mediated by cytokine-induced oxidative
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stress. This delayed induction was demonstrated in osteoarthritic chondrocytes 
following incubation with IL-10 (Fernandez et a l ,  2003) and therefore, HO-1 induction 
may mediate the protective effects o f IL-10. Within this context, and because it appears 
that HO-1 is directly responsible for the anti-inflammatory effects of IL-10 (Lee and 
Chau, 2002), future work should investigate the relationship between pro- and anti­
inflammatory cytokines and the induction of HO-1 in vivo and in vitro.
Acute exercise induces an immune response which is characterised by changes in the 
cell number of leukocyte subpopulations (Field et a l ,  1991; Hoffman-Goetz and 
Pedersen, 1994). In the hours following exercise, there is a decline in the number of 
lymphocytes which generally falls below normal levels. Several investigations have 
shown that lymphocyte responses to mitogen stimulation are lowered in the recovery 
period (0-2 h) following exercise (Field et a l,  1991; MacNeil et a l ,  1991; Nielsen,
2003). The post-exercise decline in lymphocyte concentration is not accompanied by a 
compensatory increase in lymphocyte function and, consequently, the lymphocyte 
function in the blood is considered to be suppressed (Pedersen and Hoffman-Goetz,
2000). This suppression of immunity post-exercise may last between 3 and 72 h and is 
often described as an ‘open window’ to infection (Nieman and Pedersen, 1999). In the 
present thesis, 2 h post-exercise the induction of HO-1 protein following ex vivo H2O2 
treatment was significantly reduced when compared to the corresponding time point in 
the rest trial (Chapter 5). The 2 h time point coincided with the time at which 
lymphocyte cell number was lowest. Although speculative, one possible interpretation 
of this phenomenon is that the lack of induction o f HO-1 is in someway directly 
involved in post-exercise immuno-suppression. The failure to induce HO-1 could be 
representative of a general suppression of cellular responses to any given stimulus and 
indicate a maladaptive response to demanding exercise.
Alternatively, the lower induction of HO-1 protein following ex vivo treatment post­
exercise may be related to other protective mechanisms which are induced by 
demanding exercise. For example, acute exercise increases the expression of antioxidant 
enzymes in lymphocytes (Tauler et a l,  2003) and has been shown to up-regulate the 
expression of HSP in leukocytes immediately following prolonged running (Fehrenbach 
et a l,  2000a; Fehrenbach et a l ,  2000b). Both these responses enhance the antioxidant 
defence system and this increased protection may attenuate the degree of oxidative 
stress induced by a subsequent stressor, resulting in a lower induction of HO-1 to a 
second stimulus. Therefore, it is possible that exercise ‘conditions’ lymphocytes and 
generates an adaptive response that protects lymphocytes against subsequent oxidative 
stress. As the increase in HO-1 mRNA following intermittent exercise was not as large
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as anticipated and was not accompanied by increased HO-1 protein, it is possible that 
the reduced ability of lymphocytes to induce HO-1 protein in response to ex vivo 
treatment would be greater if  prolonged exercise was used as the initial HO-1 inducing 
stimulus. Additionally, a more pronounced decline in lymphocyte concentration would 
occur and this may represent an increased susceptibility to subsequent oxidative 
challenge in vivo.
In the present thesis, the induction of HO-1 in response to treatment was not related to 
the basal expression of the gene (Chapters 3 and 5). In fact, the basal level of HO-1 
mRNA accumulation was significantly higher prior to the half marathon race and this 
may have masked the induction of HO-1 mRNA post-exercise (Chapter 3). It is possible 
that the higher basal HO-1 mRNA in these individuals can be explained by the intense 
period of training in the months preceding the race and that one of the adaptations to 
regular exercise is an increase in basal HO-1. This adaptive response to regular exercise 
was demonstrated in skeletal muscle with a 2-fold increase in HO-1 mRNA found in the 
exercised leg when compared to the control leg following five days of consecutive 
exercise (Pilegaard et a l , 2000). Alternatively, it is possible that increased basal 
expression of HO-1 mRNA is influenced by anxiety prior to competition in the 
knowledge that demanding exercise is imminent. Since catecholamines are known to be 
powerful pro-oxidants (Halliwell and Gutteridge, 1999), it is possible that they induce 
HO-1. Although there is no evidence that catecholamines induce HO-1 in leukocytes, 
several investigations have demonstrated that catecholamines induce HO-1 mRNA 
accumulation and HO-1 protein in endothelial cells and astrocytes in vitro (Schmidt et 
al., 1999; Berger et al., 2000; Khorchid et al., 2002). Indeed, increased basal HO-1 was 
observed in seven out o f eight individuals prior to the exercise trial (Chapter 5). As trial 
order was randomised and had no affect on basal HO-1 expression, this finding was 
related to the exercise trial alone. One implication from this finding is that in future 
work subjects should arrive in the laboratory without knowing whether they will 
participate in rest or exercise trials.
An increased level o f basal HO-1 protein was demonstrated in individuals who engaged 
in vigorous physical activity (> 6  METS) (Chapter 6 ). One potential explanation for this 
phenomenon is that regular vigorous physical activity increases the expression of HO-1 
through repeated ‘exposure’ to exercise-induced oxidative stress and that the increase in 
HO-1 is similar to the increases previously observed for antioxidant enzymes such as 
SOD (Miyazaki et al., 2001). In contrast, other investigators have reported a lower level 
of HO-1 protein in leukocytes of trained athletes (Niess et al., 1999b; Fehrenbach et a l ,  
2003a) and this was suggested to represent the lower pro-oxidant state of the athlete.
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Ostensibly, it may appear difficult to reconcile these contradictory findings. However, it 
is possible that the expression of oxidant-responsive genes in highly trained athletes is 
different to individuals who are ‘regularly active’ (Chapter 6 ). With this in mind, Sen 
(1995) suggested that elite athletes may benefit from antioxidant supplementation as the 
changes derived from regular exercise training may not be enough to suppress exercise- 
induced oxidative stress. Alternatively, the differences in basal HO-1 protein may be 
related to the effects of the last acute bout of exercise, as the time for these responses to 
return to baseline levels is not known. In the studies showing that trained individuals 
had lower basal levels of HO-1 protein, subjects refrained from ‘intense’ exercise for up 
to one week, whereas in the present investigation this was three days. Because of the 
potential importance o f HO-1 in lymphocyte and monocyte function, future experiments 
should seek to determine whether there is a dose-response between exercise and HO-1 
expression, and whether extremely demanding regular exercise is associated with 
suppressed basal HO-1.
Antioxidant supplementation enhances the body’s natural defence system and can 
attenuate oxidative stress. Traditionally, it is believed that excessive free radical 
production is ‘harmful’ and that antioxidants are beneficial to cells (Jackson et a l , 
2002). The regulation of oxidant-responsive genes is determined by redox status and 
therefore, antioxidant supplementation has the potential to modulate the expression of 
these genes (Jackson et a l , 1998; Jackson et al., 2002). As genes such as HO-1 are up- 
regulated and offer protection to cells, it is not known whether altering the response to 
oxidative stress through antioxidant supplementation is beneficial or deleterious to the 
tissue (Khassaf et a l , 2003). In the present thesis, tomato supplementation significantly 
increased plasma lycopene concentration but did not modulate HO-1 expression at basal 
levels or in response to H2O2 treatment (Chapter 6 ). The subjects used in the present 
investigation were mostly active; two thirds of individuals attained exercise 
recommendations with ~50% of this group achieving double the amount of 
‘recommended’ minutes at the appropriate intensity per week. As the HO-1 protein 
response in these individuals did not differ with or without tomato supplementation it is 
possible that individuals who are vigorously active and have benefited from adaptations 
to regular exercise do not benefit further from supplementation. There is evidence that 
people who are physically active are protected against many o f the same diseases where 
lycopene also offers protection (Erikssen et a l , 1998; Hu et a l , 2000; Wannamethee et 
al., 2001; Lee, 2003) and therefore, it is possible that people who are active ‘regularly’ 
already have increased antioxidant protection. It is not known whether people who 
participate in mostly moderate physical activity respond to antioxidant supplementation 
and this is an area which warrants further investigation. Perhaps this could be examined
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by adopting a differentiated supplementation study whereby antioxidants are provided to 
people who choose to be sedentary or are highly active.
Physical inactivity potentiates at least 20 unhealthy conditions (Booth et al., 2002) and, 
since oxidative stress is also involved in many o f these conditions, people leading a 
sedentary lifestyle may benefit from antioxidant supplementation. In the present thesis, 
tomato supplementation significantly lowered basal lymphocyte apoptosis without 
modulating the expression of HO-1. Therefore, it appears that the reduction in apoptosis 
occurred via a non-oxidative mechanism derived from lycopene supplementation. 
Apoptosis is induced by a number of hormones (Kiess and Gallaher, 1998) and therefore 
it is possible that the reduction in apoptosis may be related to decreased levels of 
circulating hormones, such as IGF-1 and prostate specific antigen (PSA), observed 
following lycopene supplementation (Bowen et al., 2002; Siler et a l , 2004; Tang et a l ,
2005). Apoptosis is a functionally important mechanism designed to eliminate non­
functional or abnormal cells and, ostensibly, this may not seem a beneficial effect of 
tomato supplementation. However, with reference to the cancer literature, the 
therapeutic gain achieved by suppressing apoptosis in normal tissues may be just as 
important as that gained through increasing apoptosis in cancerous tissues (Milas et a l , 
1994). Furthermore, lymphocytes play an important role in atherosclerosis (Song et a l ,
2 0 0 1 ) and anti-apoptotic therapy may reduce the initiation, progression or clinical 
consequences of atherosclerosis (Stoneman and Bennett, 2004). Although it is premature 
to draw major conclusions from the present investigation, it is noteworthy that high 
lycopene intakes are associated with reduced risk o f cardiovascular disease (Kohlmeier 
et al., 1997; Rissanen et al., 2003). Therefore, in some instances, a reduction in 
lymphocyte apoptosis may be a beneficial process and future work should explore the 
non-oxidant mediated functions of lycopene.
Over 60% of the global population are described as sedentary (WHO, 2002). It is 
possible that these individuals would respond to tomato supplementation in a different 
manner to the habitually active individuals used in the final study reported in this thesis. 
Therefore, future work should examine the impact of antioxidant supplementation 
(including lycopene) in a sedentary population as this group of people may benefit more 
from a nutritional intervention than individuals who are frequently active. In addition, it 
is also quite possible that elite athletes involved in extremely demanding training 
schedules could also benefit from antioxidant intervention. What appears more certain, 
however, is that because the absolute level of regular physical activity has a direct role 
in modulating antioxidant defences, investigators should take this into account when 
designing future experiments that aim to examine the impact o f dietary modification.
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APPENDICES




It is important that volunteers participating in research studies are currently in good 
health and have had no significant medical problems in the past. This is to ensure (i) 
their own continuing well-being and (ii) to avoid the possibility of individual health 
issues confounding study outcomes.
Please complete this brief questionnaire to confirm fitness to participate.
1 . At present, do you have any health problem for which you are:
(a) On medication, prescribed or otherwise Yes □ No □
(b) Attending your general practitioner Yes □ No □
(c) On a hospital waiting list Yes □ No □
2 . In the past two years, have you had any illness which requires you to:
(a) Consult your GP YesD No □
(b) Attend a hospital outpatient department YesD No □
(c) Be admitted to hospital YesD No □
3. Do you, or have you ever had, any of the following: 
(a) Convulsion/epilepsy YesD No □
(b) Asthma Yes □ No □
(c) Diabetes Yes □ No □
(d) Any blood disorder Yes □ No □
(e) Head injury Yes □ No □
(f) Digestive problems Yes □ No □
(g) Heart problems Yes □ No □
(h) Problems with bones or joints Yes □ No □
(i) Disturbance of balance/co-ordination Yes □ No □
(j) Ear/hearing problems Yes □ No □
(k) Thyroid problems Yes □ No □
193
(1) Kidney or liver problems Y esD  No □
(m) Problems with your diet Yes □  No □
If YES to any question, please describe briefly if  you wish (e.g. to confirm whether the 
problem was/is short-lived, insignificant or well-controlled).
Yes □  No □
Yes □  No □
Yes □  No □
Yes □  No □
Signature __________________________
Date __________________________
Additional questions for female participants
(a) Are your periods normal/regular?
(b) Are you on ‘the pill’?
(c) Could you be pregnant?
(d) Are you on hormone-replacement therapy?
BELOW : To be completed on subsequent visits to the laboratory, when these visits are 
more than one week after the form was first completed.
Please read the form again. If anything has changed since your first visit, please use the 
space below to provide information:
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Appendix 2: Activity Status Questionnaire
How many times per week do you exercise?
Do you exercise individually or with others, please specify?
Eg. 30 min run by myself, passing practice with team mates
Which sport (s) do you partake in on a regular basis i.e. weekly?
In your opinion, what do you view as aerobic exercise?
In your opinion, what do you view as challenging exercise?
How many years have you participated in your main sport?







Please detail a typical weekly training schedule (table 1) including the categories below. 
This can be broken up in to daily sessions of exercise for ease. Please specify the 
duration for each category that applies to you.
Warm up (WU)/ Recovery work (R) (HR <140 bpm) eg. 20 min W and 10 R
Low intensity aerobic exercise (LI) (HR 140-160 bpm) eg. 30 + min
Moderate intensity exercise (MI) (HR 160-175 bpm) eg. 10-30 min
High intensity exercise (HI) (HR 175+ bpm) eg. Sprints, max effort
Strength/ Resistance work (S)
Skill specific work (drills) (SS)
Other
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Appendix 3: Foods containing lycopene
These foods contain lycopene. Please avoid all these foods for the whole 8 weeks of the 














Curry sauces (tomato based)
Dried parsley 










Salad dressing, French 
Salad dressing, Italian 
Salsa
Seafood sauce 
Spaghetti in tomato sauce 
Sun dried tomatoes 
Sweet & sour sauce 
Thousand Island dressing
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Tomato paste, w/o salt 
Tomato puree, w/o salt 
Tomato sauce, pasta based 
Tomato sauce 
Tomato condensed soup 
Tomato soup 
Vegetable juice 
Vegetable juice cocktail 
Vegetable soup 
Watermelon
The meals below contain some of the foods listed, so take care to avoid these in 
particular:
Spaghetti bolognaise 
Chilli con came 
Lasagne






Appendix 4: Cell viability following H 2O2 treatm ent
TK6 cells were treated with H2O2 in serum free media (SFM) or PBS for 30 min and 
cell viability was determined immediately following treatment using the MTT [3-(4,5- 
dimethylthizol-2-yl)-2,5-diphenyltetrazolium bromide] assay. The MTT assay is based 
on reduction o f the tetrazolium salt, MTT, by actively growing cells to produce a blue 
formazan product (Berridge and Tan, 1993). The level o f MTT cleavage by viable cells 
and hence the amount o f formazan produced, is directly proportional to the cell number, 
enabling quantification o f viable cells and cytotoxicity (Gerlier and Thomasset, 1986).
Briefly, MTT stock solution was dissolved in SFM (1 ml o f 5 mg/ml MTT diluted in 10 
ml SFM) and added to cells following the recovery incubation. Samples diluted in MTT 
were added in triplicate (200 pl/sample) to a 96 well plate, and incubated for 3 h at 37 
°C. Following incubation, the MTT solution was aspirated and 100 pi DMSO was added 
to each well prior to analysis in a microplate reader at 550 nm (MR5000, Dynatech 
Laboratories, West Sussex, UK).
A paired t statistic was performed showing no differences in the cell viability between 
treatment media (P > 0.05) (Figure A .l). As a result, PBS was the treatment media of 











0 20 50 100 250 500
H20 2 concentration (pM)
Figure A .l Cell viability of TK6 cells immediately following 30 min treatment with 
H2 O2 in serum free media (SFM) or PBS. Values are mean ± S.D. (n=3).
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Figure A.2 The fold change in HO-1 mRNA expression following running at 75 min at 
70% V0 2 inax demonstrating the reproducibility o f the various stages of real-time RT- 
PCR, with the light cycler being used for three separate reverse transcriptions of the 
same RNA (A) and three separate light cycler runs on one aliquot of cDNA (B). The 
fold change in HO-1 mRNA was calculated by normalising to GAPDH, and then 
expressed relative to baseline (Pre). Pre: pre-exercise, Post: 0 h post-exercise. Values are 
mean ± S.D. (n=3).
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Appendix 6: Preliminary result from the intermittent treadmill protocol
The intermittent exercise protocol was performed by six individuals prior to being used 
in the main trial (Chapter 5) in order to ensure that the exercise demands and duration 
were manageable. Subjects 1 to 4 participated in intermittent sports (mainly squash, 
tennis and rugby) with subjects 5 and 6  participating in endurance activities (triathlon). 
The VC^max (m l.kg .'W n'1) are indicated for each subject with their corresponding 
speeds for the different intensities of the protocol (Table A .l). Subjects 1-3 completed 
the protocol although subjects 4-6 did not; with subject 6  only managing 20 min. The 
reasons for this may be due to their level o f fitness and efficiency of running which was 
higher in subjects 4-6 or the fact that they were not used to changing running speeds 
unlike subj ects 1 -3.
Table A .l Speeds for each subject corresponding to the three intensities of the 
intermittent running protocol and the duration of exercise completed_________________
Speed at % V 02max (km.h'1)
Subject V 02max 
(ml.kg.''min'1)
65% 85% 100% Duration
(min)
1 51.0 9.0 12.3 14.8 60
2 52.4 9.1 11.9 14.0 60
3 64.3 11.1 14.0 16.1 60
4 62.6 11.5 14.9 17.5 44
5 70.7 12.2 15.9 18.7 34
6 73.3 13.0 17.3 20.5 20
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Appendix 7: The effect of H2O2 concentration on lymphocyte viability
□  Live Sham
□  Live Treated
□  Apoptosis Sham □  Necrosis Sham
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H 20 2 C oncentra tion  (pM )
Figure A.3 The effect o f H2O2 concentration on cell viability 6  h (A) and 48 h (B) 
following 30 min incubation with H2O2 . ** denotes a significant difference between the 
sham and treated samples for a respective concentration (P < 0.01), * (P < 0.05). Values 
are mean ± S.D. (n=5).
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Appendix 8: The time course of lymphocyte viability following H 2O 2 treatm ent
□  Live Sham
□  Live Treated
□  Apoptosis Sham 
0  Apoptosis Treated
□  Necrosis Sham
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Figure A.4 The effect o f time on cell viability following 30 min incubation with 25 pM 
H2O2 (A) and 50 pM H2O2 (B). ** denotes a significant difference between the sham 
and treated samples at each respective time point (P < 0.01), * (P < 0.05). Values are 
mean ± S.D. (n=5).
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Figure A.5 Energy expenditure analysis from the acti-heart data in the least active 
individual (A) and the most active individual (B). The energy expenditure (kcal.min"1) 
represents the daily total energy expenditure (TEE = BMR + AEE).
Appendix 10: Relationships between physical activity, HO-1 and cell death
Table A.2 The relationship between min engaged in levels of physical activity and basal level of HO-1 protein and cell death (A), HO-1 protein 
response to H2O2 treatment (B) and cell death response to H2O2 treatment (C)__________________________________________________________
BASELINE NO TOMATO TOMATO
(A)
HO-1 HO-1 HO-1
Ly Mon L A N Ly Mon L A N Ly Mon L A N
Total
rho 0.310 0.284 -0.092 -0.073 0.189 -0.149 -0.156 -0.229 0.182 0.197 -0.041 0.032 -0.174 0.153 0.103
P value 0.140 0.179 0 .6 6 8 0.734 0.377 0.498 0.488 0.282 0.395 0.357 0.851 0.881 0.416 0.475 0.630
Moderate
rho 0.193 0.117 -0.166 0.017 0.252 -0.292 -0.303 -0.209 0.282 -0.174 -0.198 -.090 -0.104 -0.046 0.213
P value 0.367 0.587 0.439 0.939 0.235 0.176 0.170 0.326 0.181 0.417 0.354 0.675 0.627 0.831 0.318
Vigorous
rho 0.351 0.413 -0.15 -0.053 -0.038 0.171 0.189 -0.119 -0.026 0.525 0.194 0.218 -0.243 0.272 0.008
P value 0.093 0.045 0.944 0.807 0.859 0.434 0.399 0.579 0.904 0.008 0.364 0.307 0.253 0.199 0.971
L y :  l y m p h o c y t e s ,  M o n :  m o n o c y t e s ,  L :  l iv e  c e l l s ,  A :  a p o p t o t i c  c e l l s ,  N :  n e c r o t i c  c e l l s ,  r h o :  S p e a r m a n ’s  r a n k  c o r r e l a t i o n .  B o l d  t e x t  d e n o t e s  m o d e s t  r e l a t i o n s h i p s  ( P  <  0 .1 ) .
( n = 2 4 ) .
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Table A.2 (B) The relationship between min engaged in levels of physical activity and HO-1 protein response to H2 O2 treatment
(B)
NO TOMATO (HO-1) TOMATO (HO-1)
18 h Ly 18 h Mon 48 h Ly 48 h Mon 18 hLy 18 h Mon 48 hLy 48 h Mon
Total
rho 0.132 0 .1 2 0 0.146 0.053 -0.314 -0.014 0.017 -0.156
P value 0.539 0.575 0.497 0.806 0.135 0.948 0.939 0.467
Moderate
rho 0.087 -0.057 0.146 -0.033 -0.500 0.091 0.040 -0.067
P value 0.684 0.792 0.497 0.880 0.013 0.671 0.854 0.755
Vigorous
rho 0.260 0.384 0.148 0.168 0.106 -0.199 0.066 -0.192
P value 0 .2 2 0 0.064 0.490 0.431 0.623 0.350 0.759 0.368
L y :  l y m p h o c y te s ,  M o n :  m o n o c y t e s ,  L :  l i v e  c e l l s ,  A :  a p o p t o t i c  c e l l s ,  N :  n e c r o t i c  c e l l s ,  r h o :  S p e a r m a n ’s  r a n k  c o r r e l a t i o n .  B o l d  t e x t  d e n o t e s  m o d e s t  r e l a t i o n s h i p s  ( P  <  0 .1 ) .
( n = 2 4 ) .
Table A.2 (C) The relationship between min engaged in levels of physical activity and cell death response to H2O2 treatment
NO TOMATO TOMATO
(C)
18 h 48 h 18 h 48 h
L A N L A N L A N L A N
Total
rho 0.031 0.008 0.039 0.472 -0.449 -0.391 0.003 -0 .0 2 0 -0.004 0.004 0.251 0.267
P value 0 .8 8 6 0.971 0.856 0.041 0.054 0.098 0.987 0.926 0.986 0.989 0.300 0.270
Moderate
rho 0.213 -0.254 -0 .0 2 0 0.515 -0.487 -0.402 -0.134 -0.089 0.131 -0 .0 2 2 0.248 0.152
P value 0.319 0.231 0.928 0.024 0.034 0.088 0.532 0.680 0.542 0.929 0.307 0.535
Vigorous
rho 0.004 0.177 -0.047 0.385 -0.322 -0.402 0.168 0.101 -0.233 0.063 0.119 0.198
P value 0.984 0.408 0.827 0.104 0.179 0.088 0.433 0.637 0.274 0.797 0.629 0.418
L y :  l y m p h o c y te s ,  M o n :  m o n o c y t e s ,  L :  l iv e  c e l l s ,  A :  a p o p t o t i c  c e l l s ,  N :  n e c r o t i c  c e l l s ,  r h o :  S p e a r m a n ’s  r a n k  c o r r e l a t i o n .  B o l d  t e x t  d e n o t e s  m o d e s t  r e l a t i o n s h i p s  ( P  <  0 .1 ) .  
( n = 2 4  a t  1 8  h ,  n = 1 9  a t  4 8  h ) .
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